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Emphysema is a degenerative lung disease which, it is suggested,
results probably from repeated periods of proteinase:antiproteinase
imbalance during which excess of enzyme attacks the extracellular matrix.
Of the many enzymes produced by inflammatory cells human neutrophil
elastase (HNE) is thought to be the major offending enzyme. It attacks
elastin, which is responsible for the elastic recoil of the lung. If emphysema
was simply a result of the destruction of elastin by HNE then degradation
products of elastin would inevitably be present, at least transiently, in the
serum of patients. The aim of this project was to separate and characterise
the soluble peptides resulting from the digestion of elastin with HNE and/or
human neutrophil cathepsin G (HNCG), another neutrophilic enzyme, which
is primarily bactericidal and, to determine if any of the peptides were
characteristic of digestion by one enzyme or combination of enzymes.
HNE and HNCG were isolated from purulent sputum, and elastin was
isolated by two methods from post-mortem lungs. The digestion of the
elastin by the enzymes was followed by measuring the amino groups
liberated during the course of the digestion. A method was developed for
the measurement of the insoluble as well as the soluble products of
digestion. Initially, the amounts of soluble and insoluble products were
similar, but the amount of soluble products soon exceeded the amount of
insoluble products. The soluble products of digestion were separated by
reverse-phase chromatography. The peptides separated into two groups (A
ill
and B), regardless of which enzyme was involved in the initial digestion.
Both groups were heterogeneous mixtures of peptides. Filtration
experiments and amino acid analysis showed that the groups of peptides
differed in size and composition.
HNE digested elastin to a greater extent than did HNCG. However,
the peptide profiles produced when elastin was digested with HNE or with
HNCG did not differ obviously; consistent, specific peptides produced
exclusively as the result of the action of a particular enzyme could not be
identified.
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ABBREVIATIONS, CONVENTIONS AND BUFFERS
Abbreviations
a., Achy alpha-1 -antichymotrypsin
a-1-PI alpha-1 -proteinase inhibitor
BCA bicinchoninic acid




EDTA ethylene diamine tetra acetic acid
HNCG human neutrophil cathepsin G
HNE human neutrophil elastase
NAD+ nicotinamide adenine dinucleotide
PPE porcine pancreatic elastase





TNBS 2,4,6-trinitrobenzene sulphonic acid
Tnp-peptide 2,4,6-trinitrophenylated peptide
U A unit of enzyme activity defined as the activity
which produces one pmol of product per minute
b) Conventions- Amino acid nomenclature
The standard three letter abbreviations are used for all the natural
amino acids of the proteins and Des and Ide for the cross-links desmosine
and isodesmosine respectively throughout the thesis.
c) Buffer compositions
(i) 50mM sodium acetate buffer pH 4.5
Acetic acid was added to sodium acetate such that the final
concentrations of the acid and base were 31.75mM and 18.25mM
respectively.
(ii) 0.1 M sodium phosphate buffer. dH 8.0
A solution (approximately 90ml) containing 0.01 moles of disodium
hydrogen orthophosphate was adjusted to pH 8.0 at room temperature with
HCI. The volume was then made up to 100ml with distilled water so that the
solution was 0.1 M with respect to phosphate.
(iii) 50mM Tris-HCI. pH 8.0
A solution (approximately 480ml) containing 25mmoles of Tris was
adjusted to pH 8.0 at room temperature with HCI. The volume was then
made up to 500ml with distilled water giving a solution with a concentration
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Chronic obstructive pulmonary diseases (COPD) may be divided into
bronchitis and emphysema. Emphysema is defined as "an anatomical
alteration of the lung characterised by an abnormal enlargement of the air
spaces distal to the terminal, non-respiratory bronchiole, accompanied by
destructive changes in the alveolar walls" (Meneely et al. (1962) Am. Rev.
Respir. Dis. 8 5, 762-768).
In the early 1960's two major discoveries opened a new avenue of
research in the study of the pathogenesis of emphysema. First, Laurell and
Eriksson (1963) suggested that some emphysema is a consequence of a
genetic deficiency of alpha-1-proteinase (a-1-PI) (further elaboration of this
work was presented by Erikkson, 1965). In 1966 Kueppers and Bern
showed that a-1-PI inhibits the proteolytic enzymes of neutrophils and
Ohlsson (1971) showed that a-1-PI has a high affinity for human neutrophil
elastase (HNE). Secondly, Gross et al (1964) demonstrated that
emphysematous-like lesions could be produced by instilling papain into the
trachea of hamsters. The same type of lesions could be produced in
response to an instillation of elastase (Kaplan et al. 1973). Interestingly,
Janoff (1985a) stated that papain has been shown to possess elastolytic
activity when used in a crude form. These two discoveries were linked
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together as the proteinase:antiproteinase theory of emphysema. The theory
suggests that a deficiency of active inhibitors leads to an excess of
proteinases in the lung. These proteinases may attack the extracellular
matrix proteins of the lung and produce emphysema.
However the majority of patients who develop emphysema do not
have a genetic deficiency of a-1-PI. The genetic deficiency of a-1-PI is the
result of a homozygous recessive inheritance which produces the Pizz
phenotype. Lieberman (1969) and Hutchison et al (1971) found that only
10% and 11% respectively of patients with emphysema were Pizz
individuals, so approximately 90% of patients develop emphysema as a
result of conditions other than a genetic deficiency of circulating inhibitor.
These patients are usually smokers. The link between cigarette smoke and
emphysema gave rise to a second theory for the pathogenesis of
emphysema known as the oxidant:antioxidant theory. This theory suggests
that excess endogeneous or exogeneous oxidants can oxidatively inactivate
the inhibitors of the lung. This produces an increased proteinase burden in
the tissue which may lead to tissue destruction. However, the theory does
not explain why the majority of cigarette smokers do not develop
emphysema. Cohen (1991) summarised the present state of emphysema
research by declaring that, "All of these hypotheses remain unproven. We
have fallen into somewhat of a trap in that we have performed an enormous
number of experiments to show what may happen and very few experiments
to show what does happen".
Before any experiments can be designed to investigate a scientific
problem, it is useful to consider the results presented by previous
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investigations. This introduction will be divided into 4 sections. Each
section will examine a particular topic of importance in the study of the
destruction of a protein of the extracellular matrix during emphysema. First,
the cellular origins of HNE and the role of neutrophils in phagocytosis will be
discussed and the circumstances which may cause the cells to release
excess enzymes will be considered. Secondly, the classical mechanism of
HNE and another neutrophilic enzyme, cathepsin G (HNCG) and the natural
inhibitory mechanisms used by the lung to control these enzymes will be
discussed. Excess HNE has the potential to digest proteins of the
extracellular matrix. Elastin is one component of the extracellular matrix
which is known to be digested by HNE (Janoff and Scherer, 1968). So the
third section will review the biology of elastin. Finally, the evidence
implicating elastin digestion in the pathogenesis of emphysema, and the
potential use of degradation products will be discussed. This section will
state the aims of the work presented in this Thesis.
1.1 The role of neutrophils in the destruction of the luna
The human body contains many types of cells which protect it against
infection. A significant role is played by inflammatory cells such as
monocytes, macrophages and polymorphonuclear leukocytes, which are all
capable of producing destructive enzymes. One type of polymorphonuclear
leukocyte of some importance in defence and tissue turnover is the
neutrophil. Neutrophils are granular cells which contain many enzymes
including proteolytic enzymes such as neutrophil elastase which is found in
the azurophil granules and hydrolytic enzymes such as lysozyme which is
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found in the specific granules. They also contain oxidative enzymes such
as the reduced nicotinamide adenine dinucleotide phosphate (NADPH)
oxidase complex and myeloperoxidase.
The phagocytic mechanism used by neutrophils to protect the lung
during infection have been extensively reviewed by Ryan and Majno (1977)
and Haslett and Warren (1990). Briefly, when bacteria are inhaled the
complement system becomes activated and complement factors such as
C3b and C5a are produced. The invading bacteria become coated with
opsonins such as the complement factor C3b and neutrophils are
chemotactically attracted to the site of infection in response to the presence
of complement factor C5a. The opsonins coating the bacterium induce the
contact between the neutrophil and the bacterium and they bind together via
the C3b receptors on the neutrophil membrane. After contact the bacterium
is ingested into a phagosome in the neutrophil. The azurophil granules
merge with the phagosome (Malech and Gallin, 1987), and the enzymes in
the granule (HNE, HNCG and proteinase-3) destroy the bacterium. The
bactericidal actions of HNCG have been documented by Odeberg and
Olsson (1976). The ability of HNE and HNCG to digest the proteins of E.
coli have been documented by Blondin et al (1978). The oxidants of the
neutrophil such as hydrogen peroxide, hypochlorous acid and superoxide
radicals are also involved in the destruction of bacteria during phagocytosis
(Weiss, 1989). After the bacterium has been destroyed the remaining
oxidants are removed by enzymes such as catalase or antioxidant such as
glutathione, and the proteolytic enzymes are controlled by inhibitors with
which the enzymes form a complex. HNE:a-1-PI complexes may be
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removed by macrophages (Campbell et al. 1979). Some leakage of the
proteolytic enzymes may occur on the death of the neutrophil (Weissmann £l
al, 1980), but any leakage can be controlled by inhibitors.
So, the enzymes and oxidants used during phagocytosis to destroy
invading pathogens or in tissue turn-over are controlled by inhibitors and
antioxidants. However, the phagocytic mechanisms may be activated in
response to an irritant. Niewoeher et al. (1974) demonstrated that
polymorphonuclear leukocytes accumulate in the airspaces and tissues of
the respiratory bronchioles of cigarette smokers, and Janoff (1983)
concluded that the products of cigarette smoke can activate
polymorphonuclear leukocytes in vitro causing them to release oxygen-
derived free radicals. The excess of radicals will cause an imbalance
between the oxidants and antioxidants which can potentially cause disease.
The excess oxidants have the potential to oxidatively inactivate inhibitors
(Johnson and Travis, 1978; see Section 1.2) to produce an increase of the
proteinase burden of the lung. Similarly, if a patient has a genetic deficiency
of an inhibitor it will not be possible to establish a proteinase:antiproteinase
balance after phagocytosis, so free active enzyme may remain in the tissue
where they could potentially cause the destruction of the extracellular matrix.
There are many enzymes derived from inflammatory cells which could
reach excessive levels during a proteinase:antiproteinase imbalance. The
enzymes which have been implicated with emphysema are the elastases
(reviewed by Janoff, 1985b). Macrophages (Werb and Gordon, 1975) and
monocytes (Senior et al. 1982; Campbell et al. 1989) are both capable of
secreting elastases, but the enzyme which has attracted most attention as a
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Figure 1,1 The mechanism of action of serine proteinases (chvmotrvpsln numbering)
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causative agent in emphysema is HNE.
1.2 Characterisation of human neutrophil elastase and
human neutrophil cathepsin G
HNE (EC 3.if.21.37) is located in the azurophil granule of neutrophils
at a concentration of 3pg/cell (Ohlsson and Olsson, 1974). The other
proteolytic, azurophilic granular contents are HNCG (EC 3.4.21.20) and
proteinase-3. The three enzymes are endoproteinases which are classified
as serine proteinases along with porcine pancreatic elastase, trypsin and
chymotrypsin.
Serine proteinases have a characteristic active site triad, consisting of
histidine, serine and aspartic acid, which is located in a crevice between two
antiparallel p-barrel cylindrical domains (Bode et al. 1989). The substrate of
the enzyme is accommodated in the crevice, and proteolysis proceeds at
alkaline pH as shown in Figure 1.1.
Although the enzymes share the same catalytic mechanism and have
a great deal of sequence homology they differ in their substrate
requirements. Traditionally, the residue at the carbonyl side of the peptide
bond cleaved by an enzyme is referred to as the P-, residue of the substrate
and the residue on the amino side of the bond is the P.,' residue (Schechter
and Berger, 1967). The different substrate requirements of the various
serine proteinases are dictated by subtle differences in the sequence of the
active site of the enzyme, which leads to a requirement for substrates with
different P1 residues. For example, the active site pocket of chymotrypsin
contains non-polar residues so it binds bulky non-polar residues including
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aromatic residues. In the case of trypsin, an aspartic acid residue replaces a
serine of chymotrypsin to give a negatively charged active site which attracts
basic residues such as lysine and arginine.
Zimmerman and Ashe (1977), Nakajima et al (1979) and Tanaka et al
(1985) studied the subsite specificity of HNE and HNCG. Zimmerman and
Ashe (1977) measured the kcat/Km of various substrates which differed at
the Pi position. They concluded that HNE had a preference for valine in the
Pi position, but also cleaved adjacent to alanine and to a lesser extent
isoleucine. Nakajima et al (1979) and Tanaka et al (1985) expanded this
study and examined the extended substrate requirements of HNE and
HNCG. The substrate requirements of proteinase-3, the third serine
proteinase of the azurophil granules were studied by Rao et al (1991). The
best substrates for the three enzymes were concluded to be:-
Cleavage site
P4 P3 P2 Pi Pi* P2'
HNE: Ala Ala Pro Val Thr Ala
HNCG: Ala Ala Pro Phe Ala Ala
Proteinase-3: Ala Ala Pro Val
It may be concluded that HNE has a requirement for small
hydrophobic amino acids in the P1 position of its substrate. Interestingly,
HNE is capable of accommodating alanine-isoleucine-proline-methionine in
its binding site and cleaves at the carbonyl side of methionine (Travis and
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Salvesen, 1983). This is significant because this tetrapeptide corresponds
to the reactive site sequence of a-1-PI (Johnson and Travis, 1978; Nakajima
et ai. 1979). Proteinase-3 displays a great deal of similarity to HNE. It also
requires a small aliphatic amino acid in the P-| position of its substrate, and
is inhibited by a-1-PI. However, it has an absolute requirement for proline in
the P2 position (Rao et al. 1991) and so is unable to cleave succinyl-L-
alanyl-L-alanyl-L-alanyl-p-nitroanilide (STANA) which is commonly used to
measure the activity of HNE.
HNCG has a requirement for bulky or aromatic residues in the P1
position; it is more inclined to cleave substrates with leucine or methionine
in the P1 position than tryptophan or tyrosine in the P1 position (Tanaka et al.
1985). The natural inhibitor of HNCG is a-1-antichymotrypsin (a-| Achy)
which has a leucine in the P1 position of the reactive site sequence so the
mechanism of the reaction between a-|Achy and HNCG is probably similar
to that between a-1-PI and HNE.
In general, the catalytic action of serine proteinases may be
irreversibly inhibited by reacting the active site serine with organic
fluorophosphates such as di-isopropylphosphorofluoridate. A more
selective inhibition of the serine proteinases may be achieved by using
synthetic chloromethylketones which act to alkylate the histidine of the active
site triad.
Inhibitors are used to control the activity of enzymes in the body.
Serum contains a number of inhibitors of serine proteinases which are
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termed serpins. These include a-1-PI which inhibits trypsin, HNE and
HNCG and a-\ Achy which inhibits chymotrypsin and HNCG.
Usually, 90% of the circulating inhibitory capacity against HNE is
provided by a-1-PI; the other 10% of the serum inhibitory capacity against
serine proteinases is provided by a2macroglobulin. a-1-PI is a 52kDa
glycoprotein which has an active site methionine (Met25®) positioned in a
reactive site loop near the C-terminus. The inhibitor binds with a 1:1
stoichiometry to the active site of HNE to form an inactive enzyme inhibitor
complex which cannot be broken by denaturing agents (Travis and
Salvesen, 1983). The inhibitor in the complex does not appear to be
digested by the HNE (Carrell and Owen, 1985). Longstaffe and Gaffney
(1991) recently presented evidence to suggest that a covalent bond is not
formed between the serpin a2antiplasmin and the serine proteinase
plasmin during inhibition, so a pseudoirreversible inhibition occurs. The
conformations which may be adopted by the complex have recently been
discussed by Mast et al (1991). The complex is removed from the circulation
by other inflammatory cells (see page 4) via receptor-mediated mechanisms.
Native inhibitor and proteolytically cleaved inhibitor are not cleared from the
circulation (Mast et al. 19911.
In assigning a role for a-1-PI in the control of proteinases within the
lung tissue it is assumed that the inhibitor is capable of moving from the
serum to the tissues. So, a second level of control may exist within the
tissue itself. This control may be provided by low molecular weight inhibitors
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such as mucus proteinase inhibitor (Hochstrasser et al. 1972; Ohlsson and Tegner,
1977) and elastase-specific inhibitor (Hochstrasser et al. 1981; Sallenave
and Ryle, 1991). Sallenave et al. (1992) recently showed that elastase-
specific inhibitor from sputum has sequence homology with elafin, an
inhibitor isolated from the skin of patients with psoriasis, which is an
inflammatory condition (Wiedow et al. 1990). So, low molecular weight
inhibitors produced in different tissues during inflammation appear to be
related. The importance of such low molecular weight inhibitors should not
be understated, especially in light of the work presented by Morrison et al.
(1990) which showed that mucus proteinase inhibitor, but not a-1-PI, is
capable of inhibiting HNE which has been adsorbed onto elastin. However,
the kass of HNE with a-1-PI is 65 pM"1.s"1 (Beatty et al. 1980) but the values
for the kass of HNE with elastase specific inhibitor and mucus proteinase
inhibitor are 16.7pM~1.s~1 (Sallenave and Ryle, 1991) and 6.4|iM"1.s"1
(Boudier and Bieth, 1989) respectively. So, even though the low molecular
weight inhibitors are undoubtably of some importance, a-1-PI is considered
to be the major physiological inhibitor of HNE when judged on the basis of
these association constants.
Since a-1-PI is the major physiological inhibitor of HNE the presence
of insufficient active a-1-PI is the most logical cause of an imbalance
between HNE and the antiproteinases of the lung. In a minority of cases the
inhibitor may be inactivated during a bacterial infection. For example,
Staphylococcus aureus has been implicated in the production of
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elastinolytic damage to tissue during Staphylococcal pneumonia (Nowak
and Miedzobrodski, 1991), possibly as a result of the production by the
bacterium of a serine proteinase which is capable of inactivating cc-1-PI.
However, the generally accepted reason for a deficiency of active a-1-PI is a
genetic inability to produce normal a-1-PI. The most characteristic
deficiency is the consequence of the inheritance of a homozygous Pizz
phenotype instead of the normal Pi^ phenotype. The a-1-PI synthesised
by Pizz individuals appears to be abnormally glycosylated, and is retained in
inclusion bodies within their hepatocytes (Eriksson and Larsson, 1975). As
a result of this retention the serum level of a-1-PI in Pizz subjects is less than
10% of the normal. Although the a-1-PI which does appear in the serum has
normal inhibitory activity. The homozygous Pizz subjects were predisposed
to the development of emphysema (Laurell and Eriksson, 1963); but
heterozygous Pi^ subjects are no more susceptible to developing
emphysema than normal subjects (Eriksson, 1965; Lieberman, 1969;
Hutchison et al. 1971).
Patients with this genetic deficiency of a-1-PI will tend to develop
emphysema by the age of 50 (Hutchison et al. 1971). In a recent familial
study, Apprill et al (1990) concluded that a-1-PI deficiency alone does not
automatically condemn the subject to an emphysematous state. The study
found that only one of three Pizz siblings developed severe emphysema and
this subject was a heavy smoker; so the risk of developing emphysema may
be increased if the Pizz individual is a smoker.
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The majority of emphysematous patients do not have a genetic
deficiency of a-1-PI (see page 2). These patients are usually heavy
cigarette smokers who develop emphysema in their 8th decade. The link
between smoking and emphysema suggested that the
proteinase:antiproteinase imbalance is related to an oxidant:antioxidant
imbalance in which excessive oxidants oxidise the antiproteinase. This is
supported by experiments which showed that the active site methionine of a-
1 -PI may be chemically oxidised giving a sulphoxide derivative (Johnson
and Travis, 1979) which associates 2000 times more slowly with HNE than
does normal a-1-PI (Beatty et al. 1980). a-1-PI may be oxidised
enzymically by the myeloperoxidase system (Matheson et al. 1982), which
has implications in vivo. Mucus proteinase inhibitor also has an active site
methionine which can potentially be oxidised (Janoff et al. 1980).
The mechanisms surrounding the production of a
proteinase:antiproteinase imbalance and the oxidant:antioxidant imbalance
are the subject of some debate, but it is universally accepted that
uncontrolled proteinase within the lung will have the ability to cause
extensive damage to the structural proteins of the extracellular matrix. This
damage could be associated with the development of emphysema.
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1.3 The destruction of elastin and the extracellular
matrix
The extracellular matrix of the lung consists of insoluble structural
macromolecules including collagen, elastin, proteoglycans and
glycoproteins. HNE is capable of digesting collagen type in (Mainardi si
al,1980), fibronectin (McDonald and Kelley, 1980) and elastin (Janoff and
Scherer, 1968).
Elastin is the insoluble protein component of elastic fibres found in all
tissues which is responsible for the elastic recoil of lungs and the major
blood vessels (Rosenbloom, 1987). The elastic fibres in the lung are
intimately associated with collagenous fibres. Elastic fibres encircle each
alveolar duct and the mouth of the alveoli (Pierce and Ebert, 1965).
Damage to the elastic fibres was first associated with emphysema in 1907
when Orsos observed fraying and rupture of elastic fibres in areas of
alveolar destruction. Elastic fibres are morphologically arranged as discrete
fibres or fenestrated sheets (Cleary and Cliff, 1978). The fibres consist of a
microfibrillar component made up of glycoproteins such as the microfibril
associated glycoprotein (Gibson et al. 1986) and fibrillin (Sakai et al. 1986),
which acts as a scaffolding on which the protein, elastin, is deposited.
Elastin is synthesised as the soluble precursor, tropoelastin by
smooth muscle cells (Ross, 1971; Thyberg et al. 1979), fibroblasts
(Fahrenbach et al. 1966) and chondroblasts (Quintarelli et al. 1979).
Tropoelastin is encoded by a 40 kilobase single copy gene which is located
on chromosome 2 (Emmanuel et al. 1985). The DNA encoding tropoelastin
has an intron:exon ratio of 15:1 (Indik et al. 1989), and has 34 exons
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containing 2,358 translated nucleotides (Rosenbloom et al. 1991). At least
6 of the exons may be alternatively spliced (Indik et al. 1987), which gives
rise to 3.5 kilobase primary transcripts which have differing sequences (Indik
et al. 1989).
The sequence of human foetal aortic tropoelastin was determined by
Indik et al (1987) who examined cDNA clones. Tropoelastin is
approximately 70 kDa and consists of approximately 780 amino acids. The
hydrophobic and hydrophilic domains of the protein are encoded by different
exons flndik et al. 1987) so the amino acids of tropoelastin are arranged as
alternating hydrophobic and hydrophilic domains. Tropoelastin contains a
large proportion of small amino acids. Glycine and alanine account for 29%
and 22% respectively of the composition of tropoelastin, so the mean
residue weight of the amino acids in tropoelastin is only 85.
After translation, molecules of tropoelastin are packaged into vesicles
and secreted into the extracellular matrix (Rosenbloom, 1987) where the
tropoelastin is deposited onto the microfibril. Recent evidence suggests the
that deposition of the tropoelastin may involve a receptor-mediated
mechanism. Fibroblasts synthesise a 120kDa receptor complex which is
found on the cell surface and has a 67kDa receptor subunit (reviewed by
Robert et al. 1989). The subunit has a protein-binding site which recognises
the Val-Gly-Val-Ala-Pro-Gly hexapeptide unit of elastin (Wrenn et al. 1988)
and a carbohydrate binding site (Hinek et al. 1988). It has been proposed
by Mecham (1991) that tropoelastin may bind to the receptor during
secretion from the fibroblast via the protein binding site. The receptor
eventually binds to the microfibril glycoproteins via the carbohydrate binding
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Figure 1,2 The formation of Desmosine
(Adapted from Piez, 1968 and Sandberg et al, 1981)
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Figure 1.3. The possible routes of spontaneous condensation of the aldol

















This depicts the various ways in which the cross-links may be formed
from residues of allysine (Eyre et al, 1984).
site, which decreases the affinity between the tropoelastin and the protein
binding site. So, the tropoelastin is then transferred onto the microfibril. At
the same time the receptor is released from its transmembrane anchor.
Molecules of tropoelastin are capable of associating together
hydrophobically to form coacervates (detailed further in Section 6.3.1); this
characteristic may be of particular importance in aligning the tropoelastin
onto the microfibril at the end of secretion events (Cox et al. 1974;
Narayanan et al. 1978). After secretion into the extracellular matrix and
deposition on the microfibril the soluble tropoelastin must be converted to
insoluble elastin by the formation of cross-links.
The hydrophilic domains of tropoelastin are rich in polyalanine
regions which contain doublets of lysine residues. These lysine residues
may be oxidatively deaminated at the 6-amino group to give the
corresponding adipic semialdehyde residue (allysine). The oxidation is
catalysed by lysyl oxidase (EC 1.4.3.13), a copper-dependent enzyme
secreted by fibroblasts (Siegel, 197^). Three modified lysine residues and
the 6-amino group of a fourth lysine are capable of condensing together to
give tetrafunctional cross-links (Figure 1.2) called desmosine and
isodesmosine. Desmosine and the isomer, isodesmosine are unique to
elastin, and are primarily responsible for the insoluble nature of elastin.
However, the route of cross-link formation is uncertain and the various
possibilities may be represented as detailed in Figure 1.3. Eyre et al (1984)
stated that oniy 8-10 of the lysine residues from a molecule of tropoelastin
will be accommodated in the desmosine and isodesmosine cross-links, and
up to 15 will exist as cross-link intermediates, including the bifunctional
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cross-link lysinonorleucine (Franzblau et al. 1969). Richmond (1990) has
presented evidence to suggest that elastin may form lysinonorleucine cross¬
link with the glycoproteins of the microfibril.
The hydrophobic domains of elastin contain a number of small
peptide sequences which are repeated several times in succession. These
peptide units are stabilised by hydrophobic interactions. The combination of
the tetrafunctional cross-links and hydrophobic interactions make elastin
extremely insoluble. This insolubility may be exploited when elastin is
purified. Mature, cross-linked elastin is more resistant to hydrolysis by
sodium hydroxide treatment at 90°C for 45 minutes than collagens which
will be dissolved by this treatment (Lansing et al. 1952). Ross and Bornstein
(1969) considered that this treatment was harsh and probably caused some
damage to the elastin, so they developed a method of isolation which
involved removing the contaminating proteins from the elastin with
denaturants and enzymes which were incapable of digesting elastin (the
purification of elastin is discussed further in Section 3.2).
Although elastin is very stable, it is not immune to attack by enzymes.
Elastin is a natural substrate for HNE, porcine pancreatic elastase and to a
lesser extent HNCG because it is very rich in valine, proline, glycine and
alanine (13%, 13%, 29% and 22% respectively; see Section 1.2). So elastin
degradation is a potential consequence of a proteinase:antiproteinase
imbalance towards excessive active HNE.
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1.4 The evidence implicating elastin destruction bv HNE
in the pathogenesis of emphysema
A number of pieces of evidence suggested that elastin destruction
may occur during the development of emphysema. Animal experiments
suggested that elastic tissue was damaged when elastases were instilled
into the trachea of the animal (Kaplan et al. 1973). The repaired fibres were
shown to be abnormal (Fierer et al. 1976), and emphysema was
exacerbated if the animals were rendered deficient in lysyl oxidase (Kuhn
and Starcher, 1976). This suggested that proteins which were substrates for
lysyl oxidase i.e., elastin and collagens, are damaged in the lung disease.
Further evidence implicating elastin destruction in emphysema was the
observation that the lungs of typical emphysematous patients displayed a
loss of elastic recoil (Karlinsky and Snider, 1978 ), and Senior et al (1977)
observed that treatment with HNE caused a decrease of lung elastin content.
However, the only experiments to directly correlate HNE and elastin
destruction in emphysema were performed by Damiano et al (1986). They
used immunocytochemical techniques to observe the presence of HNE on
elastin in areas of lung with emphysema. However, Fox et al (1988) were
unable to re-produce these experimental results.
If elastin damage is associated with the pathogenesis of emphysema
then it may be suggested that degradative products must appear in the body
fluids of emphysematous patients. This suggestion was confirmed by Stone
et al (1991), who used reverse-phase chromatography to confirm the
presence of elevated levels of desmosine in the urine of hamsters with
elastase-induced emphysema, and by a number of immunological
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investigations (Harel et al. 1980; Gunja-Smith, 1985; Kucich et al. 1985; Pai
et al. 1985; Laurent et al. 1988). The immunological investigations
suggested that patients with emphysema had elevated levels of elastin-
derived peptides in their urine (Harel et al. 1980) and plasma (Kucich et al.
1985). Kucich et al (1985) took their studies a step further and isolated the
urinary elastin-derived peptides from COPD patients and non-smokers.
They discovered that 90% of the peptides in the urine of COPD patients
were between 4kDa-20kDa, and 10% were approximately 1kDa, and the
urine of the non-smokers did not contain any of the smaller peptides.
The antibodies used in the immunological investigations were raised
against a mixture of soluble elastin-derived peptides. In general, the
antibodies raised against elastin map to two epitopes on the elastin
(Mecham and Lange, 1982). The first group of antibodies maps to the
alanine-rich cross-link regions, and the second group of antibodies
recognises the hydrophobic elastic regions, which are subject to sequence
variation. The two groups of antibodies do not cross-react. Kucich et al
(1981) presented evidence to suggest that antibodies raised against
peptides obtained by oxalic acid digestion of elastin cross-reacted poorly
with peptides obtained by elastase digestion.
Since peptides produced from elastin by different digestion methods
contain different epitopes it may be suggested that some elastin-derived
peptides are specific for a particular type of chemical or enzymic digestion,
so the identification of a peptide produced specifically as a result of
digestion with HNE rather than with HNCG or elastinolytic enzymes from
other cells, such as macrophages, would be useful in confirming that elastin
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degradation in emphysema was a result of digestion by HNE.
The aim of this project was to separate and characterise the soluble
lung elastin-derived peptides produced by digestion with HNE and/or
HNCG; and identify any specific peptide(s) which were consistently liberated
by the digestion with only one enzyme or combination of enzymes. The
approach taken to achieve this aim may be divided into 4 main areas. First,
the enzymes and the elastin were isolated (detailed in Chapter 3).
Secondly, a method for measuring soluble peptides was adapted, and a
method for measuring total products of digestion regardless of whether or
not they were soluble was developed (detailed Chapters 4 and 5). Thirdly
the digestion patterns produced when elastin was digested with HNE and/or
HNCG were investigated (detailed in Chapters 6,7 and 8). Finally, the
strategies taken to separate and characterise the soluble peptides resulting
from the digestion of the elastin with the enzymes are detailed in Chapter 9.
In the course of this work two unexpected problems arose which
required further investigation. First, the development of a method for
measuring total amino groups revealed that the reaction between sulphite
and 2,6-dichlorophenolindophenol (DCPIP) had an unexpected
stoichiometry (detailed in Chapter 5 and the Appendix). Secondly, the
amino termini of the peptides resulting from the digestion of lung elastin with
HNE appeared to become resistant to detection after 24 hours of digestion.






2.1 ISOLATION OF ENZYMES
Human neutrophil elastase (HNE) and human neutrophil cathepsin G
(HNCG) were isolated from purulent sputum according to the method of
Martodam et al (1979), based on the method of Twumasi and Liener (1977),
and detailed further in Section 3.1.2. The sputum was made available by Dr.
A. Greening, Western General Hospital, Edinburgh.
2.1.1 Determination of HNE activity against succinvl-L-
alanvl-L-alanvl-L-alanvl-p-nitroanilide
The substrate (STANA) was purchased from Scientific Marketing
Associates.
The activity of HNE was determined by a method similar to the
method of Heck et al (1985).
STANA (20mM in DMSO,10pl) was mixed with 0.99ml of 50mM Tris-
HCI/1.0M NaCI, pH 8.0, and equilibrated to 37°C. Aliquots of the
chromatographic fractions (50|il) or 10pl of pure enzyme solution were
added to the assay mixture and incubated at 37°C for exactly 30 minutes in
the case of the chromatographic fractions or exactly 10 minutes for the pure
enzyme solution; the rate of reaction was constant over these time intervals.
The final substrate concentrations in the assay mixtures were 0.190mM and
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0.198mM when 50|il or 10pi respectively of sample were assayed. The rate
of change of concentration of 4-nitroaniline was determined from the rate of
increase of absorbance at 410nm. The molar absorbance of 4-nitroaniline
at 410nm was taken as 8800 l.mol"1.cm"1. (Nakajima et al. 1979). A unit of
enzyme activity was defined as the activity required to produce 1 pmol of 4-
nitroaniline per minute (as defined by IUPAC/IUB).
2.1.2 Determination of HNCG activity against succinvl-L-
alanvl-L-alanvl-L-Drolvl-L-Dhenvlalanvl-p-
nitroaniiide
HNCG activity was determined exactly as the assay of HNE except
that 10(il of 0.1 M succinyl-L-alanyl-L-alanyl-L-prolyl-L-phenylalanyl-p-
nitroanilide (Suc-Ala-Ala-Pro-Phe-pNA; purchased from Sigma) in DMSO,
was used as the substrate. This gave a final substrate concentration of
0.95mM or 0.99mM when the activity of 50pl or 10pl respectively of sample
was measured (DelMar et al. 1979: Nakaiima et al. 19791.
2.2 ISOLATION OF ELASTIN
Human post-mortem tissue was supplied by Dr. D. Lamb, Department
of Pathology, University of Edinburgh. Because of safety regulations
regarding the handling of human tissue, it was necessary for the Department
of Pathology to fix the lungs and aorta in either ethanol or acetone for 3 days
prior to use.
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2.2.1 Isolation of luna elastin
After the removal of the trachea and the major bronchi the tissue was
treated according to the degradative and non-degradative methods of Reilly
and Travis (1980) which were based on the methods of Lansing et al. (1952)
and Ross and Bornstein (1969) respectively.
2.2.2 Isolation of aortic elastin
Aortic elastin was isolated according to the method of Paz et al.
(1976).
2.2.3 Amino acid analysis
Elastin was hydrolysed at 110°C for 22 hours in 6M HCI under argon.
The hydrolysates were dried under vacuum in the presence of sodium
hydroxide, then dissolved in 0.025% potassium EDTA solution (according to
Applied Biosystems guidelines). Amino acid analysis on the hydrolysate
was performed by Mr A. D. Cronshaw of the Wei-Met Protein
Characterisation Service, University of Edinburgh on Applied Biosystems
equipment, according to the manufacturer's instructions.
2.3 DIGESTION OF ELASTIN BY ENZYMES
2.3.1 Digestion procedure
Elastin suspensions (3mg/ml in 0.1 M sodium phosphate buffer/0.15M
NaCI, pH 7.4) were treated with HNE and/or HNCG (5, 10 or 15mU/ml of
suspension) at 37°C in a shaking water bath, and aliquots were removed
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periodically. Treatment with 10mU/ml corresponds to an enzyme to
substrate (w/w) ratio of of 1:100 or 1:130 for HNE or HNCG respectively.
2.3.2 Determination of peptide production using assays for
protein
Soluble peptides were isolated from the insoluble material by
centrifugation for 10 minutes in an MSE microfuge. The quantity of soluble
peptides was measured as protein, by three methods.
a) Bradford method
Bradford reagent was prepared according to the method of Bradford
(1976). Reagent (2.5ml) was added to 0.5ml of supernatant, and the
absorbance at 595nm was measured against a reagent blank within an
hour. The quantity of peptides was estimated by comparing the absorbance
to a standard curve prepared with bovine serum albumin (BSA, purchased
from Sigma).
b) Bicinchoninic acid (BCA1 method
The BCA method (Pierce) is based on the method of Smith et al
(1985).
Duplicate digestion supernatants (1 Optl) were pipetted into a 96-well
microtitre plate (Falcon) with a capacity of 300|il per well. Reagent (200|il),
prepared according to the manufacturer's recommendations, was added to
each well. The plate was incubated at room temperature for 2 hours, after
which the absorbance at 570nm was measured in a Dynatech Microplate
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Reader (Model MR600). The quantity of peptides was estimated by
comparison to a standard curve of BSA, samples of which were included on
each plate.
c) Biuret method
Duplicate digestion supernatants (50jil) were treated with 200(il of
biuret reagent, prepared in accordance with the method of Gornall et al
(1949), in a 96-well microtitre plate (Falcon). After incubation at room
temperature for 30 minutes the absorbance at 570nm was measured in a
Dynatech Microplate Reader (Model MR600). The amount of peptides was
estimated by comparison to a standard curve of BSA, samples of which were
included on each plate.
2.3.3 Determination of soluble peptides
2,4,6-Trinitrobenzene sulphonic acid (TNBS), otherwise known as
picrylsulphonic acid, was purchased from Sigma.
The digestion sample was centrifuged in an MSE microfuge for 5
minutes at high speed. Amino groups in the supernatant were measured by
a method based on the procedure of Satake et al (1960) as modified in
Sigma protocol P2297.
Triplicate aliquots of the supernatant (30|il-200|il) were made to a
volume of 0.5ml and added to 0.5ml of 0.1M sodium phosphate buffer, pH
8.0. 0.1% TNBS (0.5ml) was added to the solutions, which were mixed and
incubated at 37°C for 2 hours. After incubation the absorbance at 420nm
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was measured in a Pye Unicam SP6-550 uv/vis spectrophotometer against
a reagent blank. The quantity of free amino groups produced per milligram
of elastin was calculated by relating the above absorbance to a standard
curve prepared with glycine (0-0.25pmol).
2.3.4 Development of a method for the determination of
total peptides
A method for the determination of total peptides was developed and is
detailed in Chapter 5. Triplicate aliquots (30pl-200|il) of the digestion
suspension were made up to a volume of 0.5ml and added to 0.5ml of 0.1 M
sodium phosphate buffer, pH 8.0; 1ml of 0.2mM 2,6-
dichlorophenolindophenol (DCPIP, purchased from BDH) in 0.05M
phosphate buffer, pH 8.0 containing 0.05% TNBS was added, and the
solutions were incubated at 37°C for 2 hours. After incubation, the
absorbance of DCPIP was measured at 605nm against water. The quantity
of free amino groups per milligram of elastin was calculated by relating the
loss of absorbance at 605nm, as compared to a reagent blank (absorbance
at 605nm approximately 1.75), to a standard curve of amount of glycine (0-
0.25(imol) against decrease of absorbance of DCPIP at 605nm.
2.3.5 Determination of insoluble peptides
The quantity of free amino groups per milligram of elastin due to
insoluble peptides was calculated as the difference between the increase in
the amount of total peptides equivalent to glycine per milligram of elastin
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and the increase in the amount of soluble peptides equivalent to glycine per
milligram of elastin.
2.4 CHROMATOGRAPHIC SEPARATION OF THE
SOLUBLE PRODUCTS OF DIGESTION
2.4.1 Molecular exclusion chromatography
Molecular exclusion chromatography was performed using a 7.8mm x
30cm Anagel-TSK G3000 SWXL column (Anachem) or a 25ml Superose-12
column (Pharmacia) in conjunction with a Gilson liquid chromatography
system.
Soluble peptides (0.2ml), separated from the insoluble material by
high speed centrifugation in an MSE microfuge for 10 minutes, were
fractionated using 50mM sodium phosphate buffer/0.15M NaCI pH 7.4 at a
flow rate of 1ml/min for 40 minutes (pressure not exceeding 4 MPa). The
absorbance of the eluate was monitored at either 220nm or 270nm and
fractions (1 minute, 1ml) were collected.
2.4.2 Reverse-phase chromatography using a PeoRPC
column
Reverse-phase chromatography was performed using a C2/C18
PepRPC HR 5/5 column (0.5cm x 5cm; Pharmacia) in conjunction with a
Gilson liquid chromatography system, at a pressure not exceeding 4 MPa.
Digestion samples (200|ig-400|ig as determined by BCA assay) were
collected after 24 or 48 hours of digestion and concentrated or diluted to
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0.5ml if necessary. The samples were centrifuged for 10 minutes at high
speed in an MSE microfuge, and the supernatant was loaded onto the
column which had been equilibrated with 2% aqueous acetonitrile (Far UV
HPLC grade, FSA)/0.1% trifluoroacetic acid (TFA, HPLC grade, FSA). All
solvents were filtered through 0.45pm nitrocellulose membranes (47mm
diameter; Whatman) and degassed by sonication (20 minutes in a sonic
bath) prior to use. The peptides were separated using a gradient of 2%-
100% acetonitrile/0.1% TFA at a flow rate of 0.5ml/min (initial pressure of
1.5MPa) over 220 minutes. The absorbance of the eluate was monitored at
220nm, unless otherwise stated, and fractions (2 minutes, 1ml) were
collected from 1 minute after injection, in a 96-well fraction collection rack
(Beckman). The path length of the flow cell was 1cm.
2.4.3 Reverse-phase chromatography using an Aquapore
RP-300 column
Single peptide peaks eluted from the PepRPC HR 5/5 column
between 25%-30% acetonitrile/0.1% TFA were concentrated by evaporation
at 37°C to approximately 50pl in a Gyrovap centrifugal evaporator (Howe).
The concentrated samples were diluted to 500pl with 1% TFA, and further
purified by Mr S. D. Peacock of the Wei-Met Protein Characterisation
Service. Briefly, aliquots (100pl - 200pl) were loaded onto a C18 Aquapore
RP-300 column (30 x 2.1mm, Brownlee, ABI) using a 130A Separation
System (ABI).
The peptides were eluted from the column with a gradient of 0%-70%
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acetonitrile/0.1% - 0.08% TFA over 45 minutes at a flow rate of 200|il/min
(initial pressure 2.0MPa). The absorbance of the eluate was monitored at
220nm and recorded at a sensitivity of 0.1 absorbance units full-scale.
Individual peaks were collected manually in Eppendorf tubes, when the
absorbance shown on the chart recorder increased above 0.03 absorbance
units.
Aliquots (100|j.l-300|il) of the peptide peaks were concentrated by






ISOLATION OF THE ENZYMES AND PREPARATION
OF THE SUBSTRATE
CHAPTER 3
ISOLATION OF THE ENZYMES AND PREPARATION OF THE
SUBSTRATE
3.1 ISOLATION OF HNE AND HNCG
3.1.1 Source of the enzymes
HNE and HNCG may be isolated from three sources of granulocytic
cells; whole blood (Baugh & Travis, 1976); neutrophils obtained by
leukophoresis of normal donors or myeloid leukaemia patients (Heck et al.
1985); or purulent sputum (Twumasi & Liener, 1977). The advantages of
using sputum are that it is readily available in large quantities from
hospitalised bronchitics whereas leukocytes, particularly from myeloid
leukaemia patients, are difficult to obtain; secondly, purulent sputum
provides higher yields of enzymes (w/w) as compared to the yields from
whole blood (w/v) (Twumasi & Liener, 1977). However, it should be noted
that the purulence of the sputum is an important factor since clear mucoid
sputum does not contain significant amounts of elastase (Stockley et al.
1984). This is presumably because elastase is produced by inflammatory
cells and the purulence is a feature of extreme inflammation of the airways
(Ryan & Majno, 1977). Since the degree of purulence between different
sputa will vary, it follows that the yield of enzymes will vary accordingly so
there is little point in comparing the yields from different pools of sputa.
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Figure 3.1 Purification scheme of the isolation of the enzymes from sputum
SPUTUM + equal volume of water
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See text for experimental details. In the interests of simplicity within the text, the
enzymes isolated from the DN'ase digestion pellet will be referred to as HNE-D
and HNCG-D; the enzymes isolated from the subsequent ammonium sulphate
precipitation of the salt extract will be referred to as HNE-G and HNCG-G; and
the HNE isolated from the unbound material will be referred to as HNE-J.
3.1.2 Isolation of the enzvmes
The enzymes were isolated on four occasions from pooled sputa
provided by bronchitic patients (0.51-1.51, depending upon availability) by a
method based on the procedures detailed by Twumasi and Liener (1977)
and Martodam et al (19791 (Figure 3.1).
(a) Preparation of the salt extract
Pooled sputa were homogenised with an equal volume of distilled
water in a Waring blender and stirred overnight at 4°C. The solution was
centrifuged at 30,000g for 20 minutes at 4°C in a J2-21 centrifuge
(Beckman) with a JA-14 rotor. The supernatant was discarded. The
enzymes were solubilised from the pellet by suspending and homogenising
the pellet in an equal volume of 2M NaCI. The pellet suspension was
centrifuged as before, producing a supernatant which was retained, and a
pellet which was homogenised in 1M NaCI, stirred at 4°C overnight and
centrifuged. The supernatant was added to the 2M NaCI treatment
supernatant, and the pellet was discarded. The pooled supernatants were
dialysed against 50mM Tris-HCI/0.035M MgCI2, pH7.4 for 24 hours at 4°C to
give the salt extract (A).
(b) Deoxvribonuclease digestion of the salt extract
The salt extract (A) was treated with deoxyribonuclease (DN'ase,
Sigma, 60U/ml) at 25°C for 3 hours; the nuclease digested DNA to release
the enzyme, as a precipitate, from nucleoprotein complexes (Lieberman &
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Figure 3,?a Affinity phrpmptpgraphy pn Trasylp|-?pphprpse pf fh?
splubilised pellet resulting from PN'ase digestion of the
salt extract
Fraction number
Fraction B (400ml) was applied to a Trasylol-Sepharose column (2.5cm x 10cm, void
volume 50ml) equilibrated with 50mM Tris-HCI/1.0M NaCI, pH8.0. After washing (^)
with the same buffer the eluent was changed (^) to 50mM sodium acetate buffer/1,0M
NaCI, pH4.5. Fractions (10ml) were collected.
Figure 3.2b lon-exchanae chromatography of the active material from
TffgylPl-Sephprpge (Figure 3.29)
Fraction number
Fraction C (230ml) was applied to a CM-Sepharose column (2cm x 25cm, void volume
80ml) equilibrated with 50mM sodium acetate buffer/0.1 M NaCI, pH4.5. After
washing with the same buffer the ionic strength was increased to 0.45M NaCI (^) to
elute HNE, and then to 1.0M NaCI (£•) to elute HNCG. Fractions (10ml) were collected.
Kurnick, 1962). The precipitated enzyme was collected by centrifugation
(30,000g for 20 minutes) as a pellet. The enzymes in the pellet were
solubilised by three extractions with 50mM Tris-HCI/1.0M NaCI, pH 8.0. The
three supernatants were pooled and the remaining pellet was suspended in
50mM Tris-HCI/1.0M NaCI, pH 8.0 and sonicated at room temperature for 20
minutes in a sonic bath (Kerry). The supernatant obtained by centrifugation,
was added to the supernatants from the 3 previous extractions to give a
pooled enzyme solution (B), and the pellet was discarded.
(c) Separation of the enzymes from other proteins in the
pooled enzvme solution (B) bv affinity chromatography
The pooled enzyme solution (B) was applied to a Trasylol-Sepharose
column (2.5cm x 10cm, prepared by Mrs. S. Libor) equilibrated with 50mM
Tris-HCI/1.0M NaCI, pH 8.0. Weakly bound material was washed off the
column with the Tris buffer and when the absorbance at 280nm of the eluate
had decreased to 0.03, the serine proteinases were eluted from the column
by decreasing the pH with 50mM sodium acetate buffer/1.0M NaCI, pH 4.5
(Figure 3.2a).
Enzymically active material was pooled (C) and dialysed against
50mM sodium acetate buffer/0.1 M NaCI, pH 4.5 for 24 hours at 4°C.
Id) Separation of the two enzvmes bv ion-exchange
chromatography
Dialysed enzymes were applied to a CM-Sepharose column (2cm x
25cm) equilibrated with 50mM sodium acetate buffer/0.1 M NaCI, pH 4.5.
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Figure 3.3a Affinity chromatography on Trasvlol-Sepharose of the
solubilised ammonium sulphate precipitate obtained from
the salt extract (El






Fraction E (400ml) was applied to a Trasylol-Sepharose column (2.5cm x 10cm, void
volume 50ml) equilibrated with 50mM Tris-HCI/1.0M NaCI, pH8.0. Unbound fractions
(^ to ,i>) were collected; after which the eluant was changed to 50mM sodium acetate
buffer/1.0M NaCI, pH4.5 and the bound fractions (10ml each) were collected.










Fraction F (230ml) was applied to a CM-Sepharose column (2cm x 25cm, void volume
80ml) equilibrated with 50mM sodium acetate buffer/0.1M NaCI, pH4.5. After washing
with the same buffer the ionic strength was increased to 0.45M NaCI (|) to elute HNE,
and then to 1,0M NaCI (^) to elute HNCG. Fractions (10ml) were collected.
The enzymes (D) were eluted from the ion-exchange column by stepwise
increases of the ionic strength of the sodium acetate buffer; HNE was eluted
with 50mM sodium acetate buffer/0.45M NaCI, pH 4.5 and HNCG was eluted
with 50mM sodium acetate buffer/1,0M NaCI, pH 4.5 (Figure 3.2b), after
which they were concentrated by ultrafiltration, dialysed against 1mM acetic
acid overnight and freeze dried.
(e) Ammonium sulphate treatment of the remaining salt
extract supernatant
The salt extract supernatant (S) remaining after the removal of the
enzyme pellet, resulting from DN'ase digestion, still contained considerable
activity against STANA and Suc-Ala-Ala-Pro-Phe-pNA. Attempts were made
to isolate further enzyme from the salt extract supernatant by 50% saturation
with ammonium sulphate. The resultant precipitate was collected by
centrifugation and the supernatant was discarded. The pellet was
solubilised in 50mM Tris-HCI/1.0M NaCI, pH 8.0, then dialysed overnight
against the Tris buffer at 4°C to remove the ammonium sulphate. The
dialysed enzyme solution (E) was applied to the Trasylol-Sepharose
column, equilibrated with 50mM Tris-HCI/1.0M NaCI, pH 8.0. Some of the
weakly bound material was active against STANA and was collected (H)
separately from the active material which bound to Trasylol-Sepharose and
was eluted (F) as previously detailed (Figure 3.3a). The serine proteinases
were then separated from each other (G) by ion-exchange chromatography
(Figure 3.3b).
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5.6 0.385 95 7.5 220
The total recovery of pure enzyme from 1.51 of pooled purulent sputa, expressed as the sum of products
D, G and J, were 16% and 21% for HNE (bold figures) and HNCG (italic figures) respectively.
(f) Isolation of HNE from the unbound material (HI
The activity against STANA demonstrated by the unbound material
(H) may simply indicate the presence of an enzyme other than HNE which is
capable of hydrolysing STANA but is incapable of binding to Trasylol-
Sepharose, for example, the metalloproteinase monocyte-derived
macrophage elastase. However, Baugh and Travis (1976) noted that HNCG
binds more tightly than HNE to Trasylol-Sepharose. Therefore it is possible
that the unbound material contained HNE which was excluded from the
Trasylol-Sepharose column because HNCG had occupied the majority of
the binding sites. The unbound material (H) was re-applied to the Trasylol-
Sepharose column. Any material which still did not bind was discarded and
assumed to contain enzyme(s) other than HNE. The bound material (I) was
eluted with 50mM sodium acetate buffer/1 .OM NaCI, pH 4.5 and then
separated (J) by ion-exchange chromatography, as previously detailed.
An example of the resultant purification scheme, when the enzymes
were isolated on a single occasion from 1.51 of pooled sputa, is shown in
Table 3.1. The enzymes were isolated on four occasions; comparison of the
results led to a number of general conclusions.
1. The recovery of HNCG after DN'ase digestion of the salt extract and
the subsequent solubilisation of the enzyme pellet is twice that of HNE; but is
only 50%.
2. After DN'ase treatment and the isolation of the resulting enzyme
pellet, enzymic activity is still detected in the remaining salt extract
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Table 3.2 The cross-contamination of each preparation of pure enzvme
with the second enzyme
a. Contamination of HNE with HNCG
Enzyme preparation Specific activity against
Suc-Ala-Ala-Pro-Phe -pNA
U/[A(280nm).ml]
Specific activity as % of the





b. Contamination of HNCG with HNE
Enzyme preparation Specific activity against STANA
U/[A(280nm).ml]
Specific activity as % of the specific




The cross-contamination between the two enzymes, when the specific activity of the contaminating
enzyme was expressed as a percentage of the specific activity of the purest sample of that enzyme,
was minimal and did not exceed 4%.
supernatant. Some of this residual activity can be precipitated by 50%
saturation with ammonium sulphate. The inclusion of this step was of
particular use in recovering further HNE.
3. Trasylol-Sepharose affinity chromatography produced low recoveries
of HNE (18%-25% of the activity loaded onto the column was recovered).
The recovery of HNCG was significantly higher (38%-65%).
4. When material which was active against STANA, but appeared
incapable of binding to Trasylol-Sepharose, was applied to the affinity
column on a second occasion, some of the material was capable of binding
to the adsorbent. This may be a consequence of preferential binding of
HNCG during the first passage through the column together with an
observed decline in column capacity with time.
5. The specific activities of the enzymes isolated from the pellet
produced by DN'ase digestion of the salt extract were lower than the specific
activities of the enzymes isolated from the subsequent ammonium sulphate
precipitate.
6. The cross-contamination between the enzymes (Table 3.2) was
minimal.
The use of DN'ase digestion of the salt extract was introduced by
Lieberman and Kurnick (1962) who suggested it was necessary for the
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release of chymotrypsin-like proteinase (HNCG) from nucleoprotein
complexes. In practice this procedure led to the recovery of a greater
proportion of the HNCG activity than the HNE activity as an enzyme
precipitate. A proportion of the remaining activity could be isolated from the
salt extract supernatant by precipitation with ammonium sulphate. However,
such precipitation will not specifically precipitate HNE and HNCG; but they
may be isolated from any contaminating proteins by affinity chromatography
on Trasylol-Sepharose, which binds serine proteinases. When the eluate
from Trasylol-Sepharose was further separated by CM-Sepharose, all the
protein eluted in the enzymically active peaks, as seen in Figure 3.2b,
confirming that only enzymically active proteins were bound by Trasylol-
Sepharose.
Although the enzymes eluted from Trasylol-Sepharose had increased
specific activities, the recoveries, particularly of HNE, were poor. A possible
explanation was that the capacity of the column diminishes with use as a
result of irreversible binding of enzyme or of enzymic degradation of the
Trasylol. Alternatively the capacity of the column may decrease as a result
of a non-specific effect, such as the irreversible occupation of the Sepharose
beads with any mucus or acid-polysaccharides co-precipitating with the
enzymes from the salt extract. In practice it was found that a column which
bound 95mg of enzyme at first use was subsequently only capable of
binding 36mg of enzymes. Unbound material was usually active against
STANA, probably because HNCG preferentially binds to the ever-
decreasing available sites on the column causing the exclusion of HNE. So,
unbound material was re-loaded onto the Trasylol-Sepharose column in an
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Table 3.3 Comparative analysis of the preparations of HNE and HNCG
with published data
Enzyme Preparations Published data
D G J D G J Heck (a)
U/mg
T & L (b)
U/mgU/A(280nm/ml) U/mg(c)





a) Activity as quoted by Heck et al (1985)
b) Calculated from the activity (0.645U/mg) quoted by Twumasi and Liener (1977)
as described in the text.
c) Protein mass estimated by the method of Bradford (1976).
attempt to isolate further HNE.
However, even when an extra affinity chromatography step and an
ammonium sulphate precipitation were included in the purification scheme,
the final recoveries of HNE and HNCG activities were only 16% and 21%
respectively. These values compare well with the recoveries of 11% and
16% of HNE and HNCG activities from the salt extract when using
leukocytes as the initial material (Heck et al. 1985); butTwumasi and Liener
(1977) report recoveries from the salt extract of sputum, donated by cystic
fibrosis patients, of 54% and 63% for HNE and HNCG activities respectively.
This sputum has been shown by Goldstein and Doring (1986) to be rich in
HNE and HNCG activities, so cystic fibrosis sputa provide a greater initial
concentration of enzymes and may be a preferable source.
In general, the quantity of enzymes isolated from sputum is variable;
and a factor of greater importance which should be considered is the quality
of the enzymes.
3.1.3 Comparison of the enzvme preparations to those
of Heck et al (19851 and Twumasi and Liener (1977)
The comparative results presented in Table 3.3 show that the final
preparations of HNE eluted from CM-Sepharose had specific activities
between 0.15-0.39U/mg. HNE-D had the lowest specific activity; but
compared well with the specific activity calculated by Heck et al (1985) who
obtained a preparation with a specific activity of 0.103U/mg after ion-
exchange chromatography, rising to 0.180U/mg when further purified by
molecular exclusion chromatography.
45
Figure 3.4 Determination of the Km values for HNE and HNCG under
stated conditions using a nen-perpmetric method
(Cornish-Bowden and Eisenthal. 1978)
a) Km of HNE against STANA in 50mM Tris-HCI/1.0M NaCI. pH8.0
and 1% DMSO at 37°C
s/v (mM/[umol/min/ml])
kl Km of HNCG against Suc-Ala-Ala-Pro-Phe-pNA in 50mM
Tris-HCI/1,0M NaCI. dH8.0. and 1% DMSO at 37°C
s/v (mM/[umol/min/ml])
The Km and Vmax values under the stated conditions were 2.33mM and
1.25pmol/min/ml respectively for the activity of HNE (0.408mg/ml) measured
against STANA; and 6.0mM and 1.18pmol/min/ml respectively for the activity
of HNCG (0.515mg/ml) measured against Suc-Ala-Ala- Pro-Phe-pNA.
In comparing these data to those of Twumasi and Liener (1977) we
must notice that they measured HNE activity in 0.2M Tris-HCI/1 .OM NaCI, pH
8.0 and 25°C with a STANA concentration of 1 mM. Therefore, the specific
activity obtained by Twumasi and Liener was converted to the value which
would have been expected when hydrolysing 0.198mM STANA in 50mM
Tris-HCI/1 .OM NaCI, pH 8.0 and 1% DMSO at 37°C by using the Michaelis-
Menten equation, given that the Km of HNE with STANA in 50mM Tris-
HCI/1 .OM NaCI, pH 8.0 and 1% DMSO at 37°C was calculated as 2.33mM
(Figure 3.4a) and the velocity of the reaction of a preparation of HNE with
0.198mM STANA was found during the course of this work to be 1.93 times
faster at 37°C when compared to the rate at 25°C. The calculated value for
the specific activity of the HNE preparation isolated by Twumasi and Liener
(1977) was 0.382U/mg, which is close to the specific activities of HNE-G and
HNE-J. Twumasi and Liener appeared to measure enzyme activity against
STANA in the absence of any solvent such as DMSO; so the calculated
value for the specific activity of this preparation of HNE against STANA, in
50mM Tris-HCI/1 .OM NaCI, pH 8.0 and 1% DMSO at 37°C, is approximate
as it neglects the effect the solvent may have on the activity of the enzyme.
Consideration of the effect of solvents on elastases is very important as 1%
N-methyl-pyrrolidone causes an increase of both the Km and kcat of PPE
(Bieth et al. 1974); and dimethylformamide exerts the same effect on HNE
(Lestienne and Bieth, 1980). In both these cases the value of kcat/Km
remained constant regardless of the amount of solvent present. So, a more
informative comparison between the HNE preparation isolated by Twumasi
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and Liener and that isolated during this investigation would be provided by
the values of kcat/Km of the two enzyme preparations. At 37°C and pH 8.0,
HNE-G (0.408mg/ml; molecular weight approximately 28000) had a Vmaxof
1.25U/ml. Given that:-
kcat = vmax/ tecJ
then has a value of 1.43s"1. So, the value of kcat/Km of HNE-G at 37°C
and pH 8.0 is 0.614mM"1. s"1, since the Km of HNE at 37°C and pH 8.0 is
2.33mM (Figure 3.4a). It has already been stated that the velocity of STANA
(0.198mM) hydrolysis at 37°C was found by experimentation to be 1.93
times greater than that at 25°C, so it is possible to calculate the value of k^
at 37°C and pH 8.0 of the Twumasi and Liener preparation of HNE by using
the quoted values of kcat and Km at 25°C and pH 8.0 (0.45s"1 and 1.82mM
respectively) and the Km of HNE at 37°C and pH 8.0 (2.33mM) as follows:-
v37°c = kcat 3y°c x Km 2s°c + s
V25°C kcat 25°C 37°C + S
So, at 0.198mM STANA
1.93 = kcat37oc x 1.82 + 0.198
kcat 25°c 2.33 + 0.198
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And the at 37°C of the HNE isolated by Twumasi and Liener is:-
kcat37°c = 1-93 x 0.45 = 1.09s"1
0.798
So, at 37°C
kcat/Km = 0.468 mM-ls"1.
Therefore, HNE-G has a kcat/Km value which is similar to that of the HNE
isolated by Twumasi and Liener, so it may be concluded that after taking into
account the differences of substrate concentration, temperature and solvent
used in measuring the activity of the two enzyme preparations, HNE-G is of
a similar quality to the enzyme isolated by Twumasi and Liener.
The specific activities of the HNCG preparations cannot be compared
to those isolated by Martodam et al (19791 and Heck et al (1985) because in
each case a different synthetic substrate was used to measure enzymic
activity. The substrate used by Martodam et al (1979) was N-benzoyl-DL-
phenylalanine-p-naphthylamide and N-benzyloxycarbonyl-L-tyrosine-p-
nitrophenyl ester was used by Heck et al (1985). For the purposes of any
future comparison of HNCG activity, the Km and Vmax of HNCG
(0.515mg/ml) in 50mM Tris-HCI/1.0M NaCI, pH 8.0 and 1% DMSO at 37°C
were determined and found to be 6mM and 1.18U/ml (Figure 3.4b).
Assuming the molecular weight of HNCG is 30 000 and that the enzyme
isolated was fully active, the kcat for the above reaction was calculated as
1.15s"1-
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Figure 3.5 SDS-PAGE of samples of the enzvme preparations using a
15% polvacrvlamide gel (Laemmli. 1970)
1 2 3456789 10
Examination of the enzymes by SDS-PAGE at pH 8.8 using a 15% polyacrylamide
separating gel and a 4.5% stacking gel (total dimensions 0.15cm x 16cm x 20cm), run
at 70V and 15mA for 16 hours and stained with Coomassie blue.
Tracks: 1 & 2, 14pg & 7pg HNCG-G (0.434U/mg); 3 & 4 , 14pg & 7pg HNE-G
(0.354U/mg); 5 & 6, 50pg & 25pg HNCG-D (0.231 U/mg); 7 & 8, 50pg & 25pg HNE-D
(0.148U/mg);9 irrelevant sample; 10 molecular weight markers
Figure 3.6 Reverse-Phase analysis of HNE/ and HNCG
■ BiMtttjllaM KPLC anetyafr HNE'i)
b R«v»r«*-ph«M hplc lnahali of hncg l>

















a) HNE[ (approximately 200pmol of a preparation with a specific activity of 0.210U/mg) and b) HNGG -£)
(approximately 200pmol of a preparation with a specific activity of 0.345U/mg) were examined by
reverse-phase chromatography using an Aquapore RP-300 column (Brownlee, ABI) eluted with a gradient
of 10-70% acetonitrile/0.1% TFA over 45 minutes (flow rate 200 pl/min). Peak A from chromatograph (a)
and peak B from chromatograph (b) were collected manually and N-tdfminal sequence analysis confirmed
them to be HNE and HNCG respectively.
3.1.4. Investigation of the difference between the specific
activity of HNE-D and HNE-G
The specific activity of HNE-D was always less than the specific
activity of HNE-G. However, each value agreed with one published value
(Heck et al. 1985 and Twumasi and Liener, 1977 respectively). Preparations
were separated by SDS-PAGE (Figure 3.5) and examined for any obvious
differences between the preparations.
The molecular weight of the HNCG and the major HNE preparations
were approximately 27-30kDa, although the HNE preparations appeared
slightly smaller than the HNCG preparations. These values are similar to
those obtained by Martodam et al (1979) and others for the HNE isoforms
and for HNCG. A noticeable difference between HNE-D and HNE-G is the
presence of a species of approximately 22kDa in the former preparation.
This is too small to be HNE, HNCG or the third serine proteinase found in
azurophil granules, known as proteinase-3, which is at least 27kDa (Kao el
al, 1988; Wilde et al. 1990) but it does explain the lower specific activity of
HNE-D. Samples of HNE-D and HNCG-D were analysed by reverse-phase
chromatography to assess the extent of contamination by other species.
3.1.5 Reverse-phase chromatographic separation of the
enzvmes and N-terminal sequence analysis
Samples of the HNE-D and the HNCG-D were examined by reverse-
phase chromatography on an Aquapore RP-300 column (Brownlee, ABI)
(Figures 3.6a and 3.6b). The peaks presumed to correspond to HNE and
HNCG were collected manually and the N-terminal sequences were
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Figure 3.7 Molecular exclusion chromatography of HNE-T)
HNE (0.30U in 200pl) was examined by molecular exclusion chromatography using a 25ml
Superose-12 column (Pharmacia) eluted with 50mM sodium phosphate buffer/0.2M NaCI, pH
7.2 at a flow rate of 0.5ml/min (pressure=1 5MPa). The absorbance of the eluate was detected
at 280nm ( ). Fractions (1ml, 2 minutes) were collected and their activity against
0.198mM-STANA was measured ( ). The specific activity of the fractions ( ) is
shown in the upper trace.





These sequences are identical to those given by Martodam et al
(1979); and the HNE N-terminal sequence is identical to that deduced from
the gene sequence of HNE (Farley et al. 1989).
The HNE appeared to be 40% contaminated with another species (by
comparison of A220 values of Figure 3.6a). The specific activity against
STANA of the preparation prior to reverse-phase chromatographic
separation was 0.210 U/mg of which only 60% of the material (as A220) was
HNE. The fact that the contaminating peak (C) has an absorbance at 220nm
is not evidence that it is a protein; assuming the contaminant was a protein
incapable of hydrolysing STANA, it follows that the specific activity of "pure"
HNE would have been 0.350 U/mg. Evidence suggesting the contaminating
material was a protein incapable of hydrolysing STANA was obtained when
a sample of the HNE was separated by molecular exclusion
chromatography (Figure 3.7). The activity against STANA was localised to
peaks which eluted at a position corresponding approximately to the
molecular weight of the HNE isoforms. The pure "HNE" showed signs of
separating into at least two isoforms (as A28o)- may tentatively
suggested that the second isoform had a greater specific activity, this may be
compared with the work of Heck et al (1985) who separated HNE into 4
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isoforms of apparently different specific activities. Their smallest isoform
appeared to have the greatest specific activity. In Figure 3.7 a smaller
contaminating species seemed to be eluted after 37 minutes, but was
incapable of hydrolysing STANA. However, this is not indicative of an
inability to hydrolyse elastin.
The ability of equal activities (as determined against STANA) of HNE-
D (specific activity 0.148 U/mg) and HNE-G (specific activity 0.354 U/mg) to
digest collagenase-treated elastin at pH 7.4 and 37°C (detailed in Section
2.3.1) were compared. Triplicate aliquots were removed after 24 hours of
digestion and the soluble peptides were measured as detailed in Section
2.3.3. The amounts of peptides produced by the action of HNE-D/mg of
elastin and HNE-G/mg of elastin were 0.890 ± 0.094(imol and 0.915 ±
0.091 pmol. Since digestion by HNE-D did not yield a greater amount of
peptides than did the digestion by HNE-G, it was concluded that the
contaminant in HNE-D was inactive against elastin. In general, preparations
with a specific activity of approximately 0.350U/mg, as determined against
0.198mM STANA at pH 8.0 and 37°C in the presence of 1M NaCI, were
used for the digestion of elastin.
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Tgble 3-4 The recovery of luna elastin as Lansing elastin and
collaaenase-treated elastin
Lung 1 Lung 2 Lung 3
Mass of Lansing elastin (g) 1.12 1.31 2.80
% of original tissue (wet weight) 0.23 0.33 0.70
Mass of collagenase-treated elastin (g) 6.40 10.68 6.42
% of original tissue (wet weight) 1.33 2.67 1.61
The recovery of Lansing lung elastin and collagenase-treated lung elastin was approximately
0.5% and 1.8 % of the original weight of tissue, which may be compared with the recoveries
noted by Reilly and Travis (1980) which were 0.05%-0.075% of the original tissue when the
elastin was isolated by either method.
3.2 ISOLATION OF ELASTIN
3.2.1 Isolation of luna elastin
Lungs were removed at post-mortem from 70 year olds who had not
died as a result of respiratory disease. The tissue was fixed for 3 days in
ethanol or acetone, then homogenised and washed several times in 50mM
Tris-HCI/0.15M NaCI, pH 8.0, defatted in acetone and air-dried to give an
acetone powder. The mass of the dry powder was 7.5%-9% of the mass of
wet tissue used.
The acetone powders were divided into two and the elastin was
isolated from one half by the method of Lansing et al (1952) and from the
other half by the method of Ross and Bornstein (1969) (Table 3.4). The
Lansing treatment is often described as "degradative" since it involves
solubilising all other proteins by boiling the tissue in 0.1M sodium hydroxide
solution. Although this provides a relatively pure preparation of elastin; it is
possible that some damage will be inflicted on the elastin. An increase of N-
terminal residues is produced by prolonged treatment with the alkali (greater
than 45 minutes) indicating that hydrolysis has occurred (Gotte et al. 1963).
In comparison, the method of Ross and Bornstein involves more gently
solubilising other proteins by treating the acetone powder with denaturants,
such as guanidine hydrochloride, and dithiothreitol and the enzyme
bacterial collagenase (Sigma). The resultant elastin is termed the
collagenase-treated elastin (Reilly and Travis, 1980).
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Tgt?ie 3.5 Amino acid analysis of Lansing elastin
Amino acid residues/1000 residues
Asx
Lung 1 Lung 2 Lung 3 Average Lansing (a) Indik (b)
0 23.1 32.1 17.7 7 4
Glx 42.7 36.8 33.5 36.3 22 19.5
Ser 0 15.5 0 5.0 7 20.5
Gly 264.5 292.7 285.9 270.2 335 290
His 0 0 0 0 6 3
Arg 18.7 13.8 0 10.4 6 15
Thr 0 0 0 0 7 17
Ala 235.6 229.5 242.2 226.7 267 217
Pro 127.4 112.1 125.7 117.0 109 130
Tyr 23.4 15.1 25.1 20.4 23 18
Val 144.5 128.0 135.4 130.8 100 127
Met 0 0 0 0 4 1
Cys 0 0 0 0 0 3
lie 27.5 25.7 21.3 23.9 19 22.5
Leu 82.7 68.7 71.0 71.3 55 45
Phe 33.0 26.8 27.9 28.1 20 20.5




a) The composition of Lansing elastin as quoted by Reilly and Travis (1980).
b) The composition of elastin determined by Indik et al (1987) from the cDNA
sequence of human tropoelastin.
Table 3.6 Amino acid analysis of collaaenase-treated elastin
Amino acid
residues/1000 residues
Lung 1 Lung 2 Lung 3 Average R & T (a) Indik (b)
Asx 45.2 72.8 67.2 58.1 12 4
Glx 83.3 86.2 62.4 72.7 26 19.5
Ser 29.3 34.2 33.1 30.3 14 20.5
Gly 277.4 268.6 227.2 242.3 309 290
His 0 0 0 0 2 3
Arg 45.1 41.6 35.2 38.2 8 15
Thr 0 0 22.2 7.0 16 17
Ala 160.5 153.1 152.5 146.1 241 217
Pro 117.6 108.9 93.0 100.1 109 130
Tyr 12.4 13.2 11.4 11.6 22 18
Val 85.4 81.5 94.8 82.0 118 127
Met 0 0 0 0 4 1
Cys 0 0 0 0 0 3
lie 24.1 23.7 67.6 36.2 21 22.5
Leu 63.3 62.1 74.4 62.6 57 45
Phe 28.0 27.6 31.0 27.2 21 20.5




a) Composition of collagenase-treated elastin as quoted by Reilly and Travis (1980).
b) Composition of elastin quoted by Indik et al (1987) from the cDNA sequence
of human tropoelastin.
3.2.2 Amino acid analysis of the preparations of luna
elastin
The relative purity of insoluble elastin is traditionally assessed by
amino acid analysis of an acid hydrolysate of elastin. Samples of all the
elastin preparations were acid hydrolysed as detailed in Section 2.2.3.
Amino acid analysis was then undertaken on 10pl sample of the hydrolysate
(containing 0.2pg of original material) by the Wei-Met Protein
Characterisation Service (Tables 3.5 and 3.6). On a separate occasion, the
temperature and gradient of the amino acid separation were altered to allow
the measurement of hydroxyproline, which would otherwise co-elute with
aspartic acid. It was only possible to analyse one pair of lung elastins by this
method.
The amounts of desmosine and isodesmosine in the acid
hydrolysates were kindly determined by Mr. G. Fiaux using a method
adapted from the procedure devised by Yamaguchi et al. (1987). Briefly, the
constituents of the acid hydrolysate (1 OjliI) were separated on a C-j g reverse-
phase column. The absorbance of the eluate was detected at 270nm;
desmosine and isodesmosine eluted at characteristic times. The amount of
each of the cross-links in the sample of hydrolysate was determined from the
peak area by consulting a standard curve relating peak area to amount of
desmosine or isodesmosine. These values were related to those of the
other amino acid's solely by the volumes applied to the analytical columns.
Comparison of the literature figures with the composition of the lung
elastins and the composition of the tropoelastin gene sequence show a
great deal of variability. This variability can also be noted when comparing
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the compositions of lung elastins isolated by the same method and when
comparing elastin isolated from the same lung but by different methods.
Variability has been noted by several other authors (Paz et al. 1976; Soskel
and Sandberg, 1983), and has been suggested to be a consequence of the
crude nature of the methods of isolation of lung elastin from lung tissue,
which is rich in other structural proteins which are also poorly soluble. A
consequence of the inconsistent compositions of the lung elastin is that it is
difficult to estimate the extent of possible contamination with collagen or
glycoprotein. Therefore, determination of purity of elastin is usually decided
on a qualitative basis as a lack of methionine and cysteine, low levels of
hydroxyproline (1-2%), and large amounts (20% or more) of alanine and
valine (greater than 7.5%) (Soskel and Sandberg, 1983). This method of
assessing purity led Soskel and Sandberg (1983) to the conclusion that the
Lansing method of isolation yielded a relatively purer elastin than non-
degradative methods such as the method of Richmond (1974) which is
based on the method of Ross and Bornstein (1969). Comparison of the
compositions with the gene sequence of tropoelastin shows that for
collagenase-treated elastin, the content of the acidic amino acids and the
most frequent amino acids such as glycine, alanine, proline and valine
deviate from the gene figures to a greater extent than do those for Lansing
elastin. The yield of collagenase-treated elastin was on average four-fold
greater than the yield of Lansing elastin from the same tissue (Table 3.4).
This suggests, in agreement with Soskel and Sandberg (1983), that elastin
isolated by a non-degradative method was less pure than the Lansing
elastin.
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Table 3.7 Amino acid composition of human skin collagen
Amino acid
residues/1000 residues




















a) The composition of skin collagen as quoted by Bornstein and Piez (1964).
b) The composition of Lansing lung elastin as quoted by Reilly and Travis (1980).
3.2.3. Determination of collagen contamination in
preparations of luna elastin
Contamination of elastin with collagen would give elevated levels of
acidic amino acids, lysine, arginine and hydroxyproline, combined with a
proportional decrease in the content of alanine and valine (Table 3.7). The
levels of acidic amino acids in elastin have been suggested to increase with
age (Indik et al. 1989) by virtue of the fact that they are localised within exon
10A, which as a result of alternative splicing, is poorly expressed in foetal
aortic elastin but appears to be expressed well in elderly aorta. The
variability of these amino acids with age suggests they are of little use in
assessing the collagen content of elastin isolated from elderly patients.
Contamination by collagen can be specifically assessed by measuring the
presence of hydroxyproline. Hydroxyproline accounts of 9%-10% of the
composition of collagen but only 1%-2% of the composition of elastin, and is
very rare in other proteins. The amounts of collagen and elastin present
within a preparation of elastin have been deduced by Stone et al (1987) to
conform to the equations:-
Collagen (pg) = 0.92 [nmol Hyp-9(nmol Des + Ide)]
and Elastin (pg) = 43 x nmol (Des + Ide)
These equations assume that the average residue masses in elastin
and collagen are 85 and 92 respectively; and the average hydroxyproline
(Hyp) and desmosine (Des) plus isodesmosine (Ide) content of elastin are
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Table 3.8 Calculation of collagen contamination of the preparations of luna elastin










Lansing elastin 0.342 0.006 2 0.145 42
Collagenase-treated
elastin
0.240 0.047 20 0.053 22
The concentration of hydroxyproline and desmosine/isodesmosine present in acid hydrolysates of 'pure'
lung elastin preparations were used to calculate the theoretical collagen and elastin contents of the
preparations (Stone et al, 1987). The resulting values were expressed as a percentage of the mass of
elastin which was hydrolysed.
18 residues per 1000 and 2 residues per 1000 respectively.
When the equations were applied to the preparation of Lansing
elastin and collagenase-treated elastin (Table 3.8) the latter preparation was
calculated to have a 10-fold greater collagen content than the former.
Further evidence to suggest collagenase-treated elastin contained a greater
proportion of collagen was produced when each preparation was digested
with bacterial collagenase (enzyme:substrate ratio 1:75 (w/w); Sigma) at
37°C and pH 7.5 for 5 hours. The quantities of soluble peptide products
were estimated by the method detailed in Section 2.3.1., and corresponded
to approximately 8% and 3% of the collagenase-treated elastin and Lansing
elastin.
The calculated amounts of collagen and elastin only accounted for
44% and 42% of the original mass of Lansing elastin and collagenase-
treated elastin respectively which suggests that either the preparations were
contaminated with other proteins or other macromolecules, or there were
large losses during the acid hydrolysis and subsequent dilutions. The latter
suggestion was investigated by acid hydrolysis and amino acid analysis of a
known amount of pure (3-lactoglobulin, which has a known composition
(Braunitzer et al. 1973). The recovery of p-lactoglobulin, as a percentage of
the material hydrolysed, was 37%. It was concluded that the low recoveries
of the elastin preparations are probably a consequence of losses produced
during hydrolysis and sample preparation rather than the presence of other
macromolecules.
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Table 3.9 Amino acid composition of human aortic elastln
Amino acid
residues/1000 residues
Human aortic elastir Dog aortic elastin (a) Human tropoelastin (b Microfibril (c)
Asx 69 6 4 68
Glx 57 24 19 222
Ser 34 15 20 45
Gly 219 338 283 45
His 0 5 3 34
Arg 24 7 15 56
Thr 19 20 17 40
Ala 182 238 212 49
Pro 91 103 127 106
Tyr 17 24 18 51
Val 110 99 124 69
Met 0 0 1 4
Cys 0 0 3 68
lie 27 26 22 22
Leu 78 44 41 72
Phe 33 24 20 22





a) The composition of dog aortic elastin isolated by Paz et al (1976).
b) The composition of tropoelastin from the cDNA sequence (Indik et al, 1987).
c) Bovine microfibrillar component (Indik et al, 1989).
3.2.4. Isolation of aortic elastin
The aorta and lung 2 were removed from the same patient. The aorta
was fixed in acetone for 3 days before the elastin was isolated by the
method of Paz et al (1976) which involved isolating the elastin from minced
aorta by trichloroacetic acid extraction followed by successive treatments
with bacterial collagenase, then dithiothreitol with 6M guanidine
hydrochloride and finally urea, dithiothreitol and sodium dodecyl sulphate.
The mass of aortic elastin recovered from 23.7g of aorta was 2.3g.
After isolation a sample of the elastin was subjected to total acid
hydrolysis and the amino acid composition of the aortic elastin, including
hydroxyproline, desmosine and isodesmosine, was determined (Table 3.9).
The values for the percentage of collagen and elastin in the aortic elastin,
calculated from the previously given equations (Stone et al. 1987), were 0%
and 38% respectively. The proportions of aspartic acid and glutamic acid in
the acid hydrolysate of the aortic elastin were much higher than expected.
The microfibril component of elastic fibres is rich in aspartic acid and
glutamic acid (Table 3.9; Indik et al. 1989), suggesting that the glycoproteins
of the microfibril component of the elastic tissue had not been completely
removed from the elastin during the isolation of the protein. Gotte et al
(1963) stated that the ease with which the other components of the matrix
were removed from the elastin varied from tissue to tissue. He observed that
aortic elastin was difficult to separate from the microfibril component of the
elastic tissue, which seemed to be interpenetrated within the elastin, and
stated that aortic elastin isolated by alkali treatment at 98°C contained some
polysaccharide-containing material.
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3.2.5 Concluding remarks about the isolation of elastin
The suggestion that the harsh treatment of lung tissue by hot sodium
hydroxide to yield pure elastin is a "degradative" procedure (Serafini-
Fracassini et al. 1975) was put into context by Gotte et al (1963) who
suggested that the damage to the elastin itself was minimal when the
treatment was limited to 45 minutes at 98°C with 0.1 M sodium hydroxide.
However, the amounts of serine and threonine are lower than expected in
the case of Lansing elastin and this may be related to the fact that they are
labile on alkali hydrolysis. In comparison, the amounts of alanine and valine
were as expected. These residues are not easily chemically damaged, and
they are the main P1 residues of substrates of HNE. Concerns about the
"degradative" procedure led to the development of "non-degradative"
methods which claimed to be less destructive; but the final preparations had
a greater degree of contamination by collagen, which complicates any study
which is concerned primarily with the products of digestion of pure elastin. A
further disadvantage of the "non-degradative" methods is that the treatment
with denaturants such as guanidine and urea may change the physical
structure of the proteins; damage to elastin is not necessarily avoided by
omitting the harsh sodium hydroxide treatment. This was observed by
Gosline (1976) who noted that the treatment of elastin with urea causes an
increase in the swollen volume of the elastin.
Therefore, none of the methods of isolation is ideal; but in the
interests of producing a relatively pure product the methods of Lansing et al
(1952) and Paz et al (1976) are most appropriate, although their
"degradative" nature should not be ignored. Similarly, although Lansing
lung elastin and Paz aortic elastin are of similar quality, they were isolated
by different methods. Although any differences between the preparations
encountered in the course of this work could be suggestive of differences
between elastins isolated from different organs (a consequence of
alternative splicing of the tropoelastin gene; Indik, et al. 1989), it cannot be
proven to be the case within the boundaries of this work, because the
tissues have been subjected to different treatments, and the aortic elastin
may contain some of the microfibril glycoprotein.
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CHAPTER 4
MEASUREMENT OF THE SOLUBLE PRODUCTS OF
ENZYMIC DIGESTION OF ELASTIN
Figure 4,1 Estimation of soluble elastin-derived peptides as detectible





















Figure 4,1 Estimation of soluble elastin-derived peptides as















Estimation of the soluble peptides from undigested control suspensions of elastin
(CON), and those produced by the enzymic digestion of a) Lansing elastin;
b) collagenase-treated elastin and c) aortic elastin with PPE, HNE or HNCG (as detailed
in section 4.1.1) by three standard methods of protein estimation (detailed in section
2.3.2).
CHAPTER 4
MEASUREMENT OF THE SOLUBLE PRODUCTS OF ENZYMIC
DIGESTION OF ELASTIN
A preliminary investigation was done to find the most suitable means
of measuring the extent of digestion of elastin.
4.1.1 Digestion of elastin and isolation of the soluble
peptides
A single suspension of each elastin preparation (3mg/ml in 0.1 M
sodium phosphate buffer/0.15M NaCI, pH 7.4) was digested for 24 hours at
37°C with either porcine pancreatic elastase (PPE; 2mU/ml, as measured
against 0.198mM STANA; corresponding to an enzyme substrate ratio of
1:1000 w/w); HNE (10mU/ml; 1:100 enzyme substrate ratio, w/w) or HNCG
(10mU/ml, 1:130 enzyme substrate ratio, w/w). After digestion, the insoluble
and soluble peptides were separated by centrifugation in an MSE microfuge
at high speed for 10 minutes.
4.1.2 Measurement of the mass of soluble peptides
The mass of the soluble elastin-derived peptides were measured by
three standard methods of protein estimation, detailed in Section 2.3.2
(Figures 4.1a, b and c).
Comparisons between the three methods show widely varying
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Figure 4.2 Demonstration of the relative abilities of standard protein
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Estimated peptide bonds/actual peptide bonds (%)
Known masses (a) and the number of peptide bonds (b) of four peptides (Gly-Gly,
glycyl-glycine; Leu-Tyr, leucyl-tyrosine; Glu-Thr-Tyr, glutamyl-threonyl-tyrosine;
Gly-Gly-Ala, glycyl-glycyl-alanine (all from Bachem AG); and Gly-Gly-Ala-Leu-Tyr,
glycyl-glycyl-alanyl-leucyl- tyrosine, synthesised by Dr A P Ryle by the condensation of
Gly-Gly-Ala with Leu-Tyr) were estimated by the Bradford method (n=3) and by the BCA
and biuret methods on three occasions in quadruplicate (n=12). The estimated mass or
number of bonds detected by each method was expressed as a percentage of the known
mass or number of bonds; thus indicating the relative ability of each method to detect
small peptides.
results. The Bradford method, which is dependent on the binding of the dye
Coomassie blue to the peptides, appeared ineffective. This is presumably
because the dye binds predominantly via arginyl residues (Compton &
Jones, 1985) (representing 1% of the composition of elastin), and does not
bind to alanine- or glycine- rich sequences which constitute large stretches
of the sequence of elastin (Indik et al. 1987). In contrast, the BCA and biuret
methods gave significantly higher and quite concordant estimates of the
soluble peptides. These methods are both based on the detection of
peptide bonds and detect peptides larger than dipeptides. The BCA method
is additionally dependent on the presence of particular residues such as
tyrosine (Wiechelman et al. 1988). Both methods are suitable for estimating
proteins and large peptides which have many peptide bonds and a
representative mixture of amino acid residues, but small peptides may be
underestimated. This is important when estimating the amount of potentially
heterogeneous elastin-derived peptides. The ability of the three methods to
detect the mass of small peptides and the peptide bonds within small
peptides was tested using some small pure peptides (Figures 4.2a and b).
As expected the Bradford method was ineffective in measuring small
peptides devoid of arginyl residues. The BCA and biuret methods were
relatively more effective in estimating the small peptides. However, the BCA
method detected tyrosine-free tripeptide ineffectively and the biuret method
appeared able to detect dipeptides, which was rather surprising, but
responded less well to peptides with 2-4 peptide bonds. Although the biuret
method was quite effective in the detection of peptide bonds, it was
concluded that with both the BCA and biuret methods the recoveries of the
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small peptides, in terms of mass, were still significantly lower than 100%, so
the smaller peptides in a heterogeneous mixture of elastin-derived peptides
may be underestimated.
4.2 Measurement of the free amino groups of the soluble
peptides
The estimation of soluble peptides in molar terms is possible by
measuring the amino groups present in a mixture of peptides; this assumes
that only 2-amino groups and no lysine 6-amino groups are found in the
peptides. Since the side groups of the majority of the few lysine residues of
elastin are oxidised to the corresponding aldehyde or incorporated into
cross-links, their contribution to the estimation of the amino groups of elastin-
derived peptides is negligible.
4.2.1. Measurement of free amino groups using TNBS
Amino groups of peptides react with TNBS at pH 8.0 to give 2,4,6-
trinitrophenylated peptides (Tnp-peptides).





Figure 4.3 The absorption 3PQCtra fll the reaction product of
the TNBS and glycine reaction at oH 8.0.
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Duplicate samples of 0.5p.mol of glycine (0 5ml) were trinitrophenylated with 0.5ml of
0.1% TNBS in 0.5ml of 0.1 M sodium phosphate buffer, pH 8.0 (see section 2.3.3). After
incubation, a further 0 5ml of the same buffer was added to one reaction mixture. This
sample and the corresponding reagent blank were diluted with an equal volume of water
and the absorption spectrum of the reaction mixture pH 8.0) was measured against the
reagent blank ( ). The second reaction mixture was acidified to pH 1.0 with 0.5ml of
4M HCI. Once again, the reaction mixture and the appropriate reagent blank were diluted
with an equal volume of water, before the absorption spectrum of the acidified sample was
read against the acidified reagent blank ( ).
Both absorption spectra were measured in a PU8700 uv/vis spectrophotometer (Philips).
Figure 4,4 Comparison of the absorbance at 420nm of Tnp-alvcine with
and without acidification
Two sets of triplicate samples of glycine (0-0.5p.mol in 0.5 ml) were
trinitrophenylated as in section 2.3.3. After incubation, 0.5ml of 4M HCI was
added to each of one set of triplicates (giving final volumes of 2ml and
approximate pH of 1), whilst the other set of triplicates remained untreated
(giving final volumes of 1.5ml). The absorbance of each set of Tnp-glycine
standards was measured at 420nm against the appropriate reagent blank; and
the absorbance values of the neutral standards were corrected to the value
expected if their volume was 2ml.




The estimation of the soluble peptides produced in section 4.1.1 by the enzymic digestion of
Lansing elastin, collagenase-treated elastin and aortic elastin with no enzyme (control: CON),
PPE, HNE or HNCG. The Tnp-peptides were measured as the absorbance at 420nm against a
reagent blank, and estimated by reference to a standard curve prepared with glycine (n=3).
Figure 4,6 Estimation of the relative size of the soluble peptides as the ratio of














The estimation of the relative size of the soluble elastin-derived peptides prepared as detailed in
section 4.1.1., as the ratio of the estimated mass of peptides to the estimated moles of peptides.
with TNBS at pH 8.0 and 37°C for 2 hours, which is the time necessary for
the complete formation of Tnp-glycine (Satake et al. 1960). The Tnp-
peptides have absorbance maxima at 350nm and 420nm, at neutral and
acidic pH (Figure 4.3). The absorbance of a neutral reagent blank at 420nm
is high because of the presence of picrate anions, a decomposition product
of TNBS. Satake et al (1960) recommend the acidification of the samples
with 4M HCI to approximately pH 1.0. The absorbance of the reagent blank
is reduced by approximately 0.4 on acidification, but this is at the expense of
sensitivity (Figure 4.4). The molar absorbances of Tnp-glycine, calculated
from Figure 4.4, are 7120 l.mol"1.cm"1 at pH 8.0 and 4300 l.mol.~1.cm~1 at pH
1.0.
4.2.2 Application of the method to the measurement of
soluble elastin-derived peptides
When the soluble peptides produced by PPE digestion of Lansing
elastin and aortic elastin (see Section 4.1.1) were trinitrophenylated and
acidified with HCI, the resulting solutions were visibly cloudy so that
spectrophotometric measurements could not be made. So, the Tnp-
peptides were measured at pH 8.0, avoiding the precipitation of the elastin-
derived peptides (Figure 4.5).
4.2.3 Estimation of the relative size of the peptides
The relative size of the soluble elastin-derived peptides was
estimated as the ratio of mass, equivalent to BSA, by the BCA method
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(Section 4.1.2) to moles, equivalent to glycine, by the TNBS method
(Section 4.2.2) (Figure 4.6). The data suggest that the peptides are
between 5 and 9 residues long. Again note that the BCA method potentially
underestimates the mass of the elastin-derived peptides, so the size of the
peptides will also be underestimated.
4.3 Concluding remarks about the estimation of soluble
elastin-derived peptides
Elastin is more susceptible to attack by PPE than by HNE (Reilly &
Travis, 1980), and the digestion by HNCG is least effective. This was not
unexpected. By assuming that PPE can cleave peptide bonds on the
carbonyl side of glycine, valine and alanine residues, that HNE can cleave
peptide bonds to the carbonyl side of valine, alanine and isoleucine, and
that HNCG can cleave peptide bonds to the carbonyl side of isoleucine,
leucine, methionine, tyrosine and phenylalanine; then it may be calculated
that PPE, HNE and HNCG can potentially cleave 70%, 37% and 12%
respectively of the residues in Lansing lung elastin . This assumes that each
bond is equally susceptible to digestion, irrespective of steric effects of the
neighbouring residues and of whether neighbouring bonds are cleaved.
This assumption is known not to be entirely justified (Nakajima et al. 1979;
and see Section 1.2 for details of the specificity of these enzymes).
Lansing elastin and aortic elastin are more susceptible to enzymic
digestion than is collagenase-treated elastin. This is probably due to the
contamination of collagenase-treated elastin with collagen (see Section
3.2.3), rather than to a possible increased susceptibility of Lansing elastin
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and aortic elastin to attack as a consequence of very limited hydrolysis of
peptide and amide bonds by sodium hydroxide or TCA during the isolation
of the elastins. If hydrolysis had occurred, the peptides from Lansing elastin
and aortic elastin would be smaller than the peptides from collagenase-
treated elastin; this did not appear to be the case (Figure 4.6).
Since the estimation of peptides produced, in molar terms, is more
meaningful than weight-based estimates related to standard proteins, the
TNBS method was adopted in further investigations of elastin digestions.
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CHAPTER 5
DEVELOPMENT OF A METHOD FOR THE
ESTIMATION OF TOTAL PEPTIDES
CHAPTER 5
DEVELOPMENT OF A METHOD FOR THE ESTIMATION OF
TOTAL PEPTIDES
Soluble peptides may be estimated spectrophotometrically as the
Tnp-peptides formed by the reaction of the amino groups of peptides with
TNBS (see Chapter 4). The spectrophotometric method cannot be used to
measure directly the amino groups of insoluble peptides or proteins,
because the absorbing Tnp-group will be sedimented on centrifugation.
However, the sulphite by-product of the TNBS reaction is soluble and should
be measurable. It seemed that sulphite could be estimated by allowing it to
reduce a suitable chromophore if a stoichiometric reaction could be
achieved.
5.1 The choice of a chromophoric oxidising reagent capable of
reacting with sulphite
Ellman's reagent (5,5'-dithiobis-2-nitrobenzoate) and potassium
dichromate were rejected because they both react to give products which
absorb around the same wavelength as Tnp-peptides.
(a) Potassium permanganate
Potassium permanganate in acid solution was tested and rejected
because the loss of absorbance at 525nm was not linearly related to the
amount of sulphite added. It has also been reported by Hass (1937) that
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elastin may reduce highly oxidised salts of metals and this reaction would
interfere further.
(b) Iodine
Iodine was tested and rejected because a misleading decrease of
absorbance at 288nm resulting presumably from the iodination of the
peptides was sometimes observed. A second reason for the rejection was
that the absorbance of iodine overlaps with the absorbance of the cross-
linking residues and aromatic residues.
(c) NAD+
NAD+ was rejected because the product of the reaction between
NAD+ and sulphite absorbs at 320nm, which overlaps with the absorbance
of Tnp-peptides.
(d) Basic fuchsin
Basic fuchsin was reduced by sulphite giving a linear decrease of
absorbance at 540nm. It was rejected because it has a high chemical
affinity for elastin (Hass, 1937), which is exploited by its inclusion in resorcin-
fuchsin, a biological stain for elastin (Weigert, 1898). The binding of the dye
to elastin and elastin-derived peptides would cause a misleading decrease
of absorbance.
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Figure 5,1 The expected mechanism of the reduction of DCPIP with sulphite
Figure 5.2 The relationship between the concentration of DCPIP and
the absorbance at 605nm
The absorbance of DCPIP (0-0.16mM) in 0.05M sodium phosphate buffer,
pH 8.0 was measured against the phosphate buffer.
5.2 Investigation of the properties of 2.6-dichlorophenol
indophenol and its response to sulphite
The absorption spectrum of DCPIP (A.,^ 605nm) does not overlap
with the absorption spectrum of Tnp-peptides and DCPIP does not bind
significantly to elastin.
5.2.1 Determination of the optimum DCPIP concentration
Sulphite was expected to reduce and decolourise DCPIP according
to the equation shown in Figure 5.1. Estimating sulphite as a decrease of
absorbance necessarily meant starting with a reagent with a high
absorbance. The maximum useful initial absorbance will be limited by the
capabilities of the spectrophotometer. The range of concentration of DCPIP
over which the reported absorbance at 605nm and pH 8.0 is proportional to
the concentration of DCPIP was investigated (Figure 5.2) using a SP6-550
UV/vis spectrophotometer (Pye Unicam). The relationship was linear up to
an absorbance of approximately 1.76, corresponding to 0.1 mM DCPIP. The
molar absorbance of DCPIP at 605nm calculated from Figure 5.2 was
17600 l.mor1.cm"1. The molar absorbance of the DCPIP was not affected
by the presence of 0.05% TNBS. Armstrong (1964) measured the molar
absorbance of DCPIP at 600nm and pH 8.0 to be 21800 l.mol"1.cm"1. The
discrepancy between Armstrong's value of 21800 l.mor1 .cm"1 and 17600
l.mol"1. cm"1, the value calculated from Figure 5.2 is substantial. However,
there are two possible explanations for the difference. First, the discrepancy
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may indicate that the pH of the DCPIP solution was not correct. Armstrong
stated that the molar absorbance of DCPIP is dependent on pH and rises
from 2700 l.mol"1.cnr1 at around pH 4 to 22000 l.mol"1. cm"1 at
approximately pH 8.5. Therefore a discrepancy of 4000 l.mol"1.cm'1 could
indicate that the pH of the DCPIP solution was approximately pH 6.5, which
is substantially less than expected. The pH of the DCPIP solution was
checked and was correct. Alternatively, the DCPIP solution used during this
investigation may have had a lower concentration than originally thought, so
the actual molar absorbance would be greater than the calculated value.
Armstrong standardised his solution of DCPIP against ascorbic acid
solution, so this method of standardisation of the DCPIP solution was
adopted. A solution of ascorbic acid (approximately 0.2mM) was
standardised against exactly 0.33mM iodine solution. The 0.2mM DCPIP
solution (10ml) was then standardised against the ascorbic acid solution,
and the exact molarity was calculated. The absorbance at 605nm of the
DCPIP solution was divided by the calculated concentration of DCPIP to
give the actual molar absorbance at 605nm of the DCPIP solution, which
was 18900 l.mol"1 .cm"1.
5.2.2 Determination of the response of DCPIP to the
addition of sulphite
A solution of sodium sulphite (approximately 10mM) was
standardised. Briefly, a solution of approximately 0.1 M sodium thiosulphate
was standardised by titration against exactly 17mM potassium iodate
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Figure 5.3 The reduction of a constant amount of DCPIP with sulphite
sulphite (umol)
Sodium sulphite (0-0.45pmol) was added to 1ml of 0.2mM DCPIP in 0.05M sodium
phosphate buffer, pH8.0 with (p) and without (m ) 0.05% TNBS. The volume of the
solutions was made up to 2ml with the buffer and they were incubated at 37°C for 2
hours.
solution in the presence of potassium iodide. The standard sodium
thiosulphate solution was used to standardise approximately 0.05M iodine
solution. The iodine solution (25ml) was reduced with 10ml of
approximately 10mM sodium sulphite and the excess iodine was measured
by back-titration with the standard sodium thiosulphate. It was then possible
to calculate the volume of iodine reduced by the sodium sulphite solution
and the exact molarity of the sodium sulphite solution.
The reaction of a fixed concentration of DCPIP at 37°C, in the
presence and absence of TNBS, with varied concentrations of sodium
sulphite caused an approximately linear decrease of absorbance of DCPIP,
except for a lack of response below 0.05pmol (Figure 5.3). The lack of
response, which was rather variable, was initially thought to be a result of
oxidation of some of the sulphite by oxygen in the reagent and buffer.
However, the lack of response was not prevented by de-gassing the
solutions under vacuum.
The molar absorbances at 605nm for the reduction of DCPIP in the
presence and absence of TNBS, were calculated from the linear portions of
Figure 5.3 to be 10110 l.moI'Vcm"1 and 8070 l.mol"1.cm~1 respectively.
These values correspond approximately to half the molar absorbance of
DCPIP, which surprisingly suggests that at pH 8.0 2 moles of sulphite are
required to reduce a mole of DCPIP. This was rather unexpected and was
investigated further. These investigations are detailed in the Appendix.
Although the actual mechanism of the reaction is not as simple as
initially hoped, the reaction between sulphite and DCPIP did produce a
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Figure 5.4 The reaction of DCPIP with the sulphite by-product of the reaction
between TNBS and glycine
Glycine (0-0.25pmol in 0.5ml of solution) was added to 0.5ml of 0.1 M sodium phosphate
buffer, pH 8.0, and 1ml of 0.2mM DCPIP in 0.05M sodium phosphate buffer, pH 8.0
containing 0.05% TNBS. The solutions were incubated for 2 hours at 37°C after which
the decrease of absorbance was measured.
linear decline of the absorbance of DCPIP and was therefore considered
useful for the measurement of sulphite liberated by TNBS during its reaction
with peptides. By incubating the TNBS and DCPIP simultaneously with the
peptides the DCPIP would be available for reduction as the sulphite was
liberated from the TNBS. This would presumably minimise the loss of
sulphite due to oxidation by oxygen in the reagents, which would be
encountered if the DCPIP was not added until after the TNBS reaction had
reached completion.
5.3 Measurement of amino groups with DCPIP and TNBS
The DCPIP and TNBS reagent reacted with a varied amount of
glycine to give a linear decrease of absorbance at 605nm (Figure 5.4). The
molar absorbance of the reduction of the DCPIP was 7230 l.moM.cm"1,
which is slightly less than the molar absorbance for the reduction of DCPIP
with sodium sulphite (8070 l.mol~1.cm~1; see Section 5.2.2). When the Tnp-
glycine was measured in these standards as the increase of absorbance at
420nm, the resulting molar absorbance was calculated to be
6070 l.mol"1.cnr1. This is less than the molar absorbance of Tnp-glycine
produced by the reaction of glycine with TNBS alone which was 7120
l.moM.cm"1 (see Section 4.2 and Figure 4.4). As expected, glycine did not
produce a decline of the absorbance of DCPIP in the absence of TNBS.
An explanation for the discrepancy between the molar absorbance of
TNBS with glycine in the presence and absence of DCPIP was provided by
the work of Goldfarb (1966) which suggested that the absorbance at 420nm
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Figure 5.5 The enhancement of the absorbance at 420nm of Tnp-alvcine with
sodium sulphite
sulphite (umol)
Tnp-glycine free from sulphite (0.06mM in 4% sodium bicarbonate solution) was prepared
as detailed in the text. Tnp-glycine (1ml) was treated with sodium sulphite (0-0.45p.mol)
and the increase of absorbance at 420nm due to enhancement by the sulphite was
measured. The final volume of each solution was 1.1ml.
of Tnp-glycine is enhanced by sulphite, with which it can form complexes.
This was investigated by using Tnp-glycine free from sulphite prepared as
detailed by Okuyama and Satake (1960). Briefly, 75mg of glycine in 200ml
of 4% sodium bicarbonate solution was trinitrophenylated with 200ml of
0.1% TNBS. The solution was acidified to pH 1.0 with HCI. The solvent was
removed by rotary evaporation leaving sulphite free Tnp-glycine which was
re-extracted into 50% (v/v) methanol. The pure Tnp-glycine was dissolved in
4% sodium bicarbonate at a suitable concentration given that the molar
absorbance of Tnp-glycine in 4% bicarbonate at 348nm is1.54x104
1.mol~1.cm~1 (Okuyama and Satake, 1960).
Tnp-glycine free from sulphite had a lower absorbance at 420nm than
Tnp-glycine treated with sulphite (Figure 5.5). The enhancement of the
absorbance at 420nm of one mole of Tnp-glycine by equimolar sulphite was
calculated from Figure 5.4 to correspond to 3050 l.mol"1.cm"1. This is more
than sufficient to account for the discrepancy of 1050 l.moM.cnr1. The
reason why the discrepancy is less than the observed molar absorbance of
enhancement is probably that the TNBS solution probably contained some
sulphite which resulted from the reaction of TNBS with water.
It was concluded that the soluble peptides may be measured with
greater sensitivity as the increase of absorbance at 420nm after their
reaction with TNBS alone. The reduction of DCPIP with the sulphite by¬
product of the TNBS reaction, measured as a decrease of absorbance at
605nm, was established to be a suitable method for measuring all peptides.
However, it was necessary to standardise the method using a soluble amino
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Figure 5.6 The measurement of peptides resulting from the digestion of












Suspensions of Lansing lung elastin (3mg/ml in 0.1 M sodium phosphate buffer/0.15M
NaCI, pH 7.4) were digested with HNE (10mU/ml) for 8 hours at 37°C. Duplicate aliquots
were removed at intervals. The soluble amino groups in the supernatant of one aliquot
were measured by the TNBS method and the total amino groups in the second aliquot
were measured by the DCPIP and TNBS method. The amount of total and soluble
peptides were estimated by reference to the appropriate glycine standard curve, and the
amount of insoluble peptides was obtained by difference.
compound e.g., glycine because a suitable insoluble model was not
available.
5.4 Application of the DCP1P and TNBS method to the
estimation of total elastin-derived peptides
Suspensions of Lansing lung elastin were digested for 8 hours as
detailed in Section 2.3.1 with HNE (10mU/ml). Aliquots were removed
periodically. Half of each aliquot was used to measure the soluble peptides
with TNBS, and the other half was used for total peptide estimation with
DCPIP and TNBS. A typical result is shown in Figure 5.6 and suggests that
during a digestion with HNE up to 8 hours, Lansing lung elastin is
hydrolysed to give similar amounts of soluble and insoluble products.
Having established that the use of DCPIP and TNBS is a valid
method of evaluating elastin digestion, it was applied to the study of the
digestion patterns produced during the proteolysis of the various elastin
preparations with HNE and HNCG.
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CHAPTER 6
THE DIGESTION OF ELASTIN WITH HNE
Figure 6.1 Soluble peptide production/24 hours from a varied
amount of lung elastins digested with a constant amount
Pf hNE
Suspensions of Lansing lung elastin (a) and collagenase-treated elastin (a)
(0-20mg/ml in 0.1 M sodium phosphate buffer/0.15M NaCI, pH7.4) were digested with
a constant amount of HNE for 24 hours at 37°C. The soluble peptides were collected
and measured by the TNBS method (section 2.3.3).











Suspensions of lung elastins (3mg/ml in 0.1 M sodium phosphate
buffer/0.15M NaCI, pH 7.4) were digested with HNE (5, 10 or 15mU/ml) at
37°C (section 2.3.1). The amounts of soluble peptides were measured
after 1, 4, 8 and 24 hours of digestion (section 2.3.3). Each data point
corresponds to the average of triplicate digestions of each of the three
preparations of each type of elastin.
CHAPTER 6
THE DIGESTION OF ELASTIN WITH HNE
The digestion patterns produced when the elastin preparations were
digested with HNE were investigated.
6.1 The investigation of the difference between the
susceptibilities of Lansing luna elastin and
collaaenase-treated elastin to digestion bv HNE
In Section 4.3 it was shown that Lansing elastin was apparently more
susceptible than collagenase-treated elastin to proteolysis by HNE at 37°C
when the extent of proteolysis was measured at 24 hours. The difference
between the preparations was most noticeable when larger amounts of
elastin were digested with a constant amount of enzyme for a fixed length of
time (Figure 6.1); or when a constant amount of the elastin (3mg/ml) was
digested with HNE (5-15mU/ml) for more than 8 hours (Figure 6.2). The
difference between the amounts of soluble peptides produced after 24 hours
of digestion with HNE from Lansing elastin and collagenase-treated elastin
was never more than 2.5 fold. Stone et al (1987) observed that collagen
and elastin from cultured cells are capable of binding similar amounts of
HNE, but collagen is less susceptible to digestion. The contamination of the
collagenase-treated elastin with collagen was documented in Sections
3.2.2-3.2.3. The amino acid compositions of the soluble elastin-derived
peptides released from Lansing lung elastin, collagenase-treated elastin
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Figure 6.3 Amino acid composition of the soluble peptides resulting
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Suspensions of Lansing elastin, collagenase-treated elastin and aortic elastin were
digested with HNE (10mU/ml) for 24 hours at 37°C. The soluble peptides were
collected, after which they were hydrolysed and their amino acid compositions
were determined (see section 2.2.3)
and aortic elastin after digestion with HNE (10mU/ml) for 24 hours (Section
4.1.1) were obtained as detailed in Section 2.2.3, to permit the assessment
of the contribution of collagen to the peptides by means of the content of
hydroxyproline (Figure 6.3). The soluble peptides produced after the
digestion of collagenase-treated elastin with HNE were relatively rich in
hydroxyproline, suggesting that some of these peptides were derived from
collagen. Therefore, the collagen contaminating the collagenase-treated
elastin probably acts as a competing substrate for HNE.
The soluble peptides released from Lansing lung elastin had
essentially the same composition as the native Lansing elastin (Table 3.5).
In comparison, the soluble peptides released from aortic elastin after 24
hours of digestion with HNE contained a greater amount of aspartic acid and
glutamic acid and a smaller amount of glycine than the native aortic elastin.
This may simply imply that the digestion of aortic elastin allows the release
of any contaminating microfibril interpenetrated within the aortic elastin
which was not removed during the isolation of the aortic elastin (see Section
3.2.4). The peptides derived from collagenase-treated elastin also
contained a higher than expected amount of glutamic acid, this may be
another consequence of the contamination of collagenase-treated elastin
with collagen since collagen contains a greater amount of glutamic acid
than elastin.
6.1.1 Standardisation of the digestion conditions
For the purposes of all future digestions, 3mg/ml suspensions of
elastin (the concentration used by Boudier et al. 1981) were digested in
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Figure 6.4 The digestion of Lansing lung elastin with HNE
W Soluble peptides
Time (hours)
Suspensions of Lansing lung elastin were digested with HNE (5 or 10mU/ml) for up to 48 hours, as
detailed in section 2.3.1. Aliquots were removed periodically and the (a) total and (b) soluble
products were measured as detailed in sections 2.3.3 and 2.3.4 .
Figure 6.4 The digestion of Lansing luna elastin with HNE (continued)
c) Insoluble peptides
Time (hours)
Suspensions of Lansing lung elastin were digested with HNE (5 or 10mU/ml) for up to 48 hours, as
detailed in section 2.3.1. Aliquots were removed periodically and the (c) insoluble products were
measured as detailed in section 2.3.5.
0.1 M sodium phosphate buffer, pH 7.4, containing 0.15M NaCI, at 37°C.
These conditions of temperature, pH and NaCI concentration were used by
Reilly and Travis (1980) (see Section 2.3.1). The data presented in Figure
6.2 showed that some variation may be expected from digestion to digestion,
so all future digestions were performed at least once on each sample of
elastin, and a typical set of data is presented.
6.2 The digestion of elastin over a prolonged period of
time
Boudier et al (1981) and Reilly et al (1984) were primarily interested
in comparing the initial rate of soluble peptide release from elastin in
response to digestion by different enzymes, so it was not necessary for them
to follow the digestions to equilibrium.
In order to study the products of a digestion it is of some importance to
know when the reaction has reached completion. In a case such as this
where the products of the reaction will be studied, it is important to know if
the peptides were intermediates or if they were end-products of a digestion
which had reached completion. So preparations of elastin were digested for
a prolonged period of time in an attempt to establish how long the digestion
took to reach its equilibrium.
6.2.1 Digestion of Lansing lung elastin
Lansing lung elastin was digested for 48 hours with two doses of HNE
(5 or 10mU/ml, specific activity 0.324U/mg). The total, soluble and insoluble
amino groups were measured at regular intervals (Figures 6.4 a, b and c). In
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all cases the amount of peptides reached a maximum after approximately 24
hours of digestion, followed by a rather surprising decline of all the amino
groups; this pattern also occurred when the elastin was digested in 0.02M
sodium phosphate buffer/0.15M NaCI, pH 7.4 (phosphate buffered saline).
The samples were usually frozen after collection, and the peptides
measured within 48 hours.
It was assumed that freezing the samples would be sufficient to stop
further digestion by the enzyme. This was investigated by measuring the
amount of soluble amino groups in 3 samples before and after freezing. The
amounts did not differ, so confirming that freezing was sufficient to stop the
digestion. A second conclusion from this fact is that the freeze-thaw cycle
inflicted on the samples was not responsible for the apparent loss of amino
groups.
The fact that the amount of peptide production reached a maximum
suggests that either the enzyme was no longer active or the maximum
amount of digestion had occurred. Attempts were made to measure the
amount of enzyme activity remaining after 24 hours of digestion. Lansing
lung elastin was digested with HNE (10ml)/ml) for 24 hours at pH 7.4 and
37°C. The soluble material was separated from the remaining insoluble
material by centrifugation as detailed in Section 2.3.2. A sample of the
supernatant (0.1ml) was added to 0.9ml of 50mM Tris-HCI/1.0M NaCI pH
8.0, and 10(il of 20mM STANA. The solution was incubated at 37°C for an
hour, after which the absorbance at 410nm of the solution was measured
against a control solution which was identical except that the STANA was
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Figure 6.5 The effect of adding HNE to fractions of pre-diaested
elastin
0.5-
D Pellet, no enzyme
■ Pellet + enzyme
♦ Supernatant, no enzyme






A suspension of elastin was digested for 24 hours with HNE (5mU/ml) at 37°C and pH
7.4. The soluble and insoluble material was separated by centrifugation and the
insoluble pellet suspended in fresh buffer. The supernatant and the pellet
suspension were divided in half. One half of each was treated with more enzyme
(5mU/ml) (aand<>); and the other half represented an untreated control (»andA).
Aliquots were removed periodically up to 54 hours from the initial time of digestion,
and the soluble peptides were measured by the TNBS method (see section 2.3.3).
omitted. The amount of enzyme activity, measured against STANA, which
was detectible in the digestion mixture after 24 hours of digestion typically
corresponded to 25% of the initial enzyme activity. This represents the
minimum amount of remaining enzyme, because it does not include the
enzyme which was preferentially digesting the soluble elastin-derived
peptides or the enzyme which was adsorbed on the elastin and had been
removed by centrifugation.
Having established that some of the enzyme activity was still present
after 24 hours of digestion, it was concluded that peptide production did not
cease after 24 hours because there was no active enzyme present. The
possibility still remained that the maximal point of digestion after 24 hours
represented the fact that no further bonds in the elastin could be hydrolysed;
this was investigated. Suspensions of elastin were pre-digested with HNE
for 24 hours and 37°C, after which the insoluble material was removed from
the soluble peptides and suspended in fresh buffer. The pellet suspension
and supernatant were divided approximately in half, and one half of each
was treated with a second dose of enzyme. Aliquots were removed
periodically and the soluble peptides were measured (Figure 6.5). Very little
further digestion of the pellets occurred, even when a second dose of
enzyme had been added, suggesting that no further enzyme could be
productively adsorbed onto the elastin or that the hydrolysis of the elastase-
susceptible bonds was complete. The addition of further enzyme did not
produce any increase in the amount of soluble peptides or prevent the
decline in free amino groups. So the apparent decline in the amino groups
was not due to a lack of active enzyme.
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Figure 6.6 The measurement of the soluble peptide produced bv the
digestion of collaaenase-treated elastin with HNE




Suspensions of collagenase-treated elastin were digested with HNE (5 or10mU/ml) at 37°C
and pH 7.4 for up to 54 hours (section 2.3.1). Aliquots were removed periodically and the
amount of soluble peptides were measured by the TNBS method (section 2.3.3). Each
data point was measured in triplicate.
Figure 6.7 Jhe measurement of the soluble peptides produced bv the
<Jjqe?fi9n 9f apufc elastin with HNE
Suspensions of aortic elastin were digested with HNE (10mU/ml) at 37°C and pH 7.4 for 48
hours (section 2.3.1). Aliquots were removed periodically and the amount of soluble
peptides were measured by the TNBS method (section 2.3.3). Each data point was
determined at least in duplicate.
6.2.2 Digestion of collagenase-treated elastin
As expected, when collagenase-treated elastin was digested with
HNE (5-10mU/ml) the maximum amount of detectible amino groups was less
than the maximum amount of soluble peptides from Lansing elastin;
probably as a result of the contamination with collagen (see Section 6.1).
Once again, a decline in the amount of soluble amino groups was observed
(Figure 6.6) although this was later than the observed declines in Lansing
elastin-derived peptides.
6.2.3 Digestion of aortic elastin
When aortic elastin was digested with HNE (10mU/ml) the initial
amount of soluble peptides (Figure 6.7) increased in a hyperbolic way.
Maximal digestion was reached after 24 hours, and there was no significant
decline of the peptides between 24 and 48 hours of digestion.
6.2.4. Comments and comparisons with the work of other
ggthgrs
The hyperbolic relationship between the amount of lung elastin and
the amount of soluble peptide production per 24 hours of digestion (Figure
6.1) was not surprising since Baici (1990) stated that there is a hyperbolic
relationship between the initial velocity of digestion with HNE and the
amount of bovine neck ligament elastin which was digested. Although it
should be noted that a direct comparison between initial velocity and an
apparent velocity is not totally justified because the calculation of the
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apparent velocity assumes that the velocity over 24 hours was constant,
when in actual fact it is not (Figure 6.4b).
Baici (1990) also presented kinetic data which supported the
mechanism of digestion proposed by Robert et al (1974). They suggested
that elastase is initially adsorbed onto the surface of the elastin,
predominantly by hydrophobic interaction, after which there is a limited
proteolysis to expose the interior of the elastin, providing further sites for
enzymic attack. As the amount of sites increases, so the amount of products
increases almost exponentially until a steady state is approached. The
digestion of Lansing lung elastin with HNE (Figure 6.4) was initially slow
followed by a rapid increase in the amount of products up to 24 hours of
digestion, so it appeared to comply with the proposed mechanism of elastin
digestion.
The digestion of elastin produces a conformational change, disrupting
the stability and hydrophobic interactions within the elastin (Robert et al.
1974). This is accompanied by a decrease in the affinity between the
enzyme and elastin. Therefore, it is reasonable to suggest that insoluble
pre-digested elastin (Figure 6.5) was not digested any further by the addition
of fresh enzyme because few susceptible bonds remained.
The digestion of collagenase-treated elastin appeared to follow a
normal reaction course without an initial accelerating stage. This is probably
because the early products of enzyme attack are derived from collagen (see
Section 6.1.2) which obscures the pattern of elastin digestion.
Similarly, the initial digestion of aortic elastin appeared to follow a
normal reaction course unlike the initial accelerating progression of the
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Lansing lung elastin digestion. This may be a consequence of the different
methods used for the isolation of the two types of elastin, which provided an
aortic elastin preparation which may be contaminated with microfibril (see
Section 3.2.4). Alternatively, it could be related to the morphological
difference between the elastins. Lung elastin, like neck ligament elastin,
exists as fibres, which may be unidirectional, whereas aortic elastin is
composed of fenestrated lamellae (Cleary and Cliff, 1978). Evidence to
suggest that the morphology may be significant was presented by Baici
(1990) who observed that porcine aortic elastin was digested with HNE at a
greater initial velocity than bovine neck ligament elastin. In comparing the
apparent velocity of the digestion of Lansing lung elastin and aortic elastin
as the amount of soluble peptides released over the first 4 hours of digestion
(Figures 6.4b and 6.7) it may be tentatively suggested that the aortic elastin
is initially digested with a greater velocity than Lansing lung elastin.
However, this could only be confirmed if the preparation of aortic elastin
used in the digestion was confidently shown to be devoid of any possible
signs of glycoprotein contamination.
More direct evidence to suggest that the peptides from aortic elastin
may differ from peptides derived from Lansing elastin was presented in
Figure 4.1. The quantity of peptides from aortic elastin detected by the BCA
reagent was greater than that with biuret reagent, but with Lansing lung
elastin peptides the reverse was true. This would suggest that the large
peptides from aortic elastin and Lansing elastin are different in composition
(detailed in Section 4.1.2). Although it is possible that this difference is
simply a reflection of the fact that some of the digestion products of the aortic
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elastin may be derived from the microfibril component which is
interpenetrated in the elastin.
6.3 The investigation of the apparent disappearance of
the amino groups
The apparent decline of the response of the peptidyl amino groups to
TNBS between 24 and 48 hours of digestion of Lansing lung elastin with
HNE suggests that there is a disappearance of the amino groups which was
unexpected and deserved further attention.
A simple explanation would be that the amino groups are slowly
modified by a component in the digestion buffer, but a phosphate buffer
contains no components likely to modify amino groups so this explanation
was rejected. A second explanation would be that the amino groups
become physically buried within an aggregate of peptides. This possibility
would appear unlikely, but for the fact that elastin-derived peptides are
known to associate together hydrophobically to form coacervates (Partridge
et al. 1955a). Another explanation would be that the amino groups undergo
a chemical reaction with some component of the elastin. This is possible
because aldehyde cross-link intermediates may be present in some of the
peptides (see Section 1.3), and are capable of forming Schiff's bases with
the amino groups of other peptides. The cross-link intermediates of
undigested elastin are locked in a situation which is inaccessible to amino
groups. So, the apparent loss of amino groups may be a consequence of
coacervation and/or new bond formation via the amino groups. The problem
was investigated further.
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6.3.1 Coacervation of elastin
Partridge et al (1955a) chemically digested bovine ligamentum
nuchae elastin with 0.25M oxalic acid at 100°C for several hours. The
resulting soluble peptides were termed a-elastin and p-elastin. p-Elastin
had a mean molecular weight of 5500 and consisted of 2 chains each
containing 27 amino acids (Partridge et al. 1955b). a-Elastin was much
larger, having a mean molecular mass of 60,000-84,000 and consisted of 17
chains each containing 35 residues. Partridge et al (1955a) observed that
under certain conditions of pH, temperature and ionic strength, molecules of
a-elastin were capable of associating together hydrophobically to form
coacervates. Speculative evidence to suggest that the peptides produced
by the digestion of Lansing lung elastin with HNE for 24 hours at 37°C form
coacervates was presented by Kucich et al (1985). They used polyclonal
antibodies to measure elastin-derived peptides and observed that the
recovery of peptides incubated in plasma, which contained inhibitors of the
major classes of proteolytic enzymes, for 24 hours at 37°C was less than
the recovery at 16°C. The loss was presumed to be due to coacervation.
This assumes that some of the peptides were buried within coacervates
making them inaccessible to the antibodies.
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Figure 6.8 Molecular exclusion chromatography of soluble elastln-derlved
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Suspensions of Lansing lung elastin were digested with HNE (10mU/ml) for 48 hours.
The soluble peptides (0.2ml) were isolated after 24 ( ) and 48 ( )
hours of digestion. The peptides were examined by molecular exclusion
chromatography as detailed in the text. The absorbance of the eluate was measured at
(a) 220nm and (b) 270nm. 100% corresponds to an absorbance at 220nm of 0.4 or an
absorbance at 270nm of 0.1. The path length of the flow cell was 1cm.
6.3.2 The investigation of an aggregation of the soluble
peptides
Wood (1958) stated that a production of a coacervate of elastin may
be observed as the formation of a cloudy suspension which can be
dissolved immediately after formation by heating to 40°C in 0.075M sodium
acetate buffer, pH 5.0. The solution of soluble elastin-derived peptides
produced after the digestion of Lansing lung elastin with HNE for 24 hours
appeared to be cloudy, suggesting that some of the peptides had formed
coacervates. It was presumed that the coacervates could be isolated by
high speed centrifugation, dissolved in buffer and then the amount of
peptides in the coacervate measured by the methods detailed in Sections
2.3.2-2.3.3
Lansing lung elastin was digested with HNE (10mU/ml) as detailed in
Section 2.3.1 for 48 hours. After 24 hours of digestion the suspension of
peptides was visible cloudy, even after they had been filtered through a
0.45fim filter. Samples of the soluble peptides were removed after 24 and
48 hours of digestion, and examined by molecular exclusion
chromatography using an Anagel-TSK G3000 SWXL column which was
developed with 50mM sodium phosphate buffer/0.15M NaCI, pH 7.4 as
detailed in Section 2.4.1 (Figure 6.8). The resulting elution profiles
suggested that the proportion of large peptides increased between 24 and
48 hours of digestion. It also suggested that the peptides are significantly
larger than predicted in Chapter 4 (see Section 4.3), confirming that the
protein assay underestimates the amount of peptides. Coacervates are
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large molecular weight aggregates. So, it seemed possible that the
increase in the proportion of larger peptides may result from an increase of
coacervation of the soluble peptides between 24 and 48 hours of digestion.
Further samples were removed after 24 and 48 hours of digestion,
and the cloudy supernatant was decanted from the remaining insoluble
elastin. The supernatants (0.5ml) were centrifuged at 100,000 rpm for 15
minutes at 4°C in a TL-100 Ultracentrifuge (Beckman). The precipitate was
dissolved in 0.1 M sodium phosphate buffer/0.15M NaCI pH 7.4 (0.1ml) and
the amounts of peptides in both the supernatant and dissolved precipitate
were measured. The percentage of peptides which precipitated was greater
in the case of the products of 48 hours of digestion, when measured in molar
terms (by the TNBS method) and in terms of protein (by the BCA method).
Therefore the amount of peptides capable of coacervating appeared to
increase between 24 and 48 hours of digestion.
6.3.3 The investigation of the aggregation of the inspire
material remaining after digestion
The apparent loss of the total and insoluble amino groups (Figures
6.4b and c) suggests that the amino termini of insoluble pellet were also
capable of some form of aggregation or coacervation. Kham et al (1982)
suggested that elastic coacervates are birefringent, if so the coacervates or
aggregates of the insoluble material could be examined microscopically
under polarised light. The insoluble material from elastin which had been
digested with HNE for 6, 24 and 48 hours was examined by light microscopy
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Figure 6.9 Light microscopic examination of the insoluble material
remaining after the digestion of eiastm with HNE
a) 6 hours of digestion
13.4 x magnification
hi 24 hours of digestion
13.4 x magnification
Figure 6.9 Light microscopic examination of the insoluble material
remaining after IM digestion of elastin with fcLNE
(continued)
48 hours of digestion
13.4x magnification
The insoluble elastin was isolated after (a) 6, (b) 24 and (c) 48 hours of digestion with HNE as
detailed in the text. The material was suspended in 1% (w/v) resorcin-fuchsin/4M HCI
(Weigert's stain; BDH) and viewed under polarised light using a Nikon SMX/10 microscope. The
image was photographed using an attached camera (Nikon) on 35mm, 100ASA film (Kodak).
The same pattern was observed when the resorcin-fuchsin was replaced by 0.1 M sodium
phosphate buffer, pH 8.0.
Figure 6.10 Measurement of the soluble peptides solubilised from digested
elastin bv 0.1 M NaOH
0 24 48
Hours of digestion with HNE
Undigested Lansing lung elastin, and the insoluble material remaining after 24 or 48
hours of digestion with HNE (approximately 2mg of each sample) were subjected to
alkaline hydrolysis with 0.1 M NaOH as detailed in the text.
under polarised light (Figure 6.9). It was evident that the birefringent elastin
particles seemed to associate together in a disordered fashion after
approximately 24 hours of digestion. A visible change in the consistency of
the insoluble material was also noticed. The insoluble material was seen to
associate together like rubber and was very difficult to disrupt. The
implication was that partially digested insoluble elastin is capable of re-
associating in a disordered but stable fashion.
According to Gotte et al (1963) partially digested insoluble elastin
becomes susceptible to alkaline hydrolysis because the previous
stabilisation by hydrophobic interaction and covalent cross-links is no longer
as strong. Therefore, after 24 hours of digestion of Lansing lung elastin with
HNE the insoluble remaining elastin is probably sensitive to alkaline
hydrolysis. If coacervation or aggregation of the remaining fragmented
material then followed and there was some form of stabilisation of the
aggregate it could be predicted that resistance to alkaline hydrolysis may be
re-established by 48 hours of digestion. This was investigated.
Elastin was digested with HNE (10mU/ml) for 24 and 48 hours, and
the remaining insoluble material was washed several times with distilled
water before freeze-drying. Attempts were made to hydrolyse the pellets (1-
2mg) by suspending them in 0.75ml of 0.1 M sodium hydroxide solution and
boiling for 45 minutes. The amount of soluble peptides resulting from
alkaline hydrolysis of the insoluble material was measured by the TNBS
method (see Section 2.3.3) in 0.2ml of supernatant after it had been
neutralised by the addition of 5pl of 4M HCI (Figure 6.10). The results
suggested that by 24 hours further enzymic digestion decreased the quantity
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of insoluble products so much that the amount that could be solublised after
48 hours of digestion was less than that at 24 hours. Alternatively, between
24 and 48 hours of digestion the insoluble material may be stabilised in
such a way as to re-establish alkaline resistance. Such a stabilisation is
unlikely to be produced by coacervation alone suggesting that some kind of
new bond formation must occur in order to make this a valid explanation.
A temporary loss of resistance to alkaline hydrolysis was also
observed by Stone et al (1988) who studied stabilised layers of rat aortic
smooth muscle cells in continuous culture. The cell layers were treated with
PPE (50pg or 75pg). At various times after the addition of the enzyme, a cell
layer was homogenised and incubated with 0.1 M sodium hydroxide at 98°C
for 45 minutes. The amount of insoluble elastin which remained after this
treatment was measured by amino acid analysis and expressed as a
percentage of the amount of elastin found in control cell layers which had
not been subjected to proteolysis. They found that more than 90% of the
remaining elastin was alkaline sensitive immediately after proteolysis.
However, 2 weeks after treatment with 50pg of PPE or 4 weeks after
treatment with 75pg of PPE the cell layers had re-established their
resistance to alkali.
6.3.4 Investigation of the stabilisation of the aggregates or
coacervates
The re-establishment of alkali resistance suggests that a stabilisation
of aggregates of insoluble partially digested elastin may have occurred. It
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has been stated that coacervation is reversible (Partridge et al. 1955a).
However, Wood (1958) stated that coacervates can be difficult to dissolve in
0.075M sodium acetate buffer pH 5.0 if some time has elapsed since their
formation. This suggested that a slow stabilisation occurred, which Wood
(1958) concluded to be due to an increase in the extent of aggregation.
Stone et al (1988) suggested that the restoration of alkaline resistance was
only in part due to the formation of hydrophobic interactions. They
speculated that the elastin may be repaired and stabilised by the formation
of Schiff's bases between aldehyde intermediates of cross-link formation
within the damaged elastin or newly synthesised tropoelastin, and amino
termini of the elastin-derived peptides generated during proteolysis (see
Section 1.3). Cross-link intermediates, such as residues of allysine (a-
aminoadipic-8-semialdehyde) and aldol condensation products, have been
detected in the amino acid hydrolysate of human and bovine elastin and
measured by several authors including Lent et al (1969) and Paz et al
(1976). The existence of these intermediates has been used to explain the
discrepancy between the lysine content of tropoelastin and that of mature
elastin, including the lysine accommodated within cross-links (see Section
3.2.2 and Francis et al 1973). The possibility arises that the restoration of
resistance to alkali of the aggregate may be due to the formation of Schiff's
bases such as lysinonorleucine (Franzblau et al. 1969) between aldehyde
intermediates of some peptides and the amino termini of other peptides.
This would account for the apparent loss of amino groups, and is a more




























cause an aggregation of the peptides but it is unlikely that the aggregate
would be capable of excluding TNBS, which is a small molecule, from
reacting with amino groups buried within the coacervate.
6.3.5 The reduction of elastin-derived peptides with
sodium borohvdride
The apparent loss of amino groups (Sections 6.2.1-6.2.2) could be a
consequence of the formation of Schiff's bases between new amino termini
and the aldehyde groups or reactive double-bonds in some cross-link
intermediates, rather than coacervation alone. If this was the case the
apparent loss would be prevented by reducing the aldehydes to alcohols or
-ene to -ane with sodium borohydride (Figure 6.11) which is generally used
to stabilise cross-link intermediates (reviewed by Robins, 1982).
In order to investigate this possibility it was necessary to establish
whether HNE was inactivated by the reducing conditions used. This was of
importance because HNE contain 8 cysteine residues (Farley et al. 1989).
Residues of cysteine can potentially form disulphide bridges which stabilise
the conformation of the enzyme, and disulphide bridges can be reduced with
sodium borohydride. A reduction may potentially lead to a change of the
enzyme conformation which causes an inactivation of the enzyme. A
solution of HNE (5mll in 1ml of 50mM Tris-HCI/1.0M NaCI, pH 8.0) was
added to 0.75mg of sodium borohydride. The solution was treated with I0pl
of STANA. The amount of STANA hydrolysis was measured as detailed in
Section 2.1.1. The amount of STANA hydrolysis was the same as a control
solution of enzyme which had not been treated with sodium borohydride.
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Suspensions of Lansing lung elastin were digested with HNE (5mU/ml; see section 2.3.1).
One suspension (a) was not treated further. Sodium borohydride was added to the other
suspensions (b) prior to digestion; (c) after 18 hours of digestion; and (d) after 24 hours of
digestion. The soluble and total products were measured after 24 and 48 hours of
digestion (sections 2.3.3 and 2.3.4).
Sodium borohydride was added to suspensions of Lansing lung elastin
before digestion, or after 18 or 24 hours of digestion with HNE (5mU/ml)
(Figure 6.12), at an elastin to sodium borohydride ratio of 4:1 (w/w). Sodium
borohydride is unstable at pH 7.4, so any borohydride not involved in the
reduction of the cross-link intermediates would decompose within minutes.
The apparent decline in the amount of amino groups was prevented if
the reduction was performed after 18 or 24 hours of digestion, but not when
the elastin was treated with borohydride before digestion. This suggested
that proteolysis causing the exposure of internal chemical groups was
necessary for the apparent decline of amino groups and for permitting
borohydride to prevent the loss of amino groups. These chemical groups in
the undigested elastin were not accessible to the borohydride, so explaining
why borohydride reduction of the elastin before digestion was ineffective in
preventing the decline of amino groups.
Sodium borohydride reduction after 24 hours of digestion also
prevented the apparent decline of amino groups observed when a larger
dose of HNE (10mU/ml) was used.
6.3.6 Examination of the products of digestion
Having established that borohydride was capable of preventing the
loss of amino groups, it could be predicted that the treatment may also be
capable of preventing the shift of molecular weight (Section 6.3.2 and Figure
6.8) which appeared to be associated with the loss of amino groups.
The soluble peptides from the reduction experiments (100pg, as
measured by the Bradford method, in 0.1ml of 50mM sodium phosphate
buffer, pH 7.4) which had
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Suspensions of Lansing lung elastin were digested with HNE (5mU//mI) for 48 hours (see
section 2.3.1). The suspensions were either (a) untreated controls or (b) reduced by the
addition of sodium borohydride after 18 hours of digestion. The soluble peptides (100pg by
Bradford assay) were isolated after 24 ( ) and 48 ( ) hours of digestion and
examined by molecular exclusion chromatography as detailed in the text.
Figure 6,14 Ibe effects of sodium borohydride .reduction on elastin
which had been partially digested with HNE
27 x magnification
A suspension of Lansing lung elastin was digested with HNE (see section 8.3.1) and
treated with sodium borohydride after 24 hours of digestion as detailed in the text. The
insoluble material was isolated after 48 hours of digestion, suspended in 1% (w/v)
resorcin-fuchsin/4M HCI (Weigert's stain; BDH) and examined by polarised light microscopy
using a NikonSMX/10 microscope. The image was recorded on 35mm, 100ASA film
(Kodak) using a Nikon camera.
been digested with HNE (5mU/ml) for 24 or 48 hours were examined by
molecular exclusion chromatography using a Superose-12 column
(Pharmacia). The column was developed with 50mM sodium phosphate
buffer, pH 7.4 as detailed in Section 2.4.1 (Figure 6.13). As expected, the
shift of molecular weight associated with the decline of free amino groups
between 24 and 48 hours of digestion, was prevented by reducing the
peptides after 18 hours of digestion. On examining the elution profiles it
would appear that a greater amount of peptides resulting from 48 hours of
digestion was loaded on the column as compared with the amount of
peptides resulting from 24 hours of digestion, although they had both been
equated to 100pg by the Bradford method. This suggests that a greater
proportion of the peptides resulting from 48 hours of digestion cannot be
detected by the Bradford method presumably because they do not contain
the residues necessary for detection (see Section 4.1.2). These peptides
may result from a small amount of digestion which occurs between 24 and
48 hours, although the results presented in Figure 6.5 suggests any
additional digestion between 24 and 48 hours is minimal in terms of the
amount of new amino termini released.
The effect of borohydride on the formation of birefringent insoluble
complexes (Section 6.3.3 and Figure 6.9) was also examined. A
suspension of elastin was digested with HNE and reduced with sodium
borohydride after 24 hours of digestion. The insoluble material was
collected after 48 hours of digestion and examined by microscopy under
polarised light (Figure 6.14). Although some association between the
particles was evident, it was much less pronounced than the association
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between the unreduced particles (Figure 6.9). The limited association
observed in the reduced case (Figure 6.14) may represent association due
to coacervation alone, but the stabilisation of the aggregate (Figure 6.9)
probably requires the formation of new cross-links.
6.4 The implications of the ability of elastin-derived
peptides to produce aggregates
The peptides produced by the digestion of Lansing lung elastin with
HNE would appear to be capable of associating together to form a
disorganised complex. The stabilisation of the complex could be prevented
by reducing the components with sodium borohydride. Soluble peptides
(0.1ml) resulting from 48 hours of digestion were suspended in 50% (v/v)
organic solvent (methanol, ethanol or acetonitrile). The amount of peptides
was then measured as detailed in Section 2.3.3 and related to a standard
curve of glycine which was prepared in 50% (v/v) of the appropriate solvent.
In all three cases the amount of detected peptides did not differ from the
amount in a control sample of peptides which had been prepared in 0.1 M
sodium phosphate buffer pH 8.0. So it was concluded that the stable
peptide complex was not dissociated with simple organic solvent (50% (v/v)
methanol, ethanol or acetonitrile). It was further concluded that the apparent
loss of amino groups detected in vitro may be a consequence of the ability
of elastin-derived peptides to associate together by hydrophobic interaction
to form a coacervate, which is stabilised by the formation of Schiff's bases.
This phenomenum may also occur in vivo. Stone et al (1988)
speculated that damaged elastic fibres are partially repaired by the above
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mechanism, rather than by complete synthesis of a new fibre. Since
desmosine is not re-used by the body (Harel et al. 1980) and peptides from
the elastic, non-cross-linked, region of the elastin molecule have been
implicated in coacervation (reviewed by Urry, 1982) it appears likely that
damaged elastin is partially repaired by coacervation followed by Schiff's
base formation between the amino termini of peptides from the elastic region
of the elastin and aldehyde cross-link intermediates of the frayed elastin
which had been exposed during proteolysis. If so, the resulting repaired
elastin would have altered elastic properties and cross-linking profile.
Evidence to support this hypothesis was provided by Karlinsky and Snider
(1978) who stated that proteolytic damage to hamster lungs was repaired
within 2 months but the new tissue had an altered architecture. Therefore,
cycles of proteolytic damage followed by inadequate repair over several
years may eventually cause the complete breakdown of localised areas of
the extracellular matrix; which could be the underlying mechanism of
degenerative diseases such as emphysema.
Peptides derived from aortic elastin did not appear to aggregate in the
same conditions as the peptides from Lansing lung elastin (Section 6.2).
However, it has been documented that peptides from aortic elastin are
capable of associating together in the presence of calcium and lipids; and
become incorporated into arteriosclerotic plaques which form over the site of
aortic damage (Lansing et al. 1950).
In conclusion, it would appear that elastin-derived peptides may be
capable of interacting to form stable aggregates either with or without other
compounds in vitro. The formation of such aggregates in vivo may have far
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reaching consequences in arteriosclerosis and in the repair of damaged
elastin in lung tissue.
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Suspensions of Lansing lung elastin were digested with HNCG (5 or 10mU/ml) at 37°C and
pH 7.4 as described in section 2.3.1. The total, soluble and insoluble products were
measured as detailed in sections 2.3.3-2.3.5.
CHAPTER 7
THE DIGESTION OF ELASTIN WITH HNCG
Having established the pattern of events when elastin was digested
with HNE, attention now turned to the investigation of elastin digestion with
HNCG.
7.1 The susceptibility of elastin to digestion bv HNCG
In Chapter 4 (Section 4.2.4 and Figure 4.5) it seemed that Lansing
lung elastin, collagenase-treated lung elastin and aortic lung elastin were
less susceptible to digestion by HNCG than by HNE; and there was no
appreciable difference between the susceptibility of the different
preparations to digestion with HNCG.
7.1.1 The digestion of Lansing luna elastin with HNCG for
8 hours
Suspensions of Lansing lung elastin were digested with HNCG (5-
10mU/ml) as detailed in Section 2.3.1. Aliquots were removed periodically
and the amounts of total, soluble and insoluble amino groups were
measured as detailed in Section 2.3.3-2.3.5 (Figure 7.1). A mixture of both
soluble and insoluble products was produced throughout the 8 hours of
digestion, similar to the trend resulting from the digestion of the elastin with
HNE (Figure 5.8), and could be considered typical of endopeptidase action.
The amount of new insoluble products was initially greater than the
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amount of soluble products indicating that the initial stage of hydrolysis
involved the "opening" of the elastin network to expose the interior of the
macromolecule. As the digestion continued the amount of soluble amino
groups exceeded the amount of insoluble amino groups, and the insoluble
amino groups appeared to decline. This observation is tentative, particularly
when the elastin was digested with 5mU of HNCG/ml of digestion
suspension because the decline is weighted upon a single point. Since
there was no visible decrease in the amount of insoluble material it was
assumed that this loss of amino groups may indicate that some coacervation
and Schiff's base formation may have occurred in the early stage of
digestion. However, the actual amount of insoluble amino groups lost during
this decline is a great deal less than the decline observed between 24 and
48 hours of digestion of Lansing lung elastin with HNE (Section 6.2.1 and
Figure 6.4), and therefore less significant.
7.1.2 Prolonged digestion of Lansing luna elastin with
HNCG
Having established that the pattern of digestion of Lansing lung
elastin by HNCG over 8 hours bears some similarities to the pattern of
digestion with HNE over 8 hours, the next consideration was to investigate if
the soluble products of digestion showed any apparent decline during the
later stages of digestion.
Suspensions of Lansing lung elastin were digested with HNCG (10 or
50mU/ml) at pH 7.4 and 37°C for up to 72 hours as detailed in Section 2.3.2;
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Figure 7.2 The digestion of Lansing luna elastin with HNCG for a
prolonged period of time
Suspensions of Lansing lung elastin were digested with HNCG (10 or 50mU/ml) as detailed in
section 2.3.1. The soluble peptide release was measured as described in section 2.3.3.
Figure 7.3 Molecular exclusion chromatography of soluble elastin-derived
peptides resulting from the digestion of Lansing lung elastln
With HNCO
Suspensions of Lansing lung elastin were digested with HNCG (10mU/ml) for 48 hours.
The soluble peptides (0.2ml) were isolated after (a) 24 and (b) 48 hours of digestion. The
peptides were examined by molecular exclusion chromatography as detailed in the text.
The absorbance of the eluate was measured at 220nm ( ) and 270nm (— ).
100% corresponds to an absorbance at 220nm of 0.2 or an absorbance at 270nm of 0.1.
The path length of the flow cell was 1cm.
Figure 7.4 Examination of the insoluble material remaining after elastin
was digested with HNCG for 48 hours
27 x magnification
Lansing lung elastin was digested for 48 hours with HNCG (10mU/ml) as detailed in section
4.3.1. The remaining insoluble material was removed, suspended in 1% (w/v)
resorcin-fuchsin/4M HCI (Weigert's stain; BDH) and examined under polarised light using a
Nikon SMX/10 microscope. The image was recorded on 35mm, 100ASA film (Kodak) using
a Nikon camera.
and the soluble products were measured as detailed in Section 2.3.3
(Figure 7.2). The maximal soluble peptide production was achieved by
approximately 40 hours of digestion. However, the maximum amount of
peptides, even when digested with 50mU/ml, was less than the maximal
peptide production with HNE (10mU/ml), and there was no significant
decline in the free amino groups. The soluble peptide products of 24 and 48
hours of digestion with HNCG (10mU/ml) were examined by molecular
exclusion chromatography using an Anagel TSK G3000 SWXL column
developed with 50mM sodium phosphate buffer/0.15M NaCI, pH 7.4 as
detailed in Section 2.4.1 (Figure 7.3). The peptides appeared to be smaller
than the peptides produced by the digestion of Lansing lung elastin with
HNE (Figure 6.8). The proportion of the peptides which absorbed at 270nm
was greater after 48 hours of digestion than after 24 hours of digestion.
Between 24 and 48 hours of digestion with HNCG there appeared to be a
slight shift to a higher molecular weight.
The insoluble material which was present after 48 hours of digestion
with HNCG (10mU/ml) was examined microscopically under polarised light
(Figure 7.4), and little sign of aggregation was observed. So, if the decline
in the insoluble amino groups observed in Figure 7.1 and the shift of
molecular weight (Figure 7.3) are due to coacervation followed by new bond
formation, then the actual extent of this aggregation is insufficient to be
viewed by light microscopy.
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Figure 7.5 Amino acid analysis of elastin-derlved peptides produced







lli, II. ffl. II. rt. i§
Asx HypGlxSerGly His ArgThr AlaProTy rVal lie LeuPheLys
Amino acid
Suspensions of elastin were digested with HNCG (10mU/ml) at 37°C and pH 8.0 for 48
hours. The soluble peptides were collected, hydrolysed and analysed as detailed in
the text.
7.1.3 Comparison of the products of Lansing luna elastin
digestion with HNCG with those resulting from the
digestion of collaaenase-treated elastin and aortic
elastin with HNCG
The soluble peptides resulting from the digestion of Lansing lung
elastin, collagenase-treated elastin and aortic elastin with HNCG (10mU/ml)
for 48 hours at pH 7.4 and 37°C were hydrolysed and examined by amino
acid analysis as detailed in Section 2.2.3. (Figure 7.5)
Once again the examination of the amount of hydroxyproline
suggested that many of the peptides released from collagenase-treated
elastin were collagenous. There was little difference between the amounts
of glutamic acid in the hydrolysates of peptides from Lansing lung elastin
and from aortic elastin so there is no evidence to suggest that the peptides
from aortic elastin are derived from the glycoproteins of the microfibril
component of the elastic fibres. This would not be surprising if the
glycoprotein was interpenetrated within the elastin as extensive digestion
would be required to release the glycoprotein. Since HNCG is weakly
elastinolytic in comparison with HNE it may not be able to digest elastin to
the extent needed for the release of any glycoprotein contaminants.
7.2 Concluding remarks about HNCG
HNCG has been implicated in platelet aggregation (Selak and Smith,
1990; Ferrer-Lopez et al. 1990) and in antimicrobial mechanisms (Odeberg
and Olsson, 1975), which is of particular importance in the study of chronic
granulomatous disease where the oxygen-dependent antimicrobial
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mechanisms are defective. The antimicrobial action of HNCG was still
evident after the enzymic activity had been inhibited by
diisopropylphosphorofluoridate (see Section 1.2) so the antimicrobial
activity is distinct from the enzymic activity (Odeberg and Olsson, 1975). The
enzyme was digested with clostripain and two antibacterial sequences were
identified (Bangalore et al. 1990). One sequence is found at the N-
terminus of HNCG (lle-lle-Gly-Gly-Arg) and the other starts at amino acid 77
(His-Pro-Gln-Tyr-Asn-Gln-Arg). Both of the peptides were capable of killing
Neisseria gonorhoae and Staphylococcus aureus more effectively than
tetracyclin and streptomycin. Bangalore et al (1990) speculate that the
internal sequence may be found on the exterior surface of the enzyme and
would therefore be accessible for binding to the target bacteria. Interestingly
this internal antimicrobial sequence of HNCG is similar to an antibacterial
sequence within granzyme B, a serine proteinase found in cytotoxic T
lymphocytes (Shafer et al. 1991). In contrast, HNE is not antibacterial and
does not contain a sequence similar to the antimicrobial sequence of HNCG
(Bangalore et al. 1990). However, HNE is capable of digesting some
bacterial proteins (Blondin et al. 1978; see Section 1.1).
Although HNCG is capable of hydrolysing extracellular matrix
molecules such as elastin (Reilly and Travis, 1980) and laminin (Heck et al.
1990), it is much less effective than HNE in this role. The data presented in
this chapter confirms that HNCG is relatively ineffective in hydrolysing
elastin, and the resulting products do not appear to aggregate together,
probably because they are not produced at a high enough concentration
under the conditions used here.
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CHAPTER 8
THE DIGESTION OF ELASTIN WITH BOTH HNE AND HNCG
Boudier et al (1981) suggested that the activity of HNE on Lansing
lung elastin in 50mM Tris-HCI, pH 8.0 at 37°C could be increased 7-fold by
the presence of HNCG at a 1:2 (mol/mol) ratio of HNE to HNCG when
measuring activity as the increase of absorbance at 280nm of the soluble
products of digestion. This was disputed by Reilly et al (1984) who used
three different methods of analysis to reach the conclusion that the
stimulation of the digestion of Lansing lung elastin with HNE by HNCG (1:2
mol/mol ratio of HNE:HNCG) was 1.9-2.9 fold in 50mM Tris-HCI, pH 8.0 at
25°C or 1.1 fold at physiological conditions of temperature, pH and ionic
strength. Both Boudier et al (1981) and Reilly and Travis (1984) measured
the stimulation of HNE by HNCG as follows:-
Stimulation factor = VE c - Vc
VE
where VE C, Vc and VE are the amounts of products formed over a given
period of time in response to digestion by HNE and HNCG, HNCG alone
and HNE alone, respectively.
The ability of HNCG to stimulate the action of HNE is potentially very
important in the understanding of the physiological mechanisms of elastin
destruction in response to excessive amounts of these enzymes, but the
141
































Lansing lung elastin and collagenase-treated elastin were digested with HNE
(5mU/ml) and/or HNCG (5mU/ml) at 37°C and pH 7.4 as detailed in section 2.3.1. The
soluble peptides were measured as detailed in section 2.3.3.
discrepancy between the two publications was a cause of some concern.
Therefore the effect of HNCG on HNE during the digestion of elastin was
investigated.
8.1 The digestion of elastin with both HNE and HNCG
added simultaneously
Suspensions of Lansing elastin and collagenase-treated elastin were
digested with HNE and/or HNCG (5ml)/ml) for 24 hours at pH 7.4 and 37°C
(Figure 8.1). The amounts of soluble peptides resulting from digestion of the
elastins for 4 and 24 hours with HNE and HNCG, HNE alone and HNCG
alone were applied to the above equation for the calculation of the
stimulation factor. The stimulation factors for the digestion with HNE by
HNCG of Lansing elastin and collagenase-treated elastin after 4 hours of
digestion were 0.89 and 0.67 respectively. After 24 hours of digestion the
stimulation factors for the digestion of Lansing elastin and collagenase-
treated elastin with HNE by HNCG were 0.87 and 0.78 respectively. This
suggests that at a 3:2 (moLmol) ratio of HNE:HNCG there is no evidence to
suggest that HNCG can stimulate the action of HNE on elastin, which is
comparable with the results presented by Reilly et al (1984).
8.2 The digestion of elastin with both enzvmes added at
intervals
The possibility remained that pre-digestion with HNCG may enhance
the activity of HNE; although Boudier et al (1981) stated that their observed
enhancement of the activity of HNE by HNCG of 7-fold when the enzymes
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were added simultaneously was reduced to 27% of this enhancement if the
HNCG was added 40 minutes before the HNE. However, the effect of pre-
digesting the elastin with either HNE or HNCG before the attention of the
second enzyme was considered to be worthy of further investigation.
Suspensions of each preparation of elastin were pre-digested with
HNE or HNCG (10ml)/ml) for 2 hours at pH 7.4 and 37°C (see Section
2.3.1), before the addition of the alternative enzyme (10mU/ml). The
suspensions were digested for a further 2 hours after which the amounts of
soluble peptides were measured as detailed in Section 2.3.3.
In order to measure any stimulation of the first enzyme on the activity
of the second enzyme one of two assumptions must be made. First, it may
be assumed that the rate of the digestion of elastin by the first enzyme
remained constant over 4 hours so that the amount of products due to
digestion by this enzyme during the 2 hours of pre-digestion was equal to
the amount of products released during the following 2 hours when the
second enzyme was present. In this case:-
Stimulation Factor (1) = PeptideS(2_4 hrs)" Peptides formed by enz.., (0_2 hrs)
Expected digestion by enz. 2 (2_4 hrs)
The expected amount of digestion by the second enzyme between 2-4 hours
of digestion was equated to the amount of peptides which would have been
produced if undigested elastin was treated with the second enzyme only for
2 hours.
Alternatively, it could be assumed that after two hours of digestion all
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Table 8.1 The stimulation of HNE or HNCG digestion of elastln bv the
pre-diaestion of the elastln with HNCG or HNE respectively
al The stimulation of HNE digestion bv pre-dlaestion with HNCG
Elastin preparation Stimulation factor
by Equ.1 by Equ.2
Lansing lung elastin 0.150 0.750
Collagenase-treated elastin 0.510 1.08
Aortic elastin 1.23 1.70
b) The stimulation of HNCG digestion bv pre-dlaestlon with HNE
Elastin preparation Stimulation factor
by Equ. 1 by Equ. 2
Lansing lung elastin 0.940 2.61
Collagenase-treated elastin 1.01 2.71
Aortic elastin 1.49 3.65
Suspensions of elastin were pre-digested with HNE (10mU/ml) or HNCG (10mU/ml)
o
for 2 hours at 37 C and pH7.4 (see section 2.3.1) before the addition of the other enzyme.
The stimulation factor was determined after a further 2 hours of digestion using the
equations detailed in the text.
peptide bonds which were susceptible attack by the first enzyme had been
cleaved. So, during the following two hours the first enzyme would provide
a negligible amount of further soluble products in the presence of the
second enzyme, therefore:-
Stimulation factor (2) = Peptides (2-4 hrs)
Expected digestion by enz.2 (2_4 hrs)
It should be stated that these methods would be satisfactory if a
simple digestion system with known kinetics was being considered, but the
kinetics of the digestion of elastin with these enzymes is far from simple and
so both methods over-simplify the situation. The "stimulation" of HNE by
HNCG and vice versa using both these equations was calculated (Table
8.1).
It can be seen from Figures 5.6 and 6.4b that the amount of soluble
peptide production by HNE over a 4 hour period appears to occur at a
reasonably constant rate. Assuming that the addition of HNCG after 2 hours
of pre-digestion with HNE does not induce an early acceleration stage (in
Figure 6.4b the acceleration stage is seen to occur between 8-20 hours of
digestion), then the effect of pre-digestion by HNE on digestion with HNCG
is most likely to conform to the situation expressed in stimulation factor (1).
When investigating the effect of pre-digestion with HNCG the consideration
may be more complex. In Figures 7.1 and 7.2 it can be seen that the amount
of digestion over the first 4 hours by HNCG remains at an approximately
constant rate, so stimulation factor (1) could once again be considered a
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justified simple model of this digestion. However, HNCG digests elastin to
produce less than half the amount of products released by HNE over the
same period of time. So although the contribution to peptide production by
HNCG from 2-4 hours is not negligible it is not as significant as the
production of peptides by HNE. Therefore the pattern of HNCG pre-
digestion followed by HNE digestion probably lies somewhere between the
two situations described by stimulation factor (1) and stimulation factor (2).
Even when allowing for the fact that the methods of measuring the
"stimulation" are overly simple, it would seem that HNCG did not
immediately stimulate the action of HNE and may even have acted as a
poor, alternative substrate for HNE. This would explain why the stimulation
of elastin digestion with HNE by HNCG was less than 1 (Table 8.1). The
data presented in Table 8.1 imply that it would be more reasonable to
suggest that HNE enhanced the activity of HNCG.
So, the presence of HNCG appeared to be of little benefit to the
digestion of elastin with HNE when the enzymes were added simultaneously
or when there was a 2 hour delay before the addition of the second enzyme.
Robert et al (1974) suggested (Section 6.2.4) that HNE initially binds to
elastin, hydrolyses the protein to a limited extent to "open" the insoluble
network, exposing potential internal sites of proteolysis. This theory was
used to explain the apparent slow response of HNE when digesting Lansing
lung elastin (see Section 6.2.1 and Figure 6.4). It is possible that pre-
digestion of elastin with HNCG may be sufficient to open the elastin so
avoiding this initial lack of response to the action of HNE.
Lansing lung elastin was pre-digested with HNCG for 8 hours
147
Figure 8.2 Digestion of elastin with HNE after pre-diaestion
wrthHNCG
Time (hours)
Lansing lung elastin was digested with HNCG (10mU/ml) for 8 hours at 37°C and
pH7.4, then HNE (1 OmU/ml) was added to the digestion mixture (£). Aliquots were
removed periodically and the amount of soluble peptides was measured as detailed in
section 2.3.3.
(10ml)/ml) before the addition of HNE (10mU/ml) (Figure 8.2), as detailed
previously in this Section, and in Section 2.3.1. The amount of soluble
peptides present after 20 hours of digestion with HNE and pre-digestion with
HNCG, was not greater than would be expected if the elastin was digested
with HNE alone. However, the initial lack of response to the action of HNE
on Lansing lung elastin (Figure 6.4) was not present. This would suggest
that HNCG may indeed perform some limited hydrolysis which opened the
elastin network, so that the internal sites susceptible to HNE hydrolysis were
exposed when the HNE was added to the digestion suspension.
8.3 Interpretation of the results and comparison with the
literature
It may be concluded that HNCG does not greatly enhance elastolysis
by HNE, which is in contradiction of the finding of Boudier et al (1981).
Boudier et al (1981) measured the elastin-derived peptides as the increase
of absorbance at 280nm, produced when desmosine-containing peptides
were solublised. Therefore, any small peptides which do not contain
desmosine would not be detected. This may explain why they did not reach
the same conclusion as Reilly et al (1984). Reilly et al (1984) measured the
release of peptides in three ways. First, as an increase of absorbance at
280nm, secondly as the release of tritium from tritiated elastin, and thirdly as
the liberation of amino termini with ninhydrin, which is analogous to the
TNBS method which also measures amino groups. They calculated that the
stimulation factor was no more than 2.9, by any of these methods but the
measurement of the increase of absorbance at 280nm did give the greatest
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value for the stimulation factor. They suggested that any slight enhancement
of the activity of HNE by the action of HNCG may indicate that HNCG can act
to enhance HNE activity slightly by binding to non-productive anionic sites
on the elastin so that only hydrophobic productive binding sites are
available to HNE (Reilly et al. 1984). Relevant to this argument, are the
observations of Lonky and Wohl (1983) who state that PPE adsorbs
electrostatically to elastin to produce productive cleavage. This binding is
inhibited by high sodium chloride concentrations. The adsorption of PPE
onto elastin is increased if the elastin is coated with SDS (Kagan et al.
1972). Conversely, electrostatic sites are non-productive for HNE which
interacts hydrophobically with elastin. The activity of HNE is enhanced in
high sodium chloride concentrations and by the occupation of the anionic
sites of elastin with basic compounds such as poly-lysine. Since HNCG is
more basic than HNE, it will presumably be more susceptible to the
electrostatic binding with elastin. In a typical digestion mixture 3mg of
elastin in a ml of suspension was treated with 10mU of HNCG which
corresponds to a 1:0.018 mol/mol ratio of elastin:enzyme. Since tropoelastin
contains 2 residues/mol of aspartic acid and 5 residues/mol of glutamic acid
(Indik et al. 1987) there is not sufficient HNCG to saturate the negatively
charged residues of elastin. Therefore the suggestion that HNCG aids HNE
activity by binding to the non-productive ionic sites of elastin seems unlikely.
However, if the ability of HNCG to enhance the digestion of elastin by HNE in
certain circumstances was simply due to electrostatic interaction then the
enhancement should also be noted if inactive HNCG was added to the
elastin. Boudier et al (1991) found that HNCG which had been inactivated
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with peptide chloromethyl ketone impaired the activity of HNE on dermal
elastin, so it would seem that the HNCG must be active in order to produce
any positive effect on the digestion of elastin with HNE. Boudier et al. (1991)
measured the digestion of the elastin in sections of skin as a change in the
area of specifically stained elastic fibres using a process of computerised
morphometry. It is possible that the inactive HNCG was digested by the HNE
in preference to the elastin. This digestion would not be measured be the
morphometric assay and would give the impression that the inactivated
HNCG had an inhibitory effect on the HNE.
In conclusion, the most likely explanation for the effect of HNCG on
digestion of elastin by HNE is that the HNCG binds and digests the elastin
to a limited extent to open the network. When HNE is added to elastin which
has been pre-digested it will bind to the elastin, and since the network has
already been cleaved to a limited extent, the initial lack of response to
digestion by HNE would not longer be evident.
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CHAPTER 9
THE SEPARATION AND CHARACTERISATION OF SOLUBLE
ELASTIN-DERIVED PEPTIDES
The main aim of this investigation was the separation and
characterisation of elastin-derived peptides specific for digestion with a
particular enzyme (see Section 1.4).
9.1 Unsuccessful methods of separation
9.1.1 Separation using polvacrvlamide gels
Attempts were made to examine the soluble elastin-derived peptides
resulting from 24 hours of digestion with HNE and/or HNCG (10ml)/ml) at pH
7.4 and 37°C (see Section 2.3.1) using polyacrylamide gel electrophoresis.
Unsatisfactory results were achieved with 6% and 15% SDS
polyacrylamide gels in the presence of SDS and mercaptoethanol (pH 8.8,
according to Laemmli, 1970); 5%-20% non-reducing, gradient
polyacrylamide gel at pH 8.8; and 5%-20% non-reducing, gradient
polyacrylamide gel at pH 4.5 (according to Reisfeld et al. 1962). In all cases
the peptide material was detected by Coomassie blue stain as a smear of
material. This was also observed by Smyrlaki et al (1987) who concluded it
indicated the presence of aggregates of peptides which ranged between
150kDa and 20kDa. This range is similar to the range observed in the
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Figure 9.1 SDS Urea-PAGE of elastin-derived peptides
1 2 kDa
18
Elastin-derived peptides (50pg by Bradford assay) resulting from the digestion of Lansing lung
elastin with HNE and HNCG (1 OmU/ml each) for 24 hours (see section 2.3.1) were separated on a
12.5% SDS-urea polyacryiamide gel (0.15cm x16cm x 20cm), at 100V and 42mA for 15 hours.
The peptides were visualised by silver staining (Wray et al. 1971).
Track 1: Peptides from elastin
Track 2: Molecular mass markers
molecular exclusion experiments (see Section 6.3.2, Figure 6.8, Section
7.1.2 and Figure 7.3). These results were considered unsatisfactory
especially in the light of the fact that small peptides generally do not bind
Coomassie blue (see Section 4.1.2 and Figure 4.1) or are washed out of the
gel during fixing, or both. The peptides resulting from the digestion of elastin
by HNE would be expected to be small since HNE cleaves at the carbonyl
side of alanyl-, isoleucyl- and valyl-residues (see Section 1.2) which account
for 37% of the composition of elastin (see Section 3.2.2)
Attempts were made to examine the small elastin-derived peptides by
using 12.5% SDS urea-polyacrylamide gels (Swank and Munkres, 1971)
which were stained with silver (Wray et al. 1981) (Figure 9.1). Peptides of
approximately 7-10kDa were often observed but their presence was
somewhat inconsistent.
Wrenn et al (1986) developed a method of immunoblot analysis to
detect tropoelastin using a mouse monoclonal antibody to the Val-Gly-Val-
Ala-Pro-Gly hexapeptide found in elastin. The monoclonal antibody is
commercially available (Sigma) so attempts were made to detect elastin-
derived peptides containing this particular epitope by Western blotting as
detailed by Wrenn et al (1986). This technique proved unsuccessful when
attempting to detect elastin-derived peptides which had been separated in
15% SDS-polyacrylamide gel (Laemmli, 1970). This suggested that either
the soluble elastin-derived peptides did not contain the epitope recognised
by the antibody, or the peptides containing the epitope were small and were
eluted from the gel during electrophoresis or lost during the transfer to
nitrocellulose.
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Soluble elastin-derived peptides (0.1ml) were transferred onto nitrocellulose (13cm x 9cm, Amersham)
and probed with a monoclonal antibody directed against Val-Gly-Val-Ala-Pro-Gly then sheep anti-mouse
antibody conjugated to horseradish peroxidase as detailed in the text. The blot was developed by
using the ECL chemilumenescence method (detailed in the text).
1A: monoclonal antibody and 1B: phosphate buffer
2A, 4A and 6A: peptides resulting from the digestion of Lansing lung elastin from lung 1, 2 and 3
respectively with HNE.
3A, 5A and 7A: peptides resulting from the digestion of collagenase-treated lung elastin from lung 1, 2
and 3 respectively with HNE.
8A: peptides resulting from the digestion of aortic elastin with HNE.
2B, 4B and 6B: peptides resulting from the digestion of Lansing lung elastin from lung 1, 2 and 3
respectively with HNCG.
3B, 5B and 7B: peptides resulting from the digestion of collagenase-treated elastin from lung 1, 2 and 3
respectively with HNCG.
8B: peptides resulting from the digestion of aortic elastin with HNCG.
2C-8C and 2D-8D: peptides resulting from the digestion of the preparations of elastin with both HNE
and HNCG.
Soluble peptides (100jil) resulting from 24 hours of digestion with
HNE and/or HNCG (10mU/ml) were transferred onto nitrocellulose (13cm x
9cm; Amersham) using a Dot-Blot apparatus (Bio-Rad). The nitrocellulose
was probed with the mouse monoclonal antibody directed against Val-Gly-
Val-Ala-Pro-Gly (1:500 dilution) and then with sheep anti-mouse antibody
conjugated to horseradish peroxidase (1:100 dilution; Serotec) according to
the method of Wrenn et al (1986). The blot was developed by using the ECL
chemiluminescence method (Amersham) according to the manufacturer's
guidelines, with exposure of the film (Hyperfilm, Amersham) for 5 seconds
(Figure 9.2). It appeared that some of the peptides resulting from digestion
with the HNCG alone, but not with HNE were recognised by the monoclonal
antibody directed against Val-Gly-Val-Ala-Pro-Gly, which may suggest that
some of the peptides resulting from the digestion of Lansing lung elastin by
HNCG do indeed differ from those resulting from the digestion by HNE. This
is not surprising since HNE can potentially cleave the peptide bonds to the
carbonyl side of the valyl- and alanyl-residues of the hexapeptide, but the
hexapeptide does not have any potential sites of cleavage by HNCG (see
Section 1.2).
9.1.2 Ion-exchange chromatography
Attempts were made to separate the elastin-derived peptides by
cationic ion-exchange chromatography using a Mono S column (Pharmacia)
developed with 50mM sodium acetate buffer, pH 4.6 using a gradient of
0.15-1.0M NaCI; and by anionic ion-exchange chromatography using a
Mono Q column (Pharmacia) developed with 20mM Tris-HCI, pH 8.0 using a
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gradient of 0.15-1.0M NaCI. The peptides eluted from the column were
detected by monitoring the absorbance at 215nm of the eluate. Neither
procedure separated the peptides satisfactorily; so ion-exchange
chromatography was considered to be inappropriate.
9.2 Reverse-phase chromatography
The separation of elastin-derived peptides by other authors have
usually exploited the hydrophobicity of the peptides by using reverse-phase
chromatography (Smyraki et al. 1987; Manning et al. 1989; Sandberg et al.
1990). Reverse-phase chromatography involves the partition of molecules
between a stationary phase attached to a silica matrix and a mobile phase of
increasing hydrophobicity.
9.2.1 The choice of mobile phase
The initial separations of elastin-derived peptides were performed on
a C2/C18 PepRPC HR 5/5 column (Pharmacia) which was designed for the
separation of peptides. Many of the elastin-derived peptides were not
expected to be detectible at 280nm so their elution was monitored at 220nm.
This influenced the choice of mobile phase because the chosen solvent was
required to have a minimal absorbance at 220nm but to be sufficiently
hydrophobic to elute the peptides from the column. The separation of the
peptides was attempted with a number of solvents e.g., methanol,
acetonitrile and propan-2-ol, before opting for a gradient of acetonitrile
containing 0.1% TFA (detailed in Section 2.4.2) which is similar to the mobile
phase used by Sandberg et al (19901 to separate elastin-derived peptides
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Figure 9.3 The separation of elastin-derived peptides bv reverse-phase
chromatography
a) The products of digestion with HNE for 48 hours.
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(a) The elastin-derived peptides (0.3ml) resulting from the digestion of Lansing lung elastin with
HNE (10mU/ml) for 48 hours, and (b) the elastin-derived peptides resulting from the digestion of
Lansing lung elastin with HNCG (10mU/ml) for 48 hours were separated by reverse-phase
chromatography. 100% corresponds to an absorbance at 220nm of 0.5.
resulting from digestion with thermolysin. TFA is routinely used in high
pressure liquid chromatography of amphipathic molecules to arrange that all
species have a positive charge.
Kham et al (1982) suggested that the pH of the mobile phase used for
the separation of elastin-derived peptides should be above pH 7 or below
pH 4 to prevent the aggregation of the elastin peptides. Partridge et al
(1955a) observed that coacervation at room temperature and low ionic
strength is minimal below pH 4 therefore the presence of 0.1% TFA (pH 2.0)
should discourage any aggregate formation during the peptide separation.
9.2.2 The separation of the elastin-derived peptides
When the elastin-derived peptides were separated as detailed in
Section 2.4.2 they were eluted as three main groups regardless of the
digesting enzyme (Figure 9.3). The first group was the unretained material
in which the buffer salts, unretained peptides and the relatively hydrophilic
peptides and enzymes elute. The unretained material was not further
characterised because it would be difficult to separate some peptides from
any buffer salts.
The remaining peptides were eluted in two groups which will be
referred to as groups A and B. Manning et al (1989) also separated elastin-
derived products resulting from the digestion of an elastin (from bovine
ligamentum nuchae) into two main groups. Smyrlaki et al (1987) achieved
their greatest success when separating elastin-derived peptides by using a
multi-step elution procedure. This approach was exploited to clarify the
separation between groups A and B; an isocratic step was incorporated into
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Flqvrg 9.4 Demonstration of 'ghost peaks' alutad from the reverse-phase
coim
A gradient of acetonitrile was applied to the PepRPC column (Pharmacia) as detailed in
section 2.4.2: but no sample was loaded. Therefore the peaks eiuted represented the
impurities in the buffer system. The absorbance was monitored at 220nm with a full-scale
deflection of 0.5 absorbance units (path length = 1cm).
the gradient (Figure 9.3) at 20% acetonitrile for 30 minutes (between 75-105
minutes after injection).
A fourth group of peaks was evident at the end of the gradient
(between 40%-100% acetonitrile). These "ghost" peaks also appeared
during a blank run (Figure 9.4) in which no sample was loaded and
increased in size with an increasing number of runs. The "ghost" peaks
probably result from the elution of some UV absorbing contaminants in the
solvents which are eluted at high concentrations of the organic solvent
(Corran, 1988).
The total yield of peptides in the unretained material and groups A
and B was approximately 50%, as determined by the BCA method (see
Section 2.3.2), and no more than 65% when measured by the TNBS method
(see Section 2.3.3). The proportion of detected material eluted as the
unretained material, or group A or group B peptides was typically 22%, 8%
and 70% respectively when measured by the BCA method, or 7%, 50% or
43% respectively, if measured by the TNBS method. These data suggest
that the unretained material contains the enzyme, which responds well to the
BCA reagent because it probably has a larger number of peptide bonds than
the peptides. The peptides of group A respond poorly to the BCA reagent
but have more amino groups than the peptides of group B, which display a
better response to the BCA reagent. Therefore, the peptides in group A are
probably smaller than the peptides in group B.
The BCA method is known to be ineffective in detecting small
peptides (see Section 4.1.2). Therefore, the quoted yield in response to the
BCA method may be an underestimate of the total yield which actually
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represents the yield of the large peptides. The inadequate yield of large
peptides is probably not surprising because they are potentially more
hydrophobic than smaller peptides particularly if they are denatured by the
acetonitrile to expose internal hydrophobic groups. This suggests the large,
retained peptides may accumulate on the column. This would eventually
affect the efficiency of the column.
The high retention of elastin-derived peptides on reverse-phase
columns was also observed by Smyrlaki et al (1987) and Manning et al
(1989). Attempts were made to increase the yield of the elastin-derived
peptides by developing the column with a gradient of 0%-60% propan-2-
ol/0.1 % TFA after the development with acetonitrile. Propan-2-ol is more
hydrophobic than acetonitrile and should theoretically, produce a greater
yield of large hydrophobic peptides. Unfortunately the propan-2-ol had a
high background absorbance at 220nm so the detection of peptides was not
possible. So, the use of propan-2-ol was rejected because far UV-FPLC
grade propan-2-ol is not commercially available.
9.3 Characterisation of peptide groups A and B
9.3.1 Amino acid composition of groups A and B
Lansing lung elastin was digested with either HNE (10mU/ml) or
HNCG (10mU/ml) for 24 hours at pH 7.4 and 37°C as detailed in Section
2.3.1. The soluble peptides were isolated and separated by reverse-phase
chromatography (detailed in Section 2.4.2). The peptides eluted in groups A
and B were pooled as the two groups, concentrated by evaporation, and
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Figure 9.5 Amino acid composition of groups A and B
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Elastin-derived peptides were prepared and separated by reverse-phase chromatography as
detailed in the text. The peptides of groups A and B were collected and their compositions were
determined as detailed in section 2.2.3.
Figure 9.6 The detection of the absorbance at 270nm of elastin-derlved
peptides during their separation bv reverse-phase chromatography
Elastin-derived peptides (0.4ml) resulting from the digestion of Lansing lung elastin with HNE
for 48 hours were separate by reverse-phase chromatography. 100% corresponds to an
absorbance at 270nm of 0.2.
their amino acid compositions were determined as detailed in Section 2.2.3
(Figure 9.5). The compositions of the peptides obtained by digestion with
HNE or with HNCG and which were eluted as group A were similar. The
same was true of group B. However, group A contained a high proportion of
glycine and quite large amounts of alanine, valine and proline, which
suggests that these peptides were cleaved from the non-cross-linked elastic
region of the elastin. The proportions of glycine and valine were lower in
group B as compared with group A and there was a large increase of
alanine, but the proportion of alanine was still less than the proportion of
glycine. Since poly-alanine sequences are found in the amino acid
sequence close to the cross-link regions of elastin it seemed possible that
some of them contain desmosine cross-links.
It can be seen from Figure 9.5 that there is little difference between the
amount of tyrosine in the peptides of group A and those in group B. So it
can be assumed that if one group of peptides contains a greater amount of
peptides capable of absorbing at 270nm than the other group then the
absorbance at 270nm represents peptides which have desmosine in their
sequence. Attempts were made to locate the desmosine-containing
peptides by repeating the separation and measuring the absorbance of the
eluate at 270nm (Figure 9.6). As expected, the peptides of group B but not
group A were detected at this wavelength. Unfortunately the yield of peptide
material was insufficient to allow an accurate quantitation of the amount of
desmosine by the methodology detailed in Section 3.2.2.
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Table 9.1 Fractionation of the peptides bv size
Retention size
of filter
% of peptides passing through the filter




Samples of soluble elastin-derived peptides were passed through filters
with different retention sizes as detailed in the text. The percentage of the
peptides which passed through the filters was measured by the BCA method
as detailed in section 2.3.2.
9.3.2 Determination of the relative size of the peptides in
groups A and B
The elution pattern observed in Section 9.3.1 was rather surprising
because the elastic region of elastin is relatively more hydrophobic than the
inelastic cross-linked region; but the peptides derived from the elastic region
appeared to be relatively hydrophilic and were eluted first from the column.
Manning et al (1989) observed that the elastin-derived peptides
which were eluted with 7%-20% acetonitrile were small. Therefore a
possible explanation for the elution pattern observed in Section 9.3.1 is that
Sec.
the peptides in group A are smaller than the peptides in group B. So,
although some of the peptides in group B contain the hydrophilic sequences
associated with the cross-link, they may be sufficiently large to make the
whole peptide relatively more hydrophobic than smaller peptides. A small
peptide will generally appear more hydrophilic than a large peptide which is
made up with the same amino acids because of the relatively greater
contribution to hydrophilicity made by the hydrophilic amino- and carboxyl-
termini in the small peptide.
Lansing lung elastin was digested with HNE (10mU/ml) for 24 hours
at 37°C and pH 7.4, after which the soluble peptides were isolated (see
Section 2.3.1). Samples (450|ig by BCA) of these elastin-derived peptides
were fractionated by ultrafiltration through a YM2 or a YM30 membrane
(Amicon) under nitrogen (10 psi) using a 5ml ultrafiltration cell (Amicon), or
through a 10kDa Millipore filter. The amount of peptides which passed
through each membrane was measured (Table 9.1) before they were
separated by reverse-phase chromatography as detailed in Section 2.4.2
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Elastin-derived peptides (450pg by BCA assay) were prepared as detailed in the text, and
passed through either a 2kDa, 10kDa or 30kDa membrane. The peptides which passed
through the membranes were separated as detailed in section 2.4.2. 100% corresponds
to an absorbance at 220nm of 0.5.
Figure 9.8 The removal of elastin-derlved peptides from the reverse-phase
column bv digesi Ion wtth peoeln
The reverse-phase column was treated with pepsin as detailed in the text. 100%
corresponds to an absorbance at 220nm of 0.5.
Table 9.2 The composition of elastin-derived peptides digested
from the reverse-phase column with pepsin
Amino acid
Number of residues/1000 residues
pepsin digestion
fragments
Pepsin (a) Elastin (b)
Asx 135 116 7
Glx 100 75.4 22
Ser 121 124.6 7
Gly 115 98.6 335
His 4 2.9 6
Arg 6 5.8 6
Thr 81 72.5 7
Ala 68 46.4 267
Pro 70 46.4 109
Tyr 49 46.4 23
Val 47 58 100
Met 12 11.6 4
Cys 9 17.4 0
lie 52 66.7 19
Leu 76 81.2 55
Phe 46 127.5 20
Lys 8 2.9 1
a) Based on the compostion of pepsin quoted by Rajagopalan et al (1966).
b) The composition of Lansing lung elastin quoted by Reilly and Travis (1980).
(Figure 9.7). Both groups A and B appeared to contain a heterogeneous
mixture of peptides, some of which may co-elute. The resulting profiles
tentatively suggest that the peptides in group B are relatively larger than the
peptides of group A.
9.3.3 Examination of fragments of the retained peptides
It was stated in Section 9.2.2 that some of the large elastin-derived
peptides are retained on the reverse-phase column. After several runs the
initial pressure through the column increased slightly, which may confirm
that some material was retained on the column. If some peptides remained
on the column they would eventually impair the performance of the column.
Attempts were made to remove fragments of the retained elastin-derived
peptides from the column after several runs by digesting the material with
pepsin.
Pepsin (Worthington; 20pg in 2ml of 0.1% TFA) was loaded onto the
reverse-phase column (1.1ml) which had been equilibrated with 0.1% TFA.
The flow of the mobile phase was stopped for an hour after which the
enzyme was washed off the column with 0.1% TFA (10ml). The fragments of
the retained elastin-derived peptides were eluted from the column using a
gradient of acetonitrile as detailed in Section 2.4.2 (Figure 9.8). The
fragments were pooled, concentrated by rotary evaporation and their amino
acid composition was determined as detailed in Section 2.2.3 (Table 9.2).
The composition was similar to that of pepsin. However, the amount of
protein washed off the column after digestion was always greater than the
amount of pepsin initially loaded onto the column when measured by the
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BCA method (Section 2.3.2); and the pepsin treatment was sufficient to
return the initial pressure to normal suggesting that the treatment had
removed some of the retained material.
9.3.4 Identification of borohvdride reducible peptides
If the peptides of group A were smaller than the peptides of group B it
would be reasonable to expect an endopeptidase to hydrolyse the peptides
of group B further, so that the proportion of small peptides (group A) would
be greater after 48 hours of digestion as compared with the proportion after
24 hours of digestion. However, in Section 6.3 it was suggested that some
of the peptides resulting from digestion by HNE are capable of reacting
together in 0.1 M sodium phosphate buffer/0.15M NaCI, pH 7.4 to form larger
aggregates and that the formation of the aggregates was prevented by
reducing the peptides with sodium borohydride (Section 6.4.1); so it
seemed possible that the small peptides involved in aggregate formation
could be identified by examining the peptide separation profiles produced
after 48 hours of digestion with HNE (10mU/ml) with and without sodium
borohydride reduction.
Suspensions of Lansing lung elastin were digested with HNE
(10mU/ml) as detailed in Section 2.3.1. A suspension was reduced with
sodium borohydride after 24 hours of digestion, as detailed in Section 6.4.1;
but on this occasion, tritiated sodium borohydride (Amersham; 350Ci/mol)
was used at a ratio of 1:15 (w/w) of labelled to unlabelled sodium
borohydride (this represented the addition of 4mCi of tritium/ml of elastin
suspension). Samples (1 ml) of the tritiated material were removed after 44
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Figure 9.9 Autoradiographic study of the tritium incorporation into elastin-derived
peptides
The peptides resulting from 44 hours of digestion with HNE, which had been reduced after 24 hours with
tritiated sodium borohydride (as detailed in the text) were separated by reverse-phase chromatography as
detailed in section 2.4.2. A piece of autoradiography film (Amersham) was placed over the top of the
fraction collection rack and left in the dark for 5 days after which the film was developed.
U: fractions corresponding to the unretained material.
A: fractions corresponding to the peptides in group A.
B: fractions corresponding to the peptides in group B.
The experiment was performed on a single occasion.
and 48 hours of digestion. The insoluble and soluble material were
separated by centrifugation as detailed in Section 2.3.3. The soluble
peptides 0.2ml) were made up to 0.4ml with 0.1 M sodium phosphate
buffer/0.15M NaCI pH 7.4, and the insoluble material was suspended in
0.4ml of 0.1 M sodium phosphate buffer/0.15M NaCI pH 7.4. Each sample
was treated with 3.6ml of Cocktail T (BDH) and the tritium was measured
using a 1900 CA Tri-carb liquid scintillation analyzer (Packard). Any tritium
which was not incorporated into peptides would be detected in the soluble
fraction so it was not surprising to find that the majority of the detectible
tritium was located in the soluble fraction, and only 4% and 3% was located
in the insoluble material after 44 and 48 hours of digestion respectively.
The soluble peptides (0.3ml) were separated by reverse-phase
chromatography as detailed in Section 2.4.2. The location of the tritium after
44 hours of digestion was measured qualitatively by autoradiography
(Figure 9.9). The excess of tritium was eluted with the unretained material,
probably as a by-product of hydrolysed borohydride; and some of the
peptides in group B appeared to be labelled. It was suggested in Sections
9.3.1-9.3.2 that some of the peptides in group B may be derived from the
cross-linked regions of elastin. So, the peptides in group B are most likely to
contain aldehyde cross-link intermediates which would be the borohydride-
reducible groups implicated in coacervate stabilisation (Section 6.4), and
could be expected to be labelled with the tritium.
It was hoped that the elution pattern of the peptides in group B which
had been reduced would differ from the elution pattern of those which had
not been reduced. This would allow the identification of the peptides with
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Figure 9.10 The comparison of the reverse-phase separation profiles Of
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Elastin-derived peptides resulting from 48 hours of digestion with HNE (10mU/ml) were
separated by reverse-phase chromatography as detailed in section 2.4.2. In the case of
profile (b) the peptides were reduced with sodium borohydride after 24 hours of digestion.
Figure 9.11 Measurement of tritium incorporation into
peptides derived from elastin bv digestion with HNE
Time (min)
An elastin suspension (3mg/ml) was digested with HNE (10mU/ml; 1:100 w/w). After 24
hours the suspension was treated with sodium borohydride (4:! w/w of elastin:sodium
borohydride) which was composed of a 1:15 w/w ratio of tritiated borohydride (4mCi/ml
elastin peptide suspension) to cold borohydride. The digestion was allowed to
continue as before. Fractions were removed after a further 24 hours of digestion i.e. a
total of 48 hours of digestion. The soluble peptides were separated by reverse-phase
chromatography as detailed in section 2.4.4, and the amount of radiolabel eluted from
the column was measured by counting the tritium in each alternate 1ml fraction as
detailed in the text.
The experiment was performed on a single occasion.
reducible residues. Unfortunately, when the profiles produced by reduced
and non-reduced peptides were compared (Figure 9.10) there was no more
difference than would be expected when comparing successive runs of the
same peptide mixture. This is probably because the profiles are too
complex to allow the observation of subtle changes.
An alternative way of identifying the reduced peptides produced after
48 hours of digestion with HNE was to quantitatively locate the tritium within
the eluted fractions from the reverse-phase column. Cocktail T (3.6ml) was
added to 0.4ml of each alternate fraction of the separated, tritiated peptides,
and the tritium was measured in a 1900 CA tri-carb liquid scintillation
analyzer (Packard) (Figure 9.11). The yield of tritium eluted from the column
in the fractions was 100% of that which was loaded onto the column. So it
was concluded that all the tritiated peptides were eluted from the column. It
can be seen from Figure 9.11 that many of the tritiated peptides present after
48 hours of digestion with HNE were still evident in the group B peptides, but
some tritium was also present in the early members of the group A peptides.
This suggests that tritiated members of group B present after 44 hours of
digestion may have been digested further between 44 and 48 hours to
fragments which elute as early members of the group A peptides after 48
hours of digestion. Fraction 16, from group A, and fraction 80, from group B,
were examined further. Samples (0.3ml) of the two fractions were subjected
to acid hydrolyses and their amino acid composition was determined as
detailed in Section 2.2.3.
The integer composition and the minimum mass of a peptide can be
estimated by the method of Black and Hogness (1969). If the peptide was
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The amino acid composition of the tritiated peptides in fractions (a) 16 and (b) 80 were
analysed by th6 method of Black and Hogness (1969) as detailed in the text.
assigned a molecular weight M then the minimum number of residues of
amino acid i (nj) in the peptide can be calculated according to the formula:-
nj = Fj [(M-18)/X Fj x RJ
where Fj is the average number of residue i found by amino acid analysis
and Rj is the molecular weight of residue i. After calculating the values of nj
the fraction of maximum deviation (f) from the molecular weight M may be
calculated
f = X A/ lj
0.5 X1/ lj
where As is the difference between nj and the nearest integer lj regardless of
sign. The minimum molecular weight of the peptide is taken to be the
molecular weight at which (f) reaches a minimum. A computer programme
was created by Dr. A.R Ryle based on the method of Black and Hogness
(1969). The computer programme calculates the value of (f) over a range of
molecular weights from an amino acid composition of a protein or peptide
and the integer composition of the protein or peptide at the molecular weight
at which the value of (f) is minimal. The computer programme was used to
calculate the value of (f) over a range of molecular weight from the amino
acid compositions of the peptides in fractions 16 and 80 (Figure 9.12). The
minimum values of (f) for the peptides in fraction 16 and 80 corresponded to
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Table 9.3 The integer composition and calculated mass of the
trltiated peptides of fractions 16 and 80
Amino acid Number of residues in integer composition
Fraction 16 from group A Fraction 80 from group B
Asx (0) o (6.04) 6
Glx (9.01) 9 (8.90) 9
Ser (9.10) 9 (5.61) 6
Gly (56.81) 57 (69.10) 69
His (0.68) 1 (0.92) 1
Arg (1.79) 2 (3.18) 3
Thr (3.04) 3 (2.11) 2
Ala (19.09) 19 (53.98) 54
Pro (0) 0 (4.23) 4
Tyr (1.79) 1 (7.02) 7
Val (5.91) 6 (13.77) 14
Met (0) 0 (0.89) 1
Cys (0) o (1.21) 1
lie (2.06) 2 (2.86) 3
Leu (5.06) 5 (11.90) 12
Phe (2.91) 3 (4.07) 4




min f value 0.267 0.291
Mr at min f
value
9500 16733
The compositions of the tritiated peptides at the molecular weight corresponding to the
minimum value of f are presented in brackets. The nearest integers are presented to
the right of the brackets.
Figure 9.13 Comparison of the separation profiles from the amino
acid analyzer of a standard mixture of PTC-amino acids and
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^represents unusual, unidentified peaks which are not present in the standard profile,
and may represent unusual residues such as cross-links or cross-link intermediates found
in the tritiated peptides. The single letter abbreviation is used for each amino acid.
molecular weights of 9500 and 16733 respectively. The integer
compositions of the peptides at these molecular weights are presented in
Table 9.3.
The peptide in fraction 80 (estimated molecular mass 16733) had
similar proportions of alanine and glycine, which would be expected for a
peptide from the cross-linking region of elastin which had some sequence
associated with the elastic region. When the separation profile of the acid
hydrolysed and phenylthiocarbamylated-amino acids (PTC-amino acid) of
fraction 80 was compared with the separation profile of a mixture of standard
derivatised amino acids, there appeared to be a number of unidentified
peaks (Figure 9.13) which could represent either incompletely hydrolysed
fragments of the peptides or reduced cross-link intermediates with the
potential to cause aggregation (see Sections 1.3 and 6.3.4). Paz et al
(1976) separated the amino acids of acid-hydrolysed elastin by ion-
exchange chromatography and noticed the presence of some unusual
residues, which they identified as reduced aldol condensation products and
reduced desmosines (Robins, 1982). The reverse-phase chromatogram
(Figure 9.13) cannot be compared directly with the chromatograms obtained
by Paz et al (1976). However, desmosine and isodesmosine standards
were shown by the Wei-Met Protein Characterisation Service to be eluted in
their system after approximately 12 minutes. Therefore, the extra peaks
eluted after 12-13 minutes may represent desmosine and isodesmosines.
As expected the peptide in fraction 16 (estimated molecular mass
9570.5) were smaller than the peptide in fraction 80 (Table 9.3). It has
already been suggested that the peptide of fraction 16 could be a fragment
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Fraction 16 was examined by continuous flow fast atom bombardment mass
spectrometry by Mr A. Taylor of the Department of Chemistry, University of
Edinburgh, as detailed in the text. 100% corresponds to 1387mV.
from the inelastic, reducible region of a larger peptide. If this was so the
proportion of alanine to glycine would be at least equal; but surprisingly the
proportion of glycine was much greater than the proportion of alanine (Table
9.3). This may suggest that the peptide was not derived from the cross-link
region, or there was more than one peptide in the fraction. Mass
spectrometry was used to deduce the exact mass of the peptide(s) of fraction
16, and to attempt to deduce some information about the tritiated residues of
the peptide(s).
A sample of fraction 16 (0.3ml corresponding to approximately
75pmol) was concentrated by evaporation, dissolved in a small amount of
glycerol and examined by continuous flow fast atom bombardment mass
spectrometry (courtesy of the Department of Chemistry, University of
Edinburgh) (Figure 9.14). Two major peaks were seen to approximate to the
estimated molecular mass of 9570.5 ion masses 9769.1 and 9357.7), but
they were possibly fragments of two larger peptides with ion masses of
11252.9 and approximately 11100. In both these pairs of peaks the second
peaks, but not the first, appeared to have a number of isotopic forms which
would be expected for a tritiated peptide. The peaks with smaller ion
masses correspond to the ion masses of fragments of the parent peptide(s).
The information presented by the mass spectrum may suggest that fraction
16 contained two co-eluting peptides of which only one was the tritiated
peptide of interest. This is not altogether surprising as a peptide peak was
seen to elute as fraction 16 in both the reduced and unreduced reverse-
phase chromatogram (Figure 9.10), suggesting that the tritiated peptide of
fraction 16 may be co-eluted with another peptide. Unfortunately, it was not
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possible to obtain any information about the tritiated residue of the peptide
from the spectrum, or to determine if the tritium had reduced a cross-link
intermediate.
Any further examination and isolation of reducible cross-link
intermediates would require the separation of a hydrolysate by reverse-
phase chromatography followed by scintillation counting and mass
spectrometry of any tritiated residues. This would require the harvesting of
larger amounts of the peptides, and although potentially very interesting, the
procedure would be extremely laborious and time consuming. So this work
was not pursued any further since the identification of cross-link
intermediates was outwith the original aims of the project.
9.4 The isolation of a specific peptide
Each group of peptides was examined in turn in an attempt to
determine if any peptides specific for a particular type of digestion could be
identified.
9.4.1 Examination of peptide group A
Fraction 16 eluted as an early member of group A and appeared to
contain two co-eluting peptides (see Section 9.3.4). So other members of
group A could be co-eluted when separated by the gradient conditions
detailed in Section 2.4.2, and their separation may be improved by re¬
applying them to the PepRPC reverse-phase column and developing the
column with a shallow gradient of acetonitrile.
Peptides from group A were concentrated to dryness by rotary
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Figure 9.15 Elutlon profile produced when peptides from group A
were re-loaded onto the reverse-phasa column
Peptides from group A were concentrated then dissolved in 0.1% TFA (I9ug of
peptides by BCA assay" in 0.5ml). The peptides were re-applied to the PepRPC
column which was developed with a gradient of 2-20% acetonitrile/0.1% TFA over
110 minutes. The peptides were expected to be eluted at 10-20% acetonitrile.
100% corresponds to an absorbance at 220nm of 0.38.
evaporation, then 19pg of peptides by the BCA method were dissolved in
0.5ml of 0.1% aqueous TFA. The peptides were re-applied to the reverse-
phase column which had been equilibrated with 2% acetonitrile/0.1% TFA,
and the column was developed with a gradient of 2%-20% acetonitrile/0.1%
TFA over 110 minutes. It was expected that the peptides would be eluted
from the column at the same percentage of acetonitrile (10%-20%) as
previously observed in Figure 9.3. However, when the peptides of group A
were re-applied to the reverse-phase column they were seen to elute earlier
than expected (Figure 9.15). Corran (1988) stated that a change in the
retention of a peptide or protein is a result of an irreversible change to the
peptide or protein such as denaturation and aggregation, or more likely,
dissociation.
Urry (1983) stated that the polypentapeptide (Val-Pro-Gly-Val-Gly)n
and the polyhexapeptide (Ala-Pro-Gly-Val-Gly-Val)n repeating sequences in
the elastic region of tropoelastin can form (3-spirals. A (3-spiral is a helical
repeat of (3-turns. A (3-turn is a 10-atom hydrogen bonded ring. The p-spiral
of the polypentapeptide has 2.8 pentapeptide repeats per turn and the
polyhexapeptide has 2 hexapeptide repeats per turn. Urry (1983)
suggested that during coacervation molecules of the polypentapeptide or
molecules of the polyhexapeptides are capable of associating together to
form a twisted filament. Similar associations between molecules of
tropoelastin may be necessary to correctly align the molecules prior to cross¬
link formation (Cox et al. 1974). Cross-links are formed between short, a-
helical, alanine-rich sequences which are contiguous with the elastic
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repeating sequences (see Section 1.3). It is possible that some of the
peptides from human lung elastin in 0.1 M sodium phosphate buffer/0.15M
NaCI, pH 7.4, had structural features which were changed during reverse-
phase chromatography and rotary evaporation. Any change of secondary
structure could presumably be investigated by circular dichroism
spectroscopy, which is the technique used by Mammi et al (1968) and Urry
et al (1969) to examine coacervates of a-elastin.
Circular dichroism involves the measurement the molar ellipticity of
an optically active solution at a given wavelength. A linearly polarised beam
of light may be considered to consist of a right- and a left-handed circularly
polarised component which are in phase. When the linearly polarised beam
of light is passed through an optically active solution the two components of
the light may be absorbed to different extents. The resulting difference of
absorbance of the two components is proportional to the molar ellipticity and
concentration of the optically active compound. When the molar ellipticity is
plotted against the wavelength of the polarised light the resulting spectrum
will show maxima and minima which may be characteristic of certain
structural features. For example, a (3-pleated sheet has a minimum molar
ellipticity near 220nm and a maximum molar ellipticity between 195 and
200nm.
Circular dichroism was used to examine a mixture of elastin-derived
peptides before and after they were separated by reverse-phase
chromatography and concentrated by rotary evaporation to establish
whether or not these procedures caused a change of the secondary
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Figure 9,16 Circular dlchroism examination of the peptides before and after
reverse-Phase separation
The molar ellipicity (measured in deg.cm2.dmol"1 ol amino acids) of (1) elastin-derived peptides
resulting from 48 hours of digestion with HNE (1 Omlt/ml) and (2) the unretained material, (3) group
A and (4) group B peptides produced when mixture (1) was separated by reverse-phase
chromatography, were measured in a JASCO J-600 spectropolarimeter with a path length of 0.1cm
at 20°C.
structure of the peptide mixture.
Mixtures of elastin-derived peptides resulting from 48 hours of
digestion with HNE (10mU/ml) were separated by reverse-phase
chromatography as detailed in Section 2.4.2. The unretained material and
group A peptides and group B peptides were collected separately and
concentrated to dryness by rotary evaporation. After concentration they
were dissolved in sufficient water to give solutions which had an absorbance
at 215nm of approximately 1.0. In general, the unretained material from a
single fractionation had a very small absorbance at 215nm in comparison
with the peptides of group A or the peptides of group B resulting from the
same fractionation. The concentration of amino acids in each solution of
peptides was calculated by assuming that a solution containing 1mg of
peptides per ml has an absorbance at 215nm of 15 (Harris, 1987) and the
average residue weight of elastin is 85. The concentration of amino acids in
the unfractionated material was 1.5mM, and the concentrations of amino
acids in the solution of unretained material, group A peptides and group B
peptides were 0.995mM, 0.94mM and 0.851 mM respectively. The majority
of the absorbance at 215nm of the unretained material was due to the
presence of the phosphate from the digestion buffer, so the concentration of
peptides in the unretained material is over-estimated.
Miss S Kelly and Dr. N Price (Department of Biological and Molecular
Sciences, University of Stirling) kindly examined 1ml samples of the mixture
of elastin-derived peptides and the groups of separated peptides in a
JASCO J-600 spectropolarimeter with a path length of 0.1cm at 20°C
(Figure 9.16). The amount of secondary structure of each group of peptides
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Peptide mixture 2 49+1.3 49+1.3
Group A 0 55 + 2.6 45 + 2.6
Group B 0 58 + 2.9 42 + 2.9
The percentage of Ck -helix and /3-sheet was calculated by Miss S Kelly from
the data in figure 9.16 over 196-240nm using the CONTIN computer programme
(Provercher and Glockner, 1981). There was no evidence to suggest that the
unretained material had any structural features.
was estimated from the spectra in Figure 9.16 using the CONTIN computer
programme which is based on the method of Provencher and Glockner
(1981) (Table 9.4). The CONTIN computer programme calculates the
percentage of a-helix and (3-sheet in a protein by reference to the circular
dichroism spectra of 16 reference proteins whose structural features had
been determined from X-ray diffraction data. The results of the investigation
did not provide any evidence to suggest that the peptides in group A or in
group B had undergone any great secondary structural changes as a result
of their passage through the reverse-phase column and subsequent
concentration. A possible explanation for the change of behaviour of the
peptides of group A when re-applied to the reverse-phase column is that
they were initially associated together by hydrophobic attraction, possibly as
the twisted filament-type of structure described by Urry (1983); but their
elution from the column in 10%-20% acetonitrile/0.1 % TFA caused a
dissociation of the peptide mass to the less hydrophobic, individual
peptides.
The peptides of group A were not examined any further as a source of
a specific peptide because of their apparent lack of stability and lack of
desmosine-containing peptides.
9.4.2 Examination of peptide group B
In Section 9.3.1 it was suggested that some of the peptides of group B
may contain desmosine, so the search for a specific peptide was
concentrated on this group. First, because desmosine is a marker of elastin
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A typical chromatogram of eiastin-derived peptides which elute in group B.
3eptide X was reproducibly produced from several different digestion samples.
100% corresponds to an absorbance at 220nm of 0.7.
which is not found in collagen or other matrix proteins, and so would not be
found in contaminant peptides. Secondly, because desmosine is not re¬
used by the body (Harel et al. 1980) so desmosine-containing peptides are
more likely to be evident in plasma, urine and bronchoalveolar lavage fluid
than peptides derived from the elastic region of elastin. The peptides from
the elastic region of elastin have been shown to bind to fibroblast receptors
(Wrenn et al. 1988) and to neutrophil receptors (Varga et al. 1989), and they
are chemotactic for these cell types. Therefore, peptides from the elastic
region of elastin may play a role within damaged elastic tissue by attracting
the cells necessary for tissue repair. Furthermore, as speculated in Section
6.5 they may be retained in the area of damage by forming Schiff's bases
with the damaged fibre (Stone et al. 1988).
When the elution profile of the peptides in group B was expanded
and examined it appeared that the constituent peptide peaks were not all
reproducible. The peptide profiles of several chromatograms were
compared, and a single peak (X) was selected because it appeared to be
reproduced in all the chromatograms when the absorbance at 220nm
(Figure 9.17) and at 270nm of the eluate was monitored. Peptide (X) was
quite well separated from the neighbouring peptides, so it was isolated and
subjected to further analysis.
9.4.3 Examination of peptide X
Suspensions of Lansing lung elastin from lung 1 and 2 were digested
with HNE and/or HNCG (10mU/ml) for 24 or 48 hours as detailed in Section
2.3.1. The soluble peptides were isolated and fractionated by reverse-
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Figure 9.18 Examination of peak X bv reverse-Phase chromatography on an
Aauapore RP-300 column
h> emu * ™innina frrnnHaato Urmfr'
with HMCQ for 48 hour*
Peaks X resulting from a) the digestion of Lansing elastin by HNE for 48 hours and b) the
digestion of Lansing elastin by HNCG for 48 hours were isolated as detailed in the text and
concentrated. The peptides were dissolved in 0.5ml of 0.1% TFA and 0.2ml portions were
fractionated by reverse-phase chromatography as detailed in section 2.4.3.
Table 9.5 The amino acid composition of the selected peptides resulting from
24 hours of digestion of Lansing lung elastln
Amino acid
residues/1000
lung 1/HNE lung 241NE lung 2/HNCG Iung2/HNE+HNCG
Asx 107.85 106.91 79.40 53.58
Gtx 117.45 101.08 143.74 66.42
Ser 116.30 100.00 81.46 44.86
Gly 302.00 262.88 192.09 248.62
His 0 0 96.70 0
Arg 27.31 0 7.97 15.60
Thr 0 0 61.19 20.41
Ala 134.47 201.59 15279 215.35
Pro 0 0 0 115.03
Tyr 0 47.31 24.89 32.36
Val 46.14 81.31 58.63 7721
Met 0 0 0 0
Cys 0 0 0 0
lie 31.10 0 27.71 15.49
Leu 61.08 66.67 61.72 55.80
Phe 26.85 0 11.70 20.91
Lys 28.46 32.46 0 18.26
phase chromatography according to Section 2.4.2. The peak eluting at
position X was isolated, concentrated and applied to a microbore Aquapore
RP-300 HPLC column (as detailed in Section 2.4.3).
Typical chromatograms are shown in Figure 9.18. Some of the
material was not retained and was not subject to further attention. A major
peak was eluted at approximately the same percentage of acetonitrile as
peak X. The major peptide peak (P) in all cases was collected, hydrolysed
and the amino acid composition was determined as detailed in Section
2.2.3. These peptides will be referred to as selected peptides for the
purpose of further investigation. The peaks produced at the end of the
gradient are solvent peaks which result from the change-over of the solvent
from 70% to 0% acetonitrile.
9.4.4. Comparison of the compositions of the selected
peptides eluted from the Aquapore RP-300 column
The amino acid compositions of the selected elastin-derived peptides
resulting from 24 hours of digestion of Lansing lung elastin from lung 1 with
HNE and Lansing lung elastin 2 with HNE and/or HNCG are presented in
Table 9.5. At first sight, the data does not provide any evidence to suggest
that the selected peptide resulting from the digestion of Lansing lung elastin
from lung 2 with HNE is related to the peptide resulting from the digestion of
Lansing lung elastin 1 with HNE, or that the selected peptide resulting from
the digestion of Lansing lung elastin 2 with HNE is not related to the peptide
produced from the same elastin after digestion with HNCG alone or HNE
and HNCG.
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Table 9.6 Integer composition of the selected peptides resulting
from the digestion of elastin from Luna 1 and Luna 2
with HNE for 48 hours
Amino acid Number of residues in integer composition
Lung 1 peptide Lung 2 peptide Lung 1 peptide/187 amino acids
Asx (23.56) 24 (14.87) 15 12.36
Glx (45.52) 46 (23.04) 23 23.70
Ser (26.99) 27 (28.31) 28 13.91
Gly (79.73) 80 (47.46) 47 41.21
His (0) 0 (2.92) 3 0
Arg (10.88) 11 (6.59) 7 5.67
Thr (0) 0 (7.45) 7 0
Ala (62.03) 62 (18.89) 19 31.94
Pro (9.04) 9 (0) 0 4.64
Tyr (7.00) 7 (5.52) 6 3.61
Val (30.12) 30 (6.09) 6 15.45
Met (0) 0 (0) 0 0
Cys (0) 0 (0) 0 0
lie (14.01) 14 (5.02) 5 7.21
Leu (28.06) 28 (11.91) 12 14.42
Phe (11.26) 11 (4.09) 4 5.67







minimum f value 0.269 0.357
Mr at min. f value 34869 18067
The integer composition of the specific peptides resulting from the digestion of elastins from Lung 1
and Lung 2 with HNE for 48 hours as determined by the method of Black and Hogness (1969). The
calculated number of residues to 2 decimal places are given in brackets and the nearest integers are
presented to the right of the brackets.
The data presented in Section 6.2 suggests that the digestion of
Lansing lung elastin with HNE has reached completion by 48 hours, so any
peptides present after 48 hours of digestion can be assumed to be end
products. The selected peptides resulting from 48 hours of digestion of
Lansing lung elastin from lung 1 and the Lansing lung elastin from lung 2
with HNE should theoretically be identical. Samples (100|il) of each
selected peptide were hydrolysed as detailed in Section 2.2.3 then made up
to 40(0.1 in 0.025% EDTA solution. An aliquot (IOp.1, corresponding to 25pJ of
the original peptide sample) of the hydrolysate was analysed. The amino
acid composition of both the peptides was deduced, and the integer
composition was determined using the method of Black and Hogness (1969)
which was detailed in Section 9.3.4 (Table 9.6). The analyses suggested
that the peptide from lung 1 had a molecular weight of 34923 which is twice
the predicted size of the peptide from lung 2 (18128). Although both
peptides are smaller than the peptides of a-elastin (60000-84000; see
Section 6.3.1) examined by Partridge et al (1955b) it seems unlikely that
HNE would not have cleaved the peptides further at any of their several
alanyl- and valyl- residues of both peptides. So, the size of both peptides
may have been over-estimated by the method of Black and Hogness (1969),
because the method is designed for the analysis of the composition of a
pure, single-chain peptide and not for peptides which contain
heterogeneous chains joined together by a desmosine cross-link. In both
peptides the proportion of aspartic acid and glutamic acid accounts for 20%
of the composition. Assuming the peptides contain desmosine, the
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composition suggests that at least one of the peptide chains in both lung
elastin peptides must have been encoded by exon 10a (Indik et al. 1987)
which codes for the only relatively acidic sequence of tropoelastin (exon 10a
encoded a 33 amino acid sequence of which 2 are residues of aspartic acid
and 4 are residues of glutamic acid). Indik et al (1989) stated that the
sequence encoded by exon 10a is rarely found in foetal aortic elastin and so
the expression of exon 10a may be age-related. Therefore, it would not be
surprising to find the sequence encoded by exon 10a in a peptide derived
from the lung elastin of an elderly subject. Indik et al (1989) also state that
exon 10a appears to be a 5' donor and alternative splicing may occur within
this exon. So, it is not possible to deduce how much of the compositions of
the peptides from the lung elastins are derived from exon 10a because the
position within exon 10a at which it is spliced is not provided by Indik et al
(1989).
When the number of amino acids of the peptide from lung 1 was
equated to that of the peptide from lung 2 there were several discrepancies,
particularly in the number of residues of serine, glycine, alanine, valine and
proline. These residues collectively account for 78% of the sequence of
elastin (Indik et al. 1987) so they are likely to be found in most elastin-
derived peptides and it is important that their presence is accurately
measured. The discrepancy between the peptides may simply suggest that
the peptides are different and so unrelated, or that the peptide from lung 1
consists of the peptide from lung 2 linked by a Schiff's base to a second
peptide (see Section 6.3.4). A third explanation is that one of the peptides
was impure. However, it seems rather surprising that peptides which have
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Table 9.7 The comparison of three analyses of the same peptide
Amino acid residues/189.28 residues (the number of residues in the original analysis)
original analysis same hydrolysate dffierent hydrolysate
same peptide same peptide
Asx 14.87 14.94 6.895
Glx 23.04 22.41 1217
Ser 2831 27.40 17.03
Gly 47.46 51.05 55.62
His 2.92 3.73 0
A/g 659 622 0
"Thr 7.45 7.47 0
Ala 1889 18.67 3893
Pro 0 0 14.48
Tyr 552 498 753
Val 6.09 622 1159
Met 0 0 0
Cys 0 0 0
lie 5.02 4.98 1623
Leu 11.91 1245 8.75
Phe 4.09 498 0





apparently different compositions should have the same retention time from
the reverse-phase columns, and therefore the same hydrophobicity.
The inconsistency between the behaviour of the two peptides on
reverse-phase chromatography and their difference of composition may
indicate that the analyses were unreliable. This possibility was tested. The
hydrolysate (10jil) of the peptide from lung 2 was analysed for a second
time, and another sample of the same selected peptide from Lansing lung
elastin 2 was subjected to hydrolysis. In this case 0.3ml of the peptide was
hydrolysed then made up to 0.1ml in 0.025% EDTA solution. An aliquot
(1 Ojil, corresponding to 30pl of the original peptide solution) was analysed.
From these analyses it was possible to examine the variation between two
analyses of the same hydrolysate, and the variation between different
hydrolysates of the same peptide. The number of amino acids in each of the
compositions was equated to 187 (Table 9.7), which was the number of
amino acids in the integer composition of the original analysis of the peptide
from lung 2 (Table 9.6), and the deviation (f) between the analyses was
calculated as detailed in Section 9.3.4. The values were 1.202 for the
deviation between samples of the same hydrolysate and 11.37 for samples
of different hydrolysates of the same peptide. This suggests that there is
considerable variation between analyses which should be identical.
Interestingly, the analyser detected 1057 and 1505 pmol of amino acids
during the analysis of the same hydrolysate (equivalent to the amount of
amino acid in 25(il of the original peptide solution), but only 615.8 pmol of
amino acids in the sample of the second hydrolysate (equivalent to the
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Table 9.8 The comparison of the amino acid composition of ft -lactoalobulln
determined bv amino acid analysis with the known composition of the protein




















The composition ofj^-lactoglobulin as determined by amino acid analysis was equated to 155 residues,
which is the number of residues in the sequence of ^lactoglobulin minus cysteine and tryptophan
(Braunitizer et al,1973). Cysteine and tryptophan were not measured. The deviation (f) between the
two data sets was 2.29.
amount of amino acids in 30|il of the original peptide solution).
The purity and actual expected composition of the elastin-derived
peptide was not known so it was necessary to determine if the apparent
inadequacies of the composition were due solely to a lack of purity. This
would seem unlikely since a mixture of peptides should still give consistent
analyses. A sample of pure p-lactoglobulin (provided by the Wei-Met
Protein Characterisation Service) was hydrolysed and analysed as detailed
in Section 2.2.3. The resulting composition was compared with the known
composition of p-lactoglobulin (Braunitzer et al. 1973) and the value of (f)
between the two compositions was calculated (Table 9.8). The amino acid
composition of p-lactoglobulin determined by analysis did not accurately
resemble the known composition of the protein. These data tend to support
the opinion that the analyses are not adequate enough to allow an accurate
comparison between peptides, and therefore it was not possible to state
whether or not peptides produced from different samples of Lansing lung
elastin by the same method could be shown to be identical in composition.
This may be a result of inadequate hydrolysis or an inadequacy in the
analysis itself. One source of error introduced during the analysis was the
inadequate separation of the proline from a solvent peak (PTU) which
causes either an over-estimation of the proline or no estimation of proline. It
may be concluded that a very complicated mixture of peptides was produced
by the enzymic digestion of lung elastin. The peptides were fractionated by
reverse-phase chromatography but it was not possible to determine if
peptides resulting from different conditions of digestion had different but
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consistent compositions even though they exhibited the same behaviour on
reverse-phase chromatography.
9.5 Concluding remarks about the investigation of
specific elastin-derived peptides
The use of reverse-phase chromatography to fractionate elastin-
derived peptides has been the focus of much work (Smyrlaki et al. 1987;
Manning et al. 1989; Sandberg et al. 1990) but the yields of peptide material
from the reverse-phase columns are poor, presumably because of
irreversible binding of some of the peptides. An alternative technique
allowing the separation of hydrophobic molecules is hydrophobic interaction
chromatography. This involves using a column which is very similar to a
reverse-phase column except that the concentration of the hydrophobic side
chains is less dense. It would be expected that very hydrophobic peptides
would not bind as tightly to the column and so the yield of material would
improve. The major disadvantage is that small mildly hydrophobic peptides,
such as those in group A may not bind to the column at all, so they would
have to be separated by reverse-phase chromatography. This inability to
retain small mildly hydrophobic peptides may explain why the technique has
received very little attention (It was used by Ryan et al. 1983, but was later
replaced with reverse-phase chromatography). The peptide profiles
produced when the peptides were separated by reverse-phase
chromatography using a gradient of 2%-100% acetonitrile/0.1% TFA were
very similar regardless of which enzyme was used for their production; and
many of the peptides were poorly resolved. Smyrlaki et al (1987) also
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observed that elastin-derived peptides from adult lung-elastin were only
partially resolved by reverse-phase chromatography.
When a single peptide was studied further it was evident that peptides
which should theoretically have been identical because they were subject to
identical digestion conditions and had the same hydrophobicity could not be
shown to have the same composition because of inaccuracies in the amino
acid analysis. These problems may in part be due to the fact that very little
peptide material was available for analysis so the analyser was running at
maximum sensitivity and any background peaks may be mistakenly
interpreted to be amino acids causing an over-estimation of some amino
acids.
In the case of a simple peptide the amino acid analysis could be
confirmed by sequencing the peptide. However, a desmosine-containing
peptide would have at least 2 free amino termini and 2 equimolar
sequences (see Chapter 10 and Gray et al. 1973) so that no one sequence
could be identified. It would not be possible to differentiate between a
peptide with 2 termini and a mixture of 2 peptides of approximately equal
amounts.
The fact that the peptide products resulting from the digestion with
HNCG but, not with HNE, seemed to be recognised by a monoclonal
antibody against an elastin hexapeptide suggests that some of the peptides
do differ in composition (see Section 9.1.1); but this was not obvious from
the elution patterns. So although peptides produced by the digestion with
HNCG may differ compositionally from peptides produced by digestion with






The proteinase:antiproteinase theory of emphysema in its most
primitive state suggests that HNE in excess of the inhibitory capacity of the
lungs digests the elastin of the extracellular matrix. So the isolation and
identification of a marker of elastin digestion by HNE has been a cause of
concern for many years, and was the aim of this project. Antibodies against
the marker peptide(s) could be used as a diagnostic tool to prove whether or
not the elastin-derived peptides detected in the body fluids of
emphysematous patients (Harel et al. 1980; Kucich et al. 1985) are the
products of elastin digestion by HNE. Unfortunately such specific peptides
have proved to be elusive.
Many of the problems which arise during any study on elastin and
elastin-derived peptides are due to a lack of fundamental knowledge about
elastin itself. The purification methods available for the isolation of elastin
are crude and exploit the fact that elastin is more insoluble than the other
proteins of the extracellular matrix. The purification of elastin involves
solubilising all other proteins in the hope of leaving pure elastin as the
insoluble residual material. There are few criteria for assessing the purity of
the product (Soskel and Sandberg, 1983). The insoluble protein cannot be
completely sequenced because of the complications introduced by the
presence of the tetrafunctional desmosine and isodesmosine cross-links. It
is generally accepted that desmosine and isodesmosine probably link 2
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molecules of tropoelastin rather than 3 or 4 (Gray et al. 1973). This means
that 2 peptide chains per cross-link will be sequenced simultaneously. Much
of the sequence around the cross-link is similar in all chains so it would be
difficult to assign each residue to a particular chain. Several authors have
given compositions for elastin (Lansing et al. 1952; Ross and Bornstein,
1969; Richmond, 1974; Reilly and Travis, 1980); but these authors isolated
the elastin from different tissues using different methods of isolation. In order
to clarify the discrepancies in composition due to species variation and
determine the relative merit of each isolation method, Soskel and Sandberg
(1983) isolated elastin from hamster lung by 6 different method and came to
the conclusion that the composition of the product was variable both when
isolated by the same method and when comparing the product of different
methods of isolation.
The first conclusive information about the composition and sequence
of insoluble elastin was provided by Indik et al (1987) when they published
the sequence of the cDNA of human foetal aortic tropoelastin, which is the
soluble precursor of elastin. Tropoelastin is converted to the insoluble
elastin after secretion by cross-link formation. Indik et al (1989) also
provided an explanation for some of the disagreement over the composition
of elastin by suggesting that sequence differences between the elastins of
different organs and subjects of different ages could be a consequence of
alternative splicing of the exons of a single gene (Indik et al. 1989).
Alternative splicing of the elastin gene explains why previous investigations
had led to the isolation of mRNA encoding at least 2 different forms of
tropoelastin (Foster et al. 1980). The study of the molecular biology of
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elastin has provided evidence to suggest that different exons encode the
lysine-rich potentially cross-linking hydrophilic domains and the
hydrophobic domains of the protein (Indik et al. 1989).
Elastin is a natural substrate for HNE which digests the insoluble
protein to a mixture of soluble and insoluble products (Janoff and Scherer,
1968). The soluble products liberated during the digestion of elastin are
under-estimated by standard protein assays (see Section 4.1.2) so they
were measured spectrophotometrically with TNBS as an increase of free
amino groups. If we assume that the 6-amino groups of the lysine residues
in elastin are modified to cross-links and cross-link intermediates then any
increase of free amino groups represents an increase of amino termini. The
insoluble products of digestion cannot be measured with TNBS alone
because the insoluble Tnp-peptides will sediment and will not be detected
by the spectrophotometer. The TNBS reaction with amino groups is known
to liberate sulphite as a by-product. Sulphite reacts with DCPIP to cause a
decline of the absorbance at 605nm of the DCPIP (see Chapter 5 and the
Appendix). By adding TNBS and DCPIP to a mixture of peptides it was
possible to measure the sulphite by-product liberated from the TNBS as a
decrease of absorbance at 605nm of DCPIP. This method was used to
measure the total amount of peptides and the amount of insoluble products
of digestion was calculated by subtracting the amount of soluble amino
groups measured with TNBS form the amount of total amino groups
measured with TNBS and DCPIP.
When Lansing lung elastin was digested with HNE the initial amount
of soluble and insoluble products was approximately equal. After
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approximately 2 hours of digestion the amount of soluble peptides began to
exceed the amount of insoluble products (see Section 6.2.1). These data
can be explained in terms of the proposed model of Robert et al (1974)
which suggested that after HNE has bound to the elastin there is a slow
limited hydrolysis of some peptide bonds. This exposes previously
unavailable sites of proteolysis. This stage could be expected to yield
predominantly insoluble termini together with some soluble peptides. The
availability of new sites of proteolysis induces an increase in the amount of
proteolysis to liberate predominantly soluble peptides; at this stage the
amount of soluble peptides would be expected to exceed the amount of
insoluble products.
It was expected that the digestion would eventually reach a plateau at
which no further digestion occurred because all the susceptible bonds had
been hydrolysed. However, between 24 and 48 hours of the digestion of
Lansing lung elastin with HNE there appeared to be a decline of the amount
of detectible free amino groups (see Section 6.2.1). This occurred
regardless of whether the lung had been fixed in acetone or ethanol prior to
the isolation of the elastin (see Sections 2.2 and 3.2.1). Subsequent
investigations suggested that some of the peptides were capable of
associating together. Elastin-derived peptides are known to associate
together hydrophobically to form coacervates (Partridge et al. 1955a).
However, the evidence presented in Section 6.3 suggest that coacervates of
the peptides may be stabilised by the formation of Schiff's bases. Schiff's
bases are formed when aldehyde groups react with amino groups. Some of
the intermediates in the formation of desmosine and isodesmosine are
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known to be aldol condensation products (Lent et al. 1969) which would
presumably be capable of reacting with the amino termini of the peptide
products of digestion to form Schiff's bases. In general, the formation of
Schiff's bases may be prevented by reducing the aldehyde to an alcohol
with sodium borohydride. When peptides were treated with sodium
borohydride after 18 or 24 hours of digestion (Section 6.3.5) the apparent
decline of the amino groups was prevented. Attempts were made to isolate
the groups which were reduced by using tritium-labelled borohydride and
then separating the peptides by reverse-phase chromatography. These
experiments met with little success. Any future work on the formation of
Schiff's bases between elastin-derived peptides could involve the
development of a reliable spectrophotometric assay for the presence of
aldehyde cross-link intermediates. Elastin is known to bind basic fuchsin
(Weigert, 1898; McCallum, 1973) which is used routinely to detect
aldehydes. If the fuchsin was shown to bind to the elastin via aldehyde
groups then any decline of the absorbance of the basic fuchsin after reaction
with the aldehyde cross-link intermediates of elastin-derived peptides could
be used as a method of measuring the amount of aldehydes. If the decline
of free amino groups could be correlated with a decline of detectible
aldehyde intermediates it would tend to suggest that Schiff's base formation
is responsible for the stabilisation of coacervating peptides. The
significance of the formation of Schiff's bases will be discussed later in this
Chapter.
The extent of digestion of elastin by HNCG, another serine proteinase
of neutrophils, was less than the amount of extent by HNE (see Chapter 7).
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The actions of HNCG were of some interest because HNCG was suggested
by Boudier et al (1981) to act synergistically with HNE, although this was
disputed by Reilly et al (1984). The data presented in Chapter 8 suggests
that the pre-digestion of elastin with HNCG may aid HNE digestion simply
because HNCG performs the initial limited proteolysis of the elastin.
Therefore subsequent digestion by HNE would appear to be faster than
expected simply because the susceptible, interior bonds are available for
hydrolysis as soon as the enzyme is added to the substrate.
The soluble peptides produced as a result of the digestion of elastin
with HNE and/or HNCG are potential diagnostic tools which which could be
used to confirm the alleged role of HNE in emphysema. The cross-links
desmosine and isodesmosine are unique to elastin, so peptides containing
the cross-links are natural candidates in the search for marker peptides. The
elastin-derived peptides resulting from the enzymic digestion of elastin could
be fractionated by reverse-phase chromatography (see Chapter S). This
project was concerned primarily with all peptides regardless of whether they
contained desmosine. If the study had been limited to the identification of
desmosine-containing peptides it would have been advantageous to
fractionate the peptides by affinity chromatography using either antibodies
raised against desmosine-containing peptides or anti-elastin peptide
antibodies which have been detected in the circulatory system of
emphysematous patients (Fulop et al. 1989) as the ligand. The desmosine-
containing peptides in the eluate from the affinity-column may be selected by
monitoring the absorbance at 270nm. Finally, these peptides could be
separated from one another by using reverse-phase chromatography.
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The peptides produced by digestion of elastin with HNE and with
HNCG did not differ on the basis of hydrophobicity, and it was not possible to
see any difference when they were separated by reverse-phase
chromatography. Many of the peptides appeared to co-elute when the
reverse-phase column was developed with an acetonitrile gradient. Any
future work could involve the separation of co-eluting peptides using
different reverse-phase columns developed with different solvents. There
are an infinite number of combinations of columns and solvents.
Alternatively the peptides could be examined by hydrophobic interaction
chromatography.
It was not possible to determine if the peptides produced as a result of
digestion by different enzymes were compositionally different as the amino
acid analyses of hydrolysates of the peptides were inconsistent and
unreliable. There was insufficient material available to allow analysis on a
less sensitive, but possibly more reliable amino acid analyser, so the
investigation of the peptides could not be pursued any further.
HNE is an endoproteinase which is capable of cleaving a large
number of bonds within the elastin and has a specificity which over-laps with
the specificity of other enzymes such as proteinase-3 and HNCG, so it
seems unlikely that peptides specific for HNE or HNCG digestion could be
shown to be produced consistently from elastin, which had been isolated by
a crude method which gave a product of unknown purity. Even if peptides
produced by HNE digestion but not HNCG digestion and vice-versa were
identified it would be naive to assume that they could be used as marker
peptides. Before any such assumptions can be made experimental
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evidence is required to prove that other elastinolytic enzymes are incapable
of generating these peptides. This is particularly important when comparing
the action of HNE and proteinase-3, which is also found in the azurophil
granules of neutrophils (Kao et al. 1988). Although the enzymes differ in
their specificity with synthetic substrates, they are both capable of cleaving
bonds adjacent to small amino acids such as alanine and valine in large
proteins such as elastin (Rao et al. 1991). Similar consideration should also
be given to the elastinolytic enzymes of other inflammatory cells, such as
macrophages (Werb and Gordon, 1975), and the elastases which can be
secreted by micro-organisms such as Pseudomonas aeruginosa (Morihara
et al. 1965; Hamdaoui et al. 1987) and Aspergillus fumigatus (Reichard el
al, 1990) which are commonly found in the respiratory tracts of
immunosuppressed and cystic fibrosis patients. So the detection of elastin-
derived peptides resulting from the attack of excessive enzymes from the
inflammatory cells will be complicated if the emphysematous patient is
infected with an opportunistic micro-organism which is capable of secreting
elastolytic enzymes.
Even if it was established that a particular enzyme digested elastin to
give a characteristic peptide in vitro] it would be unrealistic to assume the
same elastin-derived peptide would be produced in vivo. This is simply
because each enzyme is not found in isolation, but as a member of a
cocktail of elastinolytic enzymes. The consequence of the co-operation
between the enzymes will lead to the production of elastin-derived peptides
in vivo which were not found in vitro. Since the enzymes are assumed to
reach excessive levels because of inadequate inhibitory mechanisms it is
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important to consider the role played by the different inhibitors in controlling
excesses of enzyme. Historically emphysema has been associated with a
deficiency of a-1-PI; a correlation between a deficiency of the low molecular
weight inhibitors and emphysema has not yet been shown. Similarly,
attention should be paid to the fact that the majority of patients with
emphysema are not deficient in a-1-PI but are heavy smokers, so the
implications of the oxidant : antioxidant theory should be examined because
excess oxidants may oxidatively inactivate the inhibitors allowing the
enzymes to reach excessive levels.
Having established a realistic view of the proteinase:antiproteinase
balance, the methods discussed in this Thesis could be employed to isolate
groups of specific elastin-derived peptides which could then be used to
study imbalances; but such peptides are probably of little use. First, their
detection would be confined to bronchoalveolar lavage fluids and the blood
in the pulmonary vein. Pelham et al (1985) were unable to detect any
significant difference between the concentration of urinary desmosine of
adults with interstitial lung disease or emphysematous adults with a-1-PI
deficiency and Pizz individuals with no symptoms of emphysema. Secondly,
elastin-derived peptides will have a great deal of sequence similarity so
antibodies raised against a single peptide may well recognise several other
peptides which are not specific to a particular type of enzymic-digestion.
Thirdly, elastin may be subject to age-related changes, so the peptides
which are found in the bloodstream of a child with a genetic deficiency of a-
1 -PI will not necessarily be the same as those in the bloodstream of an
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emphysematous 70 year old who is a heavy smoker (Smyrlaki et al. 1987).
Finally, elastin is present within all tissues subjected to high pressure
differentials. The sequence of the elastin is unlikely to alter dramatically
from tissue to tissue, even allowing for the contribution of alternative splicing
(Indik et al. 1989). This is confirmed by Starcher and Galione (1976) who
showed that the amino acid composition of elastin in all tissues was
constant, although they did suggest there is some species variation.
Similarly, Kucich et al (1981) demonstrated that antibodies raised against
elastin-derived peptides from lung cross-reacted with elastin-derived
peptides from aorta. So any differences between the peptides from different
tissues is insufficient in themselves to prove conclusively that the source of
the peptides was the elastin of the lungs rather than arterial elastin.
Although there is a great deal of evidence to suggest that elevated
levels of unspecific elastin-derived peptides are found in the urine and
plasma of patients with emphysema it is concluded that the use of elastin-
derived peptides containing desmosine as markers of a specific enzyme
imbalance is probably a little optimistic because large proportions of elastin
contain similar sequences and the active enzymes capable of causing the
greatest harm have an overlapping specificity so it is unlikely that such
specific peptides exist. Weinbaum et al (1991) recently used domain-
specific antibodies to illustrate some interesting points about unspecific
elastin-derived peptides. They found that circulating antigens reacted with
an antibody directed against the carboxy terminus of tropoelastin, but did not
react with an antibody directed against a tyrosine-rich region of tropoelastin
(200-221). Both antibodies recognised the intact elastin within the alveolar
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interstitium but the antibody which recognised the carboxy terminus of the
protein did not react with the urinary elastin-derived peptides. The use of
domain-specific antibodies to screen plasma and bronchoalveolar lavage
fluid can potentially provide information about the areas of the tropoelastin
molecule which are most susceptible to degradation. The relevant antigens
could be affinity purified from the body fluids and sequenced. If the
sequence of the peptide was compared with the sequence of tropoelastin
(Indik et al. 1987) it may be possible to identify the enzyme(s) which could
have hydrolysed the peptide from elastin.
Recent research on the elastin-derived peptides from the elastic
region of the macromolecule has suggested they have some potentially very
exciting roles in the repair of the fibres and in cellular regulatory events.
These peptides and their roles have received little attention in the past
because they are difficult to distinguish from peptides of collagen or of the
protein core of proteoglycans or glycoproteins, which are all potential
substrates of HNE (see Section 1.3). When elastolytically damaged tissue is
repaired the newly formed elastic network is disorganised (Karlinksy and
Snider, 1978). This tissue will eventually be destroyed producing
emphysematous lesions, the production of which may be exacerbated by a
lysyl oxidase deficiency (Tinker et al. 1990). Therefore, inadequate repair
mechanisms may contribute to the progression of emphysema. Hornebeck
et al (1986) showed that elastin-derived peptides are chemotactic and are
capable of binding to a 120kDa cell-membrane complex designated
elastonectin which is found on the membrane of fibroblasts. The complex is
involved in cell adhesion and receptor-mediated signal transduction. So it
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is possible that the cell adheres to damaged fibres via the complex, after
which a receptor-mediated stimulation of protein synthesis occurs. Foster el
al (1990) have shown that fibroblasts in culture which have been subjected
to proteolytic attack will synthesise tropoelastin in response to elastin-
derived peptides. In contrast, the production of tropoelastin is down-
regulated by fibroblasts which have not been subjected to proteolysis in
response to the same elastin-derived peptides. The protein of the
elastonectin complex which acts as the receptor was isolated by Wrenn et al
(1988) and is a 67kDa peripheral membrane protein which specifically
recognises the hexapeptide, Val-Gly-Val-Ala-Pro-Gly, found in the elastic
region of elastin (see Section 1.3 for a discussion about the role of the
receptor in fibre assembly). This hexapeptide is also recognised by
receptors on the surface of a highly metastatic lung carcinoma cell-line
(Blood et al. 1988). Interestingly, a 67kDa membrane receptor for laminin
peptides has been isolated from A2058 melanoma cells which is structurally
and functionally similar to a 67kDa receptor for elastin peptides on the
surface of chondroblasts (Mecham et al. 1989). So a family of receptors may
be involved in the repair of the different components of the matrix.
Fibroblasts are not the only cell-type which may be influenced by
elastin-derived peptides. Neutrophils are also chemotactically attracted by
elastin peptides which, again, bind to the cells and initiate signal
transduction mechanisms which lead to the breakdown of
phosphatidylinositol (Varga et al. 1989). Activation of the neutrophils could
theoretically produce an increase in HNE synthesis and, consequently,
further damage to the matrix. However, it should be noted that not all of the
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products of HNE digestion are capable of activating neutrophil cellular
events. Recent research has suggested that the elastase-generated Fc
fragment of immunoglobulin G can actually inhibit neutrophil chemotaxis
(Eckle et al. 1991).
It is possible that when an elastic fibre is damaged some of the small
"elastic" peptides either bind hydrophobically to the damaged fibre or act as
signals causing a chemotactic response from fibroblasts. The fibroblasts
then attach to the damaged fibre and synthesise tropoelastin and lysyl
oxidase. When the tropoelastin is secreted into the region of damage it
would be expected to form desmosine cross-links. However, in the presence
of a higher-than-normal concentration of amino termini, the modified lysine
residues of the new tropoelastin and any cross-link intermediates of the
damaged fibre may form Schiff's bases which will be significantly weaker
than desmosine and isodesmosine (discussed further in Chapter 8). The
formation of Schiff's bases requires the presence of an aldehyde and amino
group whereas desmosine formation requires three aldehydes and an
amino group. So, it is possible that during repair "salvage" mechanisms
such as Schiff's base formation are used to maintain an intact fibre
regardless of the quality of cross-linking. This would produce a
disorganised fibre of low quality, which after several years of damage-repair
cycles would break down completely to form an emphysematous lesion. If
this theory was correct it would follow that fibrosis of the tissue occurs prior to
the formation of lesions; but fibrosis and emphysema have generally been
considered to be mutually exclusive (Snider et al. 1985). Recent electron
microscopy studies (Nagai and Thurbeck, 1991) have questioned this
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assumption by showing that fibrosis and emphysema have been detected
within the same lung. So further research to clarify whether or not the
diseased lung has a smaller amount of desmosine cross-linking and a
greater amount of "salvage repaired" fibres than normal could provide a very
interesting insight into the disease processes.
Although the damage inflicted on the matrix during the production of
emphysema is a consequence of proteinase:antiproteinase and
oxidant:antioxidant imbalances, the repair of the tissue and progression of
the disease may be dictated by cell-matrix interactions. So it would be
advantageous to study the balance between neutrophil and fibroblast
activation in response to the chemotactic influence of elastin-derived
peptides.
In conclusion it is highly unlikely that reproducible marker elastin-
derived peptides specific for digestion by a particular enzyme are produced
during degenerative lung disease. So, more fruitful studies on elastin-
derived peptides are possible by considering their role in cellular regulation
and cell-matrix interactions. By studying the fundamental biochemical
regulation processes associated with the extracellular matrix it may become
apparent which cellular disturbances provoke symptoms such as
proteinase:antiproteinase and oxidant:antioxidant imbalances which will
ultimately lead to matrix damage.
220
APPENDIX
Figure A.I The reaction between DCPIP and sulphite for a variable amount
of time
0J2p.mol Of DCPIP was treated with equimolar sodium sulphite at pH 8.0 and 37°C (total volume 2ml).
The absorption spectrum of the solution was determined after several time intervals, as foHows:-
(1)0, (2) 5, (3) 10, (4) 15, (5) 20, (6) 30, (7) 60, (8) 90, (9) 120, (10) 240 and (11) 340 minutes after the
addition of sulphite.
Figure A.2 The change of the maximum absorbance and the corresponding
wavelength during the course of the reaction between DCPIP and
sulphite
The change of the wavelength of the maximum absorbance
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0.2pmol of DCPIP in 0.05M sodium phosphate buffer pH 8.0 was reacted with an equimolar amount
of sodium sulphite in a solution with a total volume of 2ml. The X max and the maximal absorbance
were measured at intervals during the reaction.
APPENDIX
In Chapter 5 it was observed that DCPIP was not reduced by equimolar
amounts of sulphite, and the reaction actually appeared to have a 1:2
stoichiometry of DCPIP:sulphite. This was surprising and worthy of further
investigation, although it was not relevant to the original aims of the project.
A.1 Further investigation of the reaction between DCPIP
and sulphite
The reaction between DCPIP and a reducing agent was expected to
result in a colourless product, showing a decrease of absorbance at 605nm
and no apparent change of the wavelength of the maximum absorbance
(kmax). When DCPIP was reduced with sodium borohydride, a simple
decrease of absorbance at 605nm without a shift of the ^.max was seen.
The absorbance at 605nm of the reduced DCPIP was restored by oxidising it
with iodine. When the absorption spectra of DCPIP after reduction with one
mol of sulphite for a varied amount of time (Figure A.1) was examined it
appeared that the reduction of the DCPIP by sodium sulphite was not as
simple as expected. When the change of A.max and the absorbance at A.max
were compared to the time of reaction (Figures A.2a and b) it appeared that
during first 30 minutes of the reaction a decrease of the absorbance at Xmax
occurred, but this was followed by a rapid increase of the absorbance until
approximately 2 hours of reaction after which the absorbance continued to
increase very gradually. The shift in the wavelength of the maximum
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Figure A.3 Abeoretlpn »eeclr« pf the fOCtlon bgtWOOn—DCPIP—and—YBflfld
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0 2pmol of DCPIP was treated with (A) 0 jjmol, (B) 0.2 pmol, (C) 0.4 pmol, (D) 0.6 pmol, (E) 0.8 pmol or
(F) 1.0 pmol of sulphite at pH 8.0 in a final volume of 2ml. After 30 minutes or 2 hours of incubation at 37°C
the absorption spectra were measured. The above spectra represent a typical result.
Figure A.4 The change of absorbance at 605nm and 647nm of DCPIP after reaction
with varied sulphite
sulphite (umol)
O.lpmol of DCPIP in 0.05M sodium phosphate buffer pH 8.0 was reduced with sodium sulphite
(0-1.0pmol) at 37°C for 4 hours after which the absorbances at 650nm and 647nm of each solution (final
volume 2ml) against the phosphate buffer were measured.
absorbance occurred during the first hour of reaction. Absorption spectra
showing the reaction between 0.2(j.mol of DCPIP and a variable amount of
sulphite (0-1.0pmol) in 2ml of solution were recorded after 30 and 120
minutes of reaction (Figure A.3a and b). These spectra supported the
conclusion that over a range of concentrations of sulphite the initial reaction
may be observed as a shift in the Timax accompanied by a decline of the
maximal absorbance. After 2 hours of reaction, the absorbance of the
product of the reaction between DCPIP and one mole of sulphite had
increased to a value greater than the absorbance of the original DCPIP
solution, while the absorbance of the products of the reaction between
DCPIP and excess of sulphite had continued to decline. This suggests that
the first mole of sodium sulphite reacted with the DCPIP at pH 8.0 to cause a
shift of the Xmax to 647nm and an increase of absorbance at this new Xmax;
further sodium sulphite caused a decrease in this absorbance (Figures A.1-
A.4). It seems that the lack of response of DCPIP to small amounts of
sulphite (Figure 5.3) is due to the fact that the decrease of absorbance at
605nm in response to small amounts of sulphite (less than equimolar
amounts) is obscured by the increasing absorbance at 647nm due to the
formation of a new compound.
It seemed possible that the shift of kmax was an artifact of the pH
dependence of the absorbance of DCPIP. A 0.2mM DCPIP solution was
prepared in 0.05M sodium pyrophosphate buffer, pH 8.5, at which the molar
absorbance of DCPIP is maximal (Armstrong, 1964). The ^.max of the
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solution was 605nm. When an equimolar amount of sodium sulphite was
added to the DCPIP solution a shift of the Xmax to 647nm was observed
after 2 hours of incubation at 37°C. The buffering capacity of 0.05M sodium
pyrophosphate buffer pH 8.5 was considered sufficient to counteract any
effect on pH induced by the addition of 20pl of 10mM sodium sulphite to 1 ml
of 0.2mM DCPIP diluted to 2ml with the 0.05M sodium pyrophosphate buffer,
pH 8.5. So the shift of the kmax of DCPIP during the reaction with sodium
sulphite is not an artifact induced by a change of pH.
It was concluded that the first mole of sulphite reacts in some way with
the DCPIP, giving a shift in the ?imax, and that further sulphite reduces the
new compound. The first reaction could be a simple addition reaction in
which one mole of DCPIP reacts completely with one mole of sulphite to give
one mole of a new compound (P), or alternatively the reactants may be in
equilibrium with the new compound:-
DCPIP + S032V====— P
kmax 605nm Xmax 647nm
If an equilibrium was present then it could be assumed that the removal of
the sulphite, by oxidation to sulphate with hydrogen peroxide, would force
the equilibrium toward the left, to produce an increase of DCPIP which in
turn would cause the Xmax to shift back towards 605nm. Solutions
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Figure A-5 The oxidation with hydrogen peroxide of the compound formed after
the reaction between DCPIP and eauimolar sulphite
Solutions containing 0.1 pmol of DCPIP were treated with 0.1 (xmoi of sodium sulphite and incubated for 2
hours at 37°C and pH 8.0. Each solution was treated with hydrogen peroxide (0-1.0 pmol) to give a final
volume of 2ml. They were incubated for a further 2 hours after which the absorption spectrum of each
solution was measured. The spectra did not appear to differ.
Solutions A, B and C were treated with 0 pmol, 1.0 pmol and 0.5 pmol of hydrogen peroxide respectively.
containing O.ljimol of DCPIP and O.lpmol of sulphite were incubated at
37°C for 2 hours, after which the A.max of the solutions was 645nm. The
solutions were treated with hydrogen peroxide solution (0-1.0|imol) giving
each one a final volume of 2ml, and the absorption spectra were measured
after a further 5, 30 and 120 minutes. The spectra produced after 120
minutes of reaction with hydrogen peroxide are shown in Figure A.5. It was
concluded that hydrogen peroxide treatment did not affect the >.max of the
new compound. Similarly, the Xmax of the new compound could not be
changed from 645nm to 605nm by oxidation with an excess of iodine or an
excess of potassium ferricyanide. So the reaction between DCPIP and
equimolar sulphite was assumed to be irreversible.
By assuming that the first mole of sulphite adds to one mole of DCPIP
(Xmax 605nm) to give one mole of a compound (P; Xmax 647nm) then the
equilibrium constant for the reduction of P can be calculated using the
decrease of absorbance at 647nm produced by the addition of excess
sulphite (Figure A.4), such that:-
P + so32- ^PH2 + S042- (1)
kmax=647nm colourless
and K,■eq [PH2], [S042~] (2)
[P].[S032-]
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Figure A.6 Determination of the equilibrium constant of the reduction with













O.lpmol of DCPIP in 0.05M sodium phosphate buffer pH 8.0 was reduced with sulphite (0-0.8pmol)
at 370C for 4 hours. The final volume of each solution was 2ml. The decreases of absorbance at
647nm between the solution which had been treated with equimolar sulphite and each solution
treated with excess of sulphite were used to determine the equilibrium constant of the reduction of
the new compound (P) by sulphite, as detailed in the text.
Figure A.7 The displacement of the chloride groups of DCPIP with sulphite
2 SO'h
If the equilibrium conforms to this simple reaction then the equilibrium
constant (Keq) can be determined graphically (Figure A.6) by plotting the
Keq against varied sulphite. The Keq for the reduction of O.lpmol P with
sodium sulphite (0.2pmol-0.7ja.mol) was 0.637^0.134.
A.2 The mechanism of the reaction between DCPIP and
sulphite
The actual mechanism of the apparently complicated reaction
between DCPIP and sulphite was a cause of great interest. Three possible
models were considered. First, the sulphite displaces the chloride of DCPIP,
secondly a sulphite addition compound is formed and thirdly a single
electron transfer reaction occurs.
A.2.1 Displacement of the chloride of DCPIP with sulphite
The reaction between DCPIP and sulphite could involve the
displacement of the chloride of DCPIP as shown in Figure A.7. If this were
the case then the displaced chloride could be detected by reaction with
silver nitrate which gives a white precipitate of silver chloride.
Sodium sulphite (I.Opmol in 10Opil) was added to I.Opmol of DCPIP
in 9.9ml of 0.05M sodium phosphate buffer pH 8.0 giving a total volume of
10ml. The solution was incubated at 37°C for 2 hours, after which it was
acidified to approximately pH 4 by the addition of 15 drops of 1.5M HN03.
Hydrogen peroxide (50pl of a 26% (v/v) solution) was added to the solution
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Figure A.8 The reduction of Dhenolindophenol with sulphite
nm
0.2 pmol of phenolindophenol was treated with 0.2 pmol of sodium sulphite at pH 8.0 (final volume 2ml)
and incubated at 37°C for 2 hours after which the absorption spectra of the treated solution (- ) aftd an
untreated control ( ) were recorded.
in order to oxidise any remaining sulphite to sulphate. Potassium chromate
was added to the DCPIP reaction mixture as an indicator before the solution
was titrated with 0.1 mM silver nitrate solution. The end-point of the reaction
was seen when a red precipitate of silver chromate was formed. DCPIP is
pink at pH 4 so the end-point of the reaction between silver nitrate and any
chloride in the solution was expected to be subtle. When silver nitrate was
added to the reaction mixture, silver chromate was immediately formed. So
it was concluded that chloride was not liberated during the reaction between
DCPIP and sodium sulphite.
If the displacement of chloride by sulphite was not involved in the
reaction, then it could be predicted that if phenolindophenol was reduced
with sodium sulphite a shift of ^max would be evident even though the
compound differs from DCPIP in that it has no chloride substituted at the 2-
and 6- positions of the quinone ring. When 0.2pmol of phenolindophenol
(Sigma) in 0.05M sodium phosphate buffer pH 8.0 was reduced with
0.2|imol of sodium sulphite (the final volume of the solution was 2ml) it
seemed that phenolindophenol was incompletely reduced with one
equivalent of sodium sulphite, and the shift of ^max, from 630nm to 637nm
(Figure A.8), was very small when compared to the shift observed during the
reaction between DCPIP and sodium sulphite (Figures 5.4-5.7). It was
concluded that the presence of the chloride on the quinone ring of DCPIP
may contribute indirectly to the mechanism of the reaction between DCPIP
and sodium sulphite.
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A.2.2. The formation of a sulphite addition compound
Chloride groups are electron-withdrawing. This would give the
carbon of the oxo- group of the quinone group in DCPIP a 5+charge, which
would in turn make the carbon more attractive to reaction with a negatively
charged compound such as sulphite. So, it seemed possible that an
addition reaction occurs between the first mole of sulphite and the keto-
group on the quinone group as shown in Figure A.9. Any further sulphite
would reduce the compound as previously predicted. This seemed a likely
explanation for the reaction between DCPIP and sulphite; if a little surprising
as the addition of sulphite was predicted to move ?imax to a shorter
wavelength because the double bonds will no longer be in resonance. In
Future work will involve using nuclear magnetic resonance spectroscopy to
investigate compound P, the product of the reaction between DCPIP and
equimolar sulphite.
A.2.3 The formation of a charge transfer complex
Quinones are reduced by the addition of 2 electrons to a quinol via a
semiquinone radical (Figure A.10). This occurs in photosynthesis when
plastoquinone is reduced to plastoquinol, and in oxidative phosphorylation
when ubiquinone is reduced to ubiquinol. Charge transfer complexes can
form between semiquinones. The formation of a charge transfer complex
causes a shift of the kmax of the quinone to a longer wavelength.
DCPIP has a quinone ring. It seemed possible that the first mole of
sulphite is involved in a single electron transfer reduction to give
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semiquinones capable of forming charge transfer complexes, which would
explain the shift of Xmax (Section A.1). However, this would seem unlikely
because the formation of a charge transfer complex would be reversed by
oxidation with potassium ferricyanide.
The ability of DCPIP to form charge transfer complexes was
investigated. Sodium borohydride solution (approximately 20mM) was
added dropwise to 5ml of 0.2mM DCPIP in 0.05M sodium phosphate buffer,
pH 8.0 until the DCPIP had been completely bleached. A further 5ml of
0.2mM DCPIP solution was added to the bleached solution and incubated at
37°C for 2 hours. The ^.max of the solution of DCPIP after 2 hours was
605nm therefore DCPIP does not appear to form charge transfer complexes.
A.3 Concluding remarks about the reaction between DCPIP
and sulphite
The ^.max of DCPIP is moved to a longer wavelength during reaction
with an equimolar amount of sulphite. The addition of further sulphite to the
reaction mixture causes a decline of the absorbance at the new Xmax. The
possible mechanisms for this reaction were investigated. The displacement
of the chlorides of DCPIP with sulphite and the formation of charge transfer
complexes were eliminated, but no satisfactory explanation was produced.
Further investigations by nuclear magnetic resonance spectroscopy will be
performed in the future in an attempt to provide a satisfactory explanation for
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